Presenting Author: Shia T. Kent, PhD – Amgen
### @@@ David Pritchard, PhD, MS – Target RWE ### 1991703###Co-Author###Director, Data Management and Statistics###Target RWE###Co-Author: David Pritchard, PhD, MS – Target RWE
### @@@ Sam S. Oh, PhD, MPH – Amgen ### 1991704###Co-Author###Observational Research Director###Amgen###Co-Author: Sam S. Oh, PhD, MPH – Amgen
### @@@ Robert Urman, PhD – Amgen ### 1359004###Co-Author######Amgen###Co-Author: Robert Urman, PhD – Amgen
### @@@ Paul Muntner, PhD, MHS – University of Alabama at Birmingham, Department of Epidemiology ### 1991705###Co-Author###Professor of Epidemiology and Associate Dean for Research###University of Alabama at Birmingham, Department of Epidemiology###Co-Author: Paul Muntner, PhD, MHS – University of Alabama at Birmingham, Department of Epidemiology
### @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Co-Author###Director of Observational Research###Amgen, Inc.###Co-Author: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ M Alan Brookhart, PhD – Duke University ### 1991706###Co-Author###Professor###Duke University###Co-Author: M Alan Brookhart, PhD – Duke University
###Co-Author: Ximena A. Oyarzun-Gonzalez, Ms, PhD, Pharm (she/her/hers) – Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Ohio, USA
### she/her/hers @@@ Erin L. Abner, MS, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA ### 1358491###Co-Author###Associate Professor###Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA###Co-Author: Erin L. Abner, MS, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA
### @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Presenting Author###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###Presenting Author: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hers @@@ Anna M. Kucharska-Newton – Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA ### 1358492###Co-Author######Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA###Co-Author: Anna M. Kucharska-Newton – Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA
### @@@ Patricia R. Freeman, RPh, PhD – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA ### 1656010###Co-Author###Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA###Co-Author: Patricia R. Freeman, RPh, PhD – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA
### @@@ David W. Fardo, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA ### 1659924###Co-Author###Professor###Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA###Co-Author: David W. Fardo, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA
###Co-Author: Mikkel Zöllner Ankarfeldt – Copenhagen Phase IV unit, (Phase4CPH), Department of Clinical Pharmacology, and Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
### @@@ Aleksander Søltoft-Jensen – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1991669###Co-Author######Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###Co-Author: Aleksander Søltoft-Jensen – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Karoline Doser – MedEngine. Helsinki. Finland ### 1991671###Co-Author######MedEngine. Helsinki. Finland###Co-Author: Karoline Doser – MedEngine. Helsinki. Finland
### @@@ Eero Pukkala – Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland ### 1991672###Co-Author######Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland###Co-Author: Eero Pukkala – Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland
### @@@ Kristian Bolin – Department of Economics. Centre for Health Governance . University of Gothenburg. ### 1991673###Co-Author######Department of Economics. Centre for Health Governance . University of Gothenburg.###Co-Author: Kristian Bolin – Department of Economics. Centre for Health Governance . University of Gothenburg.
### @@@ Janne Petersen, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1655556###Co-Author######Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###Co-Author: Janne Petersen, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Espen Jimenez-Solem, MD, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1093553###Co-Author###Chief Physician###Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###Co-Author: Espen Jimenez-Solem, MD, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Marius M. Flege, MD (he/him/his) – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1991670###Presenting Author###Pharmacoepidemiologist###Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###Presenting Author: Marius M. Flege, MD (he/him/his) – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### he/him/hisPresenting Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
### @@@ Elvira D'Andrea – AbbVie ### 1991594###Co-Author######AbbVie###Co-Author: Elvira D'Andrea – AbbVie
### @@@ William B. Feldman, MD, DPhil, MPH – Brigham and Women's Hospital ### 1991429###Co-Author###Instructor###Brigham and Women's Hospital###Co-Author: William B. Feldman, MD, DPhil, MPH – Brigham and Women's Hospital
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Jun Liu – Brigham and Women’s Hospital ### 1659307###Co-Author######Brigham and Women’s Hospital###Co-Author: Jun Liu – Brigham and Women’s Hospital
### @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Elyse C. Dicesare, BA – Brigham and Women's Hospital ### 1991353###Co-Author###Research Assistant###Brigham and Women's Hospital###Co-Author: Elyse C. Dicesare, BA – Brigham and Women's Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Co-Author: Sanaa Bahmane – F. Hoffmann-LaRoche Ltd
### @@@ Chris Harbron – F. Hoffmann-LaRoche Ltd ### 1359031###Co-Author######F. Hoffmann-LaRoche Ltd###Co-Author: Chris Harbron – F. Hoffmann-LaRoche Ltd
### @@@ Devin Incerti – Entityrisk ### 1991659###Co-Author######Entityrisk###Co-Author: Devin Incerti – Entityrisk
### @@@ Michael Bretscher, MSc, PhD – F. Hoffmann-LaRoche Ltd ### 1063200###Presenting Author###Principal Data Scientist###F. Hoffmann-LaRoche Ltd###Presenting Author: Michael Bretscher, MSc, PhD – F. Hoffmann-LaRoche Ltd
###Presenting Author: Wilhelmina E. Hoogendoorn, PhD – IQVIA
### @@@ Héctor Sanz – IQVIA ### 1991545###Co-Author######IQVIA###Co-Author: Héctor Sanz – IQVIA
### @@@ Chantal Quinten – European Medicines Agency ### 1657379###Co-Author######European Medicines Agency###Co-Author: Chantal Quinten – European Medicines Agency
### @@@ Joan Largent, MPH, PhD – IQVIA ### 1062674###Co-Author###Senior Director, Epidemiology###IQVIA###Co-Author: Joan Largent, MPH, PhD – IQVIA
### @@@ Gerd Rippin, PhD – IQVIA ### 1991546###Co-Author###Senior Director, Biostatistics###IQVIA###Co-Author: Gerd Rippin, PhD – IQVIA
###Co-Author: Natalie Tikhonovsky, MSc – Health Analytics, Lane Clark & Peacock LLP
### @@@ Florence Ma, MSc, MClinPharm, BCPS – Health Analytics, Lane Clark & Peacock LLP ### 1991355###Presenting Author###Analyst###Health Analytics, Lane Clark & Peacock LLP###Presenting Author: Florence Ma, MSc, MClinPharm, BCPS – Health Analytics, Lane Clark & Peacock LLP
### @@@ Danielle E. Robinson, PhD (she/her/hers) – Health Analytics, Lane Clark & Peacock LLP ### 1655390###Co-Author###Epidemiologist###Health Analytics, Lane Clark & Peacock LLP###Co-Author: Danielle E. Robinson, PhD (she/her/hers) – Health Analytics, Lane Clark & Peacock LLP
### she/her/hers @@@ Jonathan Pearson-Stuttard, BMBCh, PhD, FRSPH, FFPH – Health Analytics, Lane Clark & Peacock LLP ### 1655397###Co-Author######Health Analytics, Lane Clark & Peacock LLP###Co-Author: Jonathan Pearson-Stuttard, BMBCh, PhD, FRSPH, FFPH – Health Analytics, Lane Clark & Peacock LLP
### @@@ Benjamin D Bray – Health Analytics, Lane Clark & Peacock LLP ### 1655391###Co-Author###Principal###Health Analytics, Lane Clark & Peacock LLP###Co-Author: Benjamin D Bray – Health Analytics, Lane Clark & Peacock LLP
###Presenting Author: Kelly M. Bryan, PharmD (she/her/hers) – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### she/her/hers @@@ Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659732###Co-Author###Graduate Student###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Diane Dong, MPH, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1655510###Co-Author######Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###Co-Author: Diane Dong, MPH, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### @@@ Rong Jiang, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1991597###Co-Author######Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###Co-Author: Rong Jiang, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### @@@ Jennifer Martin, Pharm.D., BCPP – Veterans Affairs Pharmacy Benefits Management ### 1657519###Co-Author###Deputy Chief Consultant, PBM###Veterans Affairs Pharmacy Benefits Management###Co-Author: Jennifer Martin, Pharm.D., BCPP – Veterans Affairs Pharmacy Benefits Management
### @@@ Fran Cunningham, PharmD – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1655509###Co-Author###Director, Center for Medication Safety###Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###Co-Author: Fran Cunningham, PharmD – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
###Co-Moderator: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Co-Moderator###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###Co-Moderator: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
###Presenting Author: Sudhir Venkatesan, MPH, PhD – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics
### @@@ Jonatan Hedberg – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden ### 1991547###Co-Author######Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden###Co-Author: Jonatan Hedberg – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
### @@@ Carla A. Talarico, PhD – Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca ### 1991256###Co-Author######Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca###Co-Author: Carla A. Talarico, PhD – Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca
### @@@ Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden ### 1358658###Co-Author######Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden###Co-Author: Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden
###Presenting Author: Deesha A. Patel, MS (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Victoria Cooley – Aetion, Inc. ### 1991444###Co-Author######Aetion, Inc.###Co-Author: Victoria Cooley – Aetion, Inc.
### @@@ Christopher Bush, MPH (he/him/his) – Aetion, Inc. ### 1655850###Co-Author###Sr. Scientist ###Aetion, Inc.###Co-Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Katherine E. Mues – Aetion, Inc. ### 1655854###Co-Author######Aetion, Inc.###Co-Author: Katherine E. Mues – Aetion, Inc.
### @@@ Rebecca Taylor – Aetion, Inc. ### 1991448###Co-Author######Aetion, Inc.###Co-Author: Rebecca Taylor – Aetion, Inc.
### @@@ Sahar Syed – Aetion, Inc. ### 1397917###Co-Author###Scientific Analyst###Aetion, Inc.###Co-Author: Sahar Syed – Aetion, Inc.
### @@@ Shaina Desai, MPH – Aetion, Inc. ### 1991445###Co-Author######Aetion, Inc.###Co-Author: Shaina Desai, MPH – Aetion, Inc.
### @@@ Pippa Hodgkins – Aetion, Inc. ### 1991447###Co-Author######Aetion, Inc.###Co-Author: Pippa Hodgkins – Aetion, Inc.
### @@@ Brent Arakaki – Aetion, Inc. ### 1991446###Co-Author######Aetion, Inc.###Co-Author: Brent Arakaki – Aetion, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc.
### @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hersLead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam
### @@@ Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Speaker###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Robert Gross, MD, MSCE, FISPE – University of Pennsylvania ### 1086967###Speaker###Professor of Medicine (ID) and Epidemiology###University of Pennsylvania###Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania
###Presenting Author: Adam J. Streeter, PhD – University of Munster, Germany
### @@@ William Henley – University of Exeter ### 1659798###Co-Author######University of Exeter###Co-Author: William Henley – University of Exeter
###Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
### @@@ Katja Taxis, MSc, PhD, FISPE – University of Groningen ### 1086972###Speaker###Professor###University of Groningen###Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
### @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Speaker###Assistant Professor###University of Toronto###Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Speaker###Assistant professor###Syddansk Universitet###Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
###Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company
### she/her/hers @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit ### 1062612###Speaker###Head of Research###Institute of Pharmacovigilance Sciences, Drug Safety Research Unit###Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
### she/her/hers @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Speaker###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/hisLead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
###Co-Author: Aayush Visaria, MD, MPH (he/him/his) – Rutgers Robert Wood Johnson Medical School
### he/him/his @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Presenting Author###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###Presenting Author: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
###Presenting Author: Catherine Wiener, MS (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ M Alan Brookhart, PhD – Duke University ### 1991706###Co-Author###Professor###Duke University###Co-Author: M Alan Brookhart, PhD – Duke University
###Keynote Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Keynote Speaker###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###Keynote Speaker: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ James Vrac, CAE – International Society for Pharmacoepidemiology ### 1668288###Keynote Speaker###Executive Secretary###International Society for Pharmacoepidemiology###Keynote Speaker: James Vrac, CAE – International Society for Pharmacoepidemiology
###Presenting Author: Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1655866###Co-Author###Research Associate###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
###Presenting Author: Viktor H. Ahlqvist, MMsc – Karolinska Institutet
### @@@ Paul Madley-Dowd – University of Bristol ### 1658787###Co-Author######University of Bristol###Co-Author: Paul Madley-Dowd – University of Bristol
### @@@ Harriet Forbes – London School of Hygiene and Tropical Medicine ### 1093522###Co-Author######London School of Hygiene and Tropical Medicine###Co-Author: Harriet Forbes – London School of Hygiene and Tropical Medicine
### @@@ Jessica E. Rast, PhD, MPH – Drexel University ### 1658789###Co-Author######Drexel University###Co-Author: Jessica E. Rast, PhD, MPH – Drexel University
### @@@ Caichen Zhong – Drexel University ### 1659401###Co-Author######Drexel University###Co-Author: Caichen Zhong – Drexel University
### @@@ Michael Lundberg – Karolinska Institutet ### 1658790###Co-Author######Karolinska Institutet###Co-Author: Michael Lundberg – Karolinska Institutet
### @@@ Ciarrah-Jane S. Barry, Bsc – University of Bristol ### 1900244###Co-Author###PhD student###University of Bristol###Co-Author: Ciarrah-Jane S. Barry, Bsc – University of Bristol
### @@@ Florence Z. Martin, MSc (she/her/hers) – University of Bristol ### 1991287###Co-Author###PhD Student###University of Bristol###Co-Author: Florence Z. Martin, MSc (she/her/hers) – University of Bristol
### she/her/hers @@@ Lars Torbjorn Tomson, MD, PhD – Karolinska Institutet ### 1360038###Co-Author######Karolinska Institutet###Co-Author: Lars Torbjorn Tomson, MD, PhD – Karolinska Institutet
### @@@ Daniel Berglind – Karolinska Institutet ### 1658792###Co-Author######Karolinska Institutet###Co-Author: Daniel Berglind – Karolinska Institutet
### @@@ Neil M. Davies, PhD – University of Bristol ### 1658718###Co-Author###Professor of Medical Statistics###University of Bristol###Co-Author: Neil M. Davies, PhD – University of Bristol
### @@@ Kristen Lyall – Drexel University ### 1991488###Co-Author######Drexel University###Co-Author: Kristen Lyall – Drexel University
### @@@ Dheeraj Rai – University of Bristol ### 1658793###Co-Author######University of Bristol###Co-Author: Dheeraj Rai – University of Bristol
### @@@ Cecilia Magnusson – Karolinska Institutet ### 1658794###Co-Author######Karolinska Institutet###Co-Author: Cecilia Magnusson – Karolinska Institutet
### @@@ Brian K. Lee – Drexel University School of Public Health ### 1658795###Co-Author######Drexel University School of Public Health###Co-Author: Brian K. Lee – Drexel University School of Public Health
###Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1991220###Co-Author######Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Author: Bianca Kollhorst – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###Presenting Author: Hannah Johnson, MSc (she/her/hers) – St George's, University of London
### she/her/hers @@@ Joan K. Morris – St George's, University of London, London ### 1900343###Co-Author###Professor###St George's, University of London, London###Co-Author: Joan K. Morris – St George's, University of London, London
###Co-Moderator: Mugdha Gokhale, PhD – Pfizer
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Moderator###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###Co-Moderator: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/hisLead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Elizabeth M. Garry, MPH, PhD – Aetion, Inc. ### 1062756###Speaker###Head of Scientific Research###Aetion, Inc.###Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.
###Presenting Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/his @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Co-Author###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Maria de Ridder – Erasmus University Medical Center ### 1360078###Co-Author######Erasmus University Medical Center###Co-Author: Maria de Ridder – Erasmus University Medical Center
### @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Co-Author###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###Co-Author: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC University###Co-Author: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/hisPresenting Author: Xianying Pan, MS – Bristol Myers Squibb
### @@@ Vishal Kulkarni – Mu Sigma ### 1991431###Co-Author######Mu Sigma###Co-Author: Vishal Kulkarni – Mu Sigma
### @@@ Raminder Pathak – Bristol Myers Squibb ### 1991432###Co-Author######Bristol Myers Squibb###Co-Author: Raminder Pathak – Bristol Myers Squibb
### @@@ Stefano Monda – Bristol Myers Squibb ### 1991433###Co-Author######Bristol Myers Squibb###Co-Author: Stefano Monda – Bristol Myers Squibb
### @@@ Imran Hasan – Bristol Myers Squibb ### 1991434###Co-Author######Bristol Myers Squibb###Co-Author: Imran Hasan – Bristol Myers Squibb
###Presenting Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael C. Doherty, MS – Optum Epidemiology ### 1358137###Co-Author###Principal Epidemiology Analyst###Optum Epidemiology###Co-Author: Michael C. Doherty, MS – Optum Epidemiology
### @@@ Rishav Singla – Optum Global Solutions ### 1991281###Co-Author###Data Analyst###Optum Global Solutions###Co-Author: Rishav Singla – Optum Global Solutions
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
###Presenting Author: Eng Hooi (Cheryl) Tan, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Trishna Rathod-Mistry, PhD – University of Oxford ### 1655337###Co-Author######University of Oxford###Co-Author: Trishna Rathod-Mistry, PhD – University of Oxford
### @@@ Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG ### 1088161###Co-Author###Director TA Methodology Statistician RWE ###Boehringer Ingelheim Pharma GmbH & Co. KG###Co-Author: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
### @@@ James O'Kelly, PhD – Amgen Ltd ### 1655484###Co-Author######Amgen Ltd###Co-Author: James O'Kelly, PhD – Amgen Ltd
### @@@ Francesco Giorgianni – Amgen Ltd ### 1993509###Co-Author######Amgen Ltd###Co-Author: Francesco Giorgianni – Amgen Ltd
### @@@ Richard Baxter – Amgen Ltd ### 1993510###Co-Author######Amgen Ltd###Co-Author: Richard Baxter – Amgen Ltd
### @@@ Alma B. Pedersen, PhD – Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital ### 1062926###Co-Author###Professor###Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital###Co-Author: Alma B. Pedersen, PhD – Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/hisCo-Author: Awa Diop, PhD – Cytel
### @@@ Alind Gupta, PhD – Cytel ### 1991513###Presenting Author###Research Principal###Cytel###Presenting Author: Alind Gupta, PhD – Cytel
### @@@ louis Dron – Cytel ### 1723579###Co-Author######Cytel###Co-Author: louis Dron – Cytel
### @@@ Sabrina Mueller, MSc – Cytel ### 1660161###Co-Author###Research Principal, Senior Director###Cytel###Co-Author: Sabrina Mueller, MSc – Cytel
### @@@ Gerald Smith – Cytel ### 1991514###Co-Author######Cytel###Co-Author: Gerald Smith – Cytel
###Presenting Author: Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Dongwon Yoon, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1063238###Co-Author###Post-doctoral researcher###School of Pharmacy, Sungkyunkwan University, South Korea###Co-Author: Dongwon Yoon, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1063055###Co-Author###Research Professor###School of Pharmacy, Sungkyunkwan University, South Korea###Co-Author: Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital###Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
### @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Ameet Sarpatwari, PHD JD (he/him/his) – Brigham & Womens Hospital/Harvard Medical School ### 1360165###Co-Author###Assistant Professor of Medicine###Brigham & Womens Hospital/Harvard Medical School###Co-Author: Ameet Sarpatwari, PHD JD (he/him/his) – Brigham & Womens Hospital/Harvard Medical School
### he/him/his @@@ Mufaddal Mahesri, MD, MPH (he/him/his) – Brigham and Women's Hospital ### 1655868###Co-Author###Senior Research Specialist###Brigham and Women's Hospital###Co-Author: Mufaddal Mahesri, MD, MPH (he/him/his) – Brigham and Women's Hospital
### he/him/his @@@ Elyse C. Dicesare, BA – Brigham and Women's Hospital ### 1991353###Co-Author###Research Assistant###Brigham and Women's Hospital###Co-Author: Elyse C. Dicesare, BA – Brigham and Women's Hospital
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###Co-Author: Seanna Vine – Brigham and Women's Hospital
### @@@ Helen Mogun – Brigham and Women's Hospital ### 1359929###Co-Author######Brigham and Women's Hospital###Co-Author: Helen Mogun – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Co-Author: Joshua Devine, PharmD, PhD (he/him/his) – Department of Public Health, Des Moines University
### he/him/his @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Co-Author###Assistant Professor###University of Toronto###Co-Author: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Nandita Mukhopadhyay, PhD – University of Pittsburgh ### 1991630###Co-Author###Programmer/Data Analyst###University of Pittsburgh###Co-Author: Nandita Mukhopadhyay, PhD – University of Pittsburgh
### @@@ Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego ### 1658462###Co-Author###Associate Professor###Division of Clinical Pharmacy, University of California San Diego###Co-Author: Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego
### @@@ Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA ### 1358097###Co-Author###Assistant Professor###Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA###Co-Author: Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
### @@@ Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health ### 1655370###Co-Author###Graduate Student###Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health###Co-Author: Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health
### @@@ Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh ### 1360024###Presenting Author###Professor###University of Pittsburgh###Presenting Author: Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh
### she/her/hersPresenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
### @@@ Yongmei Li – Stanford University ### 1991691###Co-Author######Stanford University###Co-Author: Yongmei Li – Stanford University
### @@@ Michelle Odden – Stanford University ### 1655753###Co-Author######Stanford University###Co-Author: Michelle Odden – Stanford University
###Co-Author: Yiyi Xu, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Rickard Ljung – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1657798###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Rickard Ljung – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Anders Sundström, PhD (he/him/his) – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991227###Co-Author###Pharmacoepidemiologist###Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Anders Sundström, PhD (he/him/his) – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### he/him/his @@@ Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659122###Co-Author######Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Ebba Hallberg – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991228###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Ebba Hallberg – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991229###Co-Author######School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Maria Larsson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991230###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Maria Larsson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Veronica Arthurson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991231###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Veronica Arthurson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358955###Co-Author######Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Rolf Gedeborg – Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991232###Co-Author######Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###Co-Author: Rolf Gedeborg – Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Presenting Author###Prof. of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Presenting Author: Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
###Presenting Author: Rong Hua, Mphil – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
### @@@ Chun Sing Lam, BPharm – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong ### 1991457###Co-Author######School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong###Co-Author: Chun Sing Lam, BPharm – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
### @@@ Natural Chu – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991655###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###Co-Author: Natural Chu – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Aimin Yang – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991656###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###Co-Author: Aimin Yang – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Elaine Chow – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991657###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###Co-Author: Elaine Chow – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Yin Ting Cheung, PhD – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong ### 1358352###Co-Author###Assistant Professor###School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong###Co-Author: Yin Ting Cheung, PhD – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
###Presenting Author: Alvi A. Rahman, MSc – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Sophie Dell'Aniello – Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada ### 1359036###Co-Author######Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada###Co-Author: Sophie Dell'Aniello – Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
### @@@ Erica E.M. Moodie – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1397943###Co-Author###Full Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Erica E.M. Moodie – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Madeleine Durand – Department of Medicine, Université de Montréal, Montreal, QC, Canada ### 1359486###Co-Author###Assistant Clinical Professor###Department of Medicine, Université de Montréal, Montreal, QC, Canada###Co-Author: Madeleine Durand – Department of Medicine, Université de Montréal, Montreal, QC, Canada
### @@@ Janie Coulombe, PhD – Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada ### 1991352###Co-Author###Assistant Professor###Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada###Co-Author: Janie Coulombe, PhD – Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada
### @@@ Jean-François Boivin – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1397945###Co-Author###Full Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Jean-François Boivin – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Pierre Ernst – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1655844###Co-Author######Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Pierre Ernst – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358292###Co-Author###Associate Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
###Presenting Author: Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Xin-Yu Fan Jiang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1991620###Co-Author######School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Xin-Yu Fan Jiang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisPresenting Author: Pilar Hernandez-Con, MD, MSCE – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Raj A. Desai, PhD – Analysis Group ### 1063320###Co-Author###PhD candidate###Analysis Group###Co-Author: Raj A. Desai, PhD – Analysis Group
### @@@ Haesuk Park, PhD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1357943###Co-Author###Associate Professor###Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Haesuk Park, PhD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
###Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain ### 1991590###Co-Author######HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain###Co-Author: Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/hisPresenting Author: Hong Yang, PhD – FDA/CBER/OBPV
###Presenting Author: Ayesha C. Sujan, PhD (she/her/hers) – Stanford University
### she/her/hers @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Co-Author######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Co-Author: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School ### 1062604###Co-Author###Research Fellow###Brigham and Women's Hospital/Harvard Medical School###Co-Author: Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1063282###Co-Author###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Co-Moderator: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Co-Moderator###Head of Real World Evidence###European Medicines Agency###Co-Moderator: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
###Lead Speaker: Kieran J. Rothnie, PhD – GSK
### @@@ Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA ### 1359083###Speaker###Chief Epidemiologist and Managing Principal###Analysis Group, Inc., Boston, MA, USA###Speaker: Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA
### she/her/hers @@@ Catherine Cohet, PhD (she/her/hers) – European Medicines Agency ### 1655442###Speaker###Pharmacoepidemiology/RWE Senior Specialist###European Medicines Agency###Speaker: Catherine Cohet, PhD (she/her/hers) – European Medicines Agency
### she/her/hers @@@ Melissa Van Dyke, PhD, MPH – GSK ### 1657832###Speaker###Senior Director and Head, Research Epidemiology###GSK###Speaker: Melissa Van Dyke, PhD, MPH – GSK
### @@@ Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc ### 1991261###Speaker###Vice President###Analysis Group, Inc###Speaker: Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc
### she/her/hers @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Speaker###Professor###London School of Hygiene & Tropical Medicine, London###Speaker: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
###Presenting Author: Yunru (Claire) Huang, MB, MS, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Tianyi Sun – Genentech, Inc. ### 1991305###Co-Author######Genentech, Inc.###Co-Author: Tianyi Sun – Genentech, Inc.
### @@@ Thibaut Sanglier – F. Hoffmann-La Roche Ltd ### 1991215###Co-Author###Senior Principal Data Scientist###F. Hoffmann-La Roche Ltd###Co-Author: Thibaut Sanglier – F. Hoffmann-La Roche Ltd
### @@@ Chiara Lambertini – F. Hoffmann-La Roche Ltd ### 1991307###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Chiara Lambertini – F. Hoffmann-La Roche Ltd
### @@@ Adam Knott – F. Hoffmann-La Roche Ltd ### 1991309###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Adam Knott – F. Hoffmann-La Roche Ltd
### @@@ Yolande Du Toit – Genentech, Inc. ### 1991310###Co-Author######Genentech, Inc.###Co-Author: Yolande Du Toit – Genentech, Inc.
### @@@ Raf Poppe – F. Hoffmann-La Roche Ltd ### 1991311###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Raf Poppe – F. Hoffmann-La Roche Ltd
### @@@ Eleonora Restuccia – F. Hoffmann-La Roche Ltd ### 1991308###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Eleonora Restuccia – F. Hoffmann-La Roche Ltd
### @@@ Sanne de Haas – F. Hoffmann-La Roche Ltd ### 1991312###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Sanne de Haas – F. Hoffmann-La Roche Ltd
### @@@ Patricia Luhn – Genentech, Inc. ### 1358236###Co-Author######Genentech, Inc.###Co-Author: Patricia Luhn – Genentech, Inc.
###Co-Moderator: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
### @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Co-Moderator###Associate Professor###McGill University###Co-Moderator: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/hisPresenting Author: Xinyue Liu, PhD – Merck & Co. Inc.
### @@@ Golnoosh Alipour Haris, MS, PharmD – Center for Drug Evaluation & Safety and the Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL ### 1659947###Co-Author######Center for Drug Evaluation & Safety and the Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL###Co-Author: Golnoosh Alipour Haris, MS, PharmD – Center for Drug Evaluation & Safety and the Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL
### @@@ Changxia Shao – Merck & Co., Inc. ### 1658775###Co-Author######Merck & Co., Inc.###Co-Author: Changxia Shao – Merck & Co., Inc.
### @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Co-Author###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###Co-Author: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Edward A. Bortnichak, Ph.D., M.P.H., MBE – Merck & Co. Inc. ### 1358697###Co-Author###Executive Director, Epidemiology###Merck & Co. Inc.###Co-Author: Edward A. Bortnichak, Ph.D., M.P.H., MBE – Merck & Co. Inc.
### @@@ Sarah Markt – Merck & Co. Inc. ### 1991282###Co-Author######Merck & Co. Inc.###Co-Author: Sarah Markt – Merck & Co. Inc.
### @@@ Thao Vo – Merck & Co. Inc. ### 1991283###Co-Author######Merck & Co. Inc.###Co-Author: Thao Vo – Merck & Co. Inc.
### @@@ Chu-Ling Yu – Merck & Co. Inc ### 1991284###Co-Author###Principal Scientist, Epidemiology###Merck & Co. Inc###Co-Author: Chu-Ling Yu – Merck & Co. Inc
###Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Jessica M. Franklin, PhD (she/her/hers) – Optum Epidemiology ### 1359343###Speaker###Principal Consultant, Real-World Evidence###Optum Epidemiology###Speaker: Jessica M. Franklin, PhD (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC ### 1088317###Speaker###Founder and President###CERobs Consulting, LLC###Speaker: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
### @@@ Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062592###Speaker###Associate Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Speaker: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Speaker###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Speaker: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hersPresenting Author: Salvatore Crisafulli, PharmD – Department of Medicine, University of Verona, Verona, Italy
### @@@ Luca L'Abbate – Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina ### 1658238###Co-Author######Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina###Co-Author: Luca L'Abbate – Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina
### @@@ Andrea Fontana – Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy ### 1658237###Co-Author######Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy###Co-Author: Andrea Fontana – Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
### @@@ Giacomo Vitturi – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 1991550###Co-Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###Co-Author: Giacomo Vitturi – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Daniele Gianfrilli – Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy ### 1991551###Co-Author######Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy###Co-Author: Daniele Gianfrilli – Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
### @@@ Alessia Cozzolino – Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy ### 1991552###Co-Author######Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy###Co-Author: Alessia Cozzolino – Section of Medical Pathophysiology and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
### @@@ Maria Cristina De Martino – Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy ### 1991553###Co-Author######Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy###Co-Author: Maria Cristina De Martino – Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy
### @@@ Gianluca Trifirò, MD, FISPE – Department of Diagnostics and Public Health, University of Verona, Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Department of Diagnostics and Public Health, University of Verona, Verona###Co-Author: Gianluca Trifirò, MD, FISPE – Department of Diagnostics and Public Health, University of Verona, Verona
###Lead Speaker: Andrew Freedman, PhD, FISPE – DHHS/NIH/NICHD
### @@@ Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia ### 1046820###Lead Speaker###Professor###University of British Columbia###Lead Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
### @@@ Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Speaker###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###Speaker: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Wei Zhou, MD, PhD, FISPE (he/him/his) – Eli Lilly and Company ### 1062524###Speaker###Associate Vice President###Eli Lilly and Company###Speaker: Wei Zhou, MD, PhD, FISPE (he/him/his) – Eli Lilly and Company
### he/him/his @@@ Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada ### 1088039###Speaker###Professor###Princess Margaret Cancer Centre, University Health Network, Toronto, Canada###Speaker: Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
### he/him/hisCo-Author: Jimmy Gonzalez – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### @@@ Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1063041###Co-Author###Instructor of Medicine###Rutgers Center for Pharmacoepidemiology and Treatment Science###Co-Author: Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Co-Author###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###Co-Author: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
### @@@ Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Co-Author###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###Co-Author: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Presenting Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Presenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###Presenting Author: Tung Hiu Li, MPhil – The University of Hong Kong
### @@@ Vincent Ka Chun Yan, BPharm – The University of Hong Kong ### 1658570###Co-Author###PhD candidate###The University of Hong Kong###Co-Author: Vincent Ka Chun Yan, BPharm – The University of Hong Kong
### @@@ Wei Kang – The University of Hong Kong ### 1358561###Co-Author######The University of Hong Kong###Co-Author: Wei Kang – The University of Hong Kong
### @@@ Xuxiao Ye, PhD, MSc – The University of Hong Kong ### 1358559###Co-Author######The University of Hong Kong###Co-Author: Xuxiao Ye, PhD, MSc – The University of Hong Kong
### @@@ Aya El Helali, MD, PhD – Department of Clinical Oncology, School of Clinical Medicine, University of Hong Kong ### 1991123###Co-Author###Clinical Assistant Professor###Department of Clinical Oncology, School of Clinical Medicine, University of Hong Kong###Co-Author: Aya El Helali, MD, PhD – Department of Clinical Oncology, School of Clinical Medicine, University of Hong Kong
### @@@ Shing Fung Lee – Department of Radiation Oncology, National University Cancer Institute, Singapore ### 1991124###Co-Author###Associate Consultant###Department of Radiation Oncology, National University Cancer Institute, Singapore###Co-Author: Shing Fung Lee – Department of Radiation Oncology, National University Cancer Institute, Singapore
### @@@ Jessica Shami – The University of Hong Kong ### 1062771###Co-Author######The University of Hong Kong###Co-Author: Jessica Shami – The University of Hong Kong
### @@@ Xue Li, PhD – The University of Hong Kong ### 1358457###Co-Author###Assistant Professor###The University of Hong Kong###Co-Author: Xue Li, PhD – The University of Hong Kong
### @@@ Hei Hang Edmund Yiu, PhD – Department of Pharmacology and Pharmacy, The University of Hong Kong ### 1991125###Co-Author######Department of Pharmacology and Pharmacy, The University of Hong Kong###Co-Author: Hei Hang Edmund Yiu, PhD – Department of Pharmacology and Pharmacy, The University of Hong Kong
### @@@ Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong ### 1358232###Co-Author###Head of Department of Pharmacology and Pharmacy###The University of Hong Kong###Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong
### he/him/his @@@ Esther Wai Yin Chan – The University of Hong Kong ### 1358455###Co-Author######The University of Hong Kong###Co-Author: Esther Wai Yin Chan – The University of Hong Kong
###Co-Author: Morten Schmidt, MD, PhD, DMSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Kasper Bonnesen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University ### 1991650###Presenting Author###Postdoc###Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University###Presenting Author: Kasper Bonnesen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University
### he/him/his @@@ Jakob Kjølby Eika – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1991654###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Jakob Kjølby Eika – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###Presenting Author: Eva-Maria Didden, PhD (she/her/hers) – Janssen
### she/her/hers @@@ Di Lu – Stanford University, Quantitative Science Unit ### 1658231###Co-Author######Stanford University, Quantitative Science Unit###Co-Author: Di Lu – Stanford University, Quantitative Science Unit
### @@@ Haley Hedlin, PhD – Stanford University, Quantitative Science Unit ### 1658233###Co-Author######Stanford University, Quantitative Science Unit###Co-Author: Haley Hedlin, PhD – Stanford University, Quantitative Science Unit
### @@@ Andrew Hsi – Stanford University, Vera Moulton Wall Center ### 1658232###Co-Author######Stanford University, Vera Moulton Wall Center###Co-Author: Andrew Hsi – Stanford University, Vera Moulton Wall Center
### @@@ Monika Brand – Global Epidemiology, Actelion Pharmaceuticals Ltd, Janssen Pharmaceutical Companies of Johnson & Johnson ### 1658234###Co-Author######Global Epidemiology, Actelion Pharmaceuticals Ltd, Janssen Pharmaceutical Companies of Johnson & Johnson###Co-Author: Monika Brand – Global Epidemiology, Actelion Pharmaceuticals Ltd, Janssen Pharmaceutical Companies of Johnson & Johnson
### @@@ Roham T. Zamanian, MD – Stanford University ### 1658236###Co-Author######Stanford University###Co-Author: Roham T. Zamanian, MD – Stanford University
###Presenting Author: Mi-Sook Kim, PhD – Seoul National University Hospital
### @@@ Jeong Pil Choi – Seoul National University College of Medicine ### 1991651###Co-Author######Seoul National University College of Medicine###Co-Author: Jeong Pil Choi – Seoul National University College of Medicine
### @@@ Eunsil Yoon – Institute of Health Policy and Management, Seoul National University Medical Research Center ### 1991652###Co-Author######Institute of Health Policy and Management, Seoul National University Medical Research Center###Co-Author: Eunsil Yoon – Institute of Health Policy and Management, Seoul National University Medical Research Center
### @@@ Joongyub Lee – Seoul National University College of Medicine ### 1660175###Co-Author######Seoul National University College of Medicine###Co-Author: Joongyub Lee – Seoul National University College of Medicine
### @@@ Joung-Ho Rha – Inha University Hospital ### 1991653###Co-Author######Inha University Hospital###Co-Author: Joung-Ho Rha – Inha University Hospital
###Presenting Author: Michael J. Munsell, PhD – Panalgo
### @@@ April Duddy, SM – Panalgo ### 1659257###Co-Author######Panalgo###Co-Author: April Duddy, SM – Panalgo
### @@@ Matthew Lucci, MPH – Panalgo ### 1991707###Co-Author######Panalgo###Co-Author: Matthew Lucci, MPH – Panalgo
### @@@ Tiffany S. Woodworth, MPH, MBA – Panalgo ### 1062696###Co-Author######Panalgo###Co-Author: Tiffany S. Woodworth, MPH, MBA – Panalgo
###Presenting Author: Mayura Shinde, MPH, DrPH – Harvard Pilgrim HealthCare & Harvard Medical School
### @@@ Austin Cosgrove, BS – Department of Population Medicine, Harvard Medical School ### 1655617###Co-Author######Department of Population Medicine, Harvard Medical School###Co-Author: Austin Cosgrove, BS – Department of Population Medicine, Harvard Medical School
### @@@ Jolene Mosley – Harvard Pilgrim Health Care Institute ### 1655461###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Jolene Mosley – Harvard Pilgrim Health Care Institute
### @@@ Maria Kempner, BA – Harvard Pilgrim Health Care Institute ### 1360312###Co-Author###Senior Research Analyst###Harvard Pilgrim Health Care Institute###Co-Author: Maria Kempner, BA – Harvard Pilgrim Health Care Institute
### @@@ Jennifer Lyons – Harvard Pilgrim Health Care Institute ### 1991678###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Jennifer Lyons – Harvard Pilgrim Health Care Institute
### @@@ Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute ### 1991682###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute
### @@@ Emma Hoffman – Harvard Pilgrim Health Care Institute ### 1991684###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Emma Hoffman – Harvard Pilgrim Health Care Institute
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Co-Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1359917###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Ben Wong – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 1655621###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration###Co-Author: Ben Wong – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration ### 1360167###Co-Author###Deputy Director for Safety###US Food and Drug Administration###Co-Author: Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359918###Co-Author######Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration###Co-Author: Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Susan Andrade – University of Massachusetts Chan Medical School, Worcester, MA USA ### 1655616###Co-Author######University of Massachusetts Chan Medical School, Worcester, MA USA###Co-Author: Susan Andrade – University of Massachusetts Chan Medical School, Worcester, MA USA
### @@@ Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 1358101###Co-Author######Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###Co-Author: Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ Wei Hua, MSc, MHS, MD, PhD – Division of Epidemiology I, Office of Surveillance and Epidemiology, CDERR, FDA ### 1358275###Co-Author###Deputy Division Director###Division of Epidemiology I, Office of Surveillance and Epidemiology, CDERR, FDA###Co-Author: Wei Hua, MSc, MHS, MD, PhD – Division of Epidemiology I, Office of Surveillance and Epidemiology, CDERR, FDA
###Presenting Author: Erwan Muros-Le Rouzic, MPH – F. Hoffmann-La Roche Ltd
### @@@ Yanic Heer – PricewaterhouseCoopers AG ### 1991217###Co-Author######PricewaterhouseCoopers AG###Co-Author: Yanic Heer – PricewaterhouseCoopers AG
### @@@ Sean Yiu – Roche Products Limited ### 1991218###Co-Author######Roche Products Limited###Co-Author: Sean Yiu – Roche Products Limited
### @@@ Viola Tozzi – PricewaterhouseCoopers AG ### 1991219###Co-Author######PricewaterhouseCoopers AG###Co-Author: Viola Tozzi – PricewaterhouseCoopers AG
### @@@ Stefan Braune – NeuroTransData GmbH ### 1991221###Co-Author######NeuroTransData GmbH###Co-Author: Stefan Braune – NeuroTransData GmbH
### @@@ Philip van Hövell – PricewaterhouseCoopers AG ### 1991222###Co-Author######PricewaterhouseCoopers AG###Co-Author: Philip van Hövell – PricewaterhouseCoopers AG
### @@@ Arnfin Bergmann – NeuroTransData GmbH ### 1991223###Co-Author######NeuroTransData GmbH###Co-Author: Arnfin Bergmann – NeuroTransData GmbH
### @@@ Corrado Bernasconi – F. Hoffmann-La Roche Ltd ### 1991224###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Corrado Bernasconi – F. Hoffmann-La Roche Ltd
### @@@ Fabian Model, PhD – F. Hoffmann-La Roche Ltd ### 1991225###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Fabian Model, PhD – F. Hoffmann-La Roche Ltd
### @@@ Licinio Craveiro – F. Hoffmann-La Roche Ltd ### 1658169###Co-Author######F. Hoffmann-La Roche Ltd###Co-Author: Licinio Craveiro – F. Hoffmann-La Roche Ltd
###Presenting Author: Yue Cheng, PhD – Institution of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky
### @@@ Chris Delcher, PhD – Department of Pharmacy Practice & Science, College of Pharmacy, University of Kentucky ### 1358837###Co-Author###Associate Professor###Department of Pharmacy Practice & Science, College of Pharmacy, University of Kentucky###Co-Author: Chris Delcher, PhD – Department of Pharmacy Practice & Science, College of Pharmacy, University of Kentucky
### @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Co-Author###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###Co-Author: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hers @@@ Bin Huang, DrPH – University of Kentucky ### 1359807###Co-Author###Professor###University of Kentucky###Co-Author: Bin Huang, DrPH – University of Kentucky
### @@@ Val Adams, PharmD – Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky ### 1359803###Co-Author######Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky###Co-Author: Val Adams, PharmD – Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky
###Co-Author: Tracey G. Simon, MD, MPH – Massachusetts General Hospital
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Julianna Mastrorilli – Brigham and Women’s Hospital ### 1659305###Co-Author######Brigham and Women’s Hospital###Co-Author: Julianna Mastrorilli – Brigham and Women’s Hospital
### @@@ Alexander Cervone – Brigham and Women’s Hospital ### 1991377###Co-Author######Brigham and Women’s Hospital###Co-Author: Alexander Cervone – Brigham and Women’s Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Presenting Author: Hsin-Yi Huang, PhD, BCCCP (she/her/hers) – School of Pharmacy, National Taiwan University, Taipei, Taiwan
### she/her/hers @@@ Chi-Chuan Wang, PhD – School of Pharmacy, National Taiwan University, Taipei, Taiwan ### 1063211###Co-Author###Associate Professor###School of Pharmacy, National Taiwan University, Taipei, Taiwan###Co-Author: Chi-Chuan Wang, PhD – School of Pharmacy, National Taiwan University, Taipei, Taiwan
### @@@ Chung-Hsuen Wu, PhD – School of Pharmacy, Taipei Medical University, Taipei, Taiwan ### 1991450###Co-Author###Professor###School of Pharmacy, Taipei Medical University, Taipei, Taiwan###Co-Author: Chung-Hsuen Wu, PhD – School of Pharmacy, Taipei Medical University, Taipei, Taiwan
###Presenting Author: William B. Feldman, MD, DPhil, MPH – Brigham and Women's Hospital
### @@@ Aaron S. Kesselheim – Brigham and Women's Hospital/Harvard Medical School ### 1655646###Co-Author######Brigham and Women's Hospital/Harvard Medical School###Co-Author: Aaron S. Kesselheim – Brigham and Women's Hospital/Harvard Medical School
### @@@ Jerry Avorn, MD – Harvard Medical School ### 1991385###Co-Author###Professor of Medicine###Harvard Medical School###Co-Author: Jerry Avorn, MD – Harvard Medical School
### @@@ Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991331###Co-Author###Instructor###Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hersCo-Author: Tracey G. Simon, MD, MPH – Massachusetts General Hospital
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Julianna Mastrorilli – Brigham and Women’s Hospital ### 1659305###Co-Author######Brigham and Women’s Hospital###Co-Author: Julianna Mastrorilli – Brigham and Women’s Hospital
### @@@ Alexander Cervone – Brigham and Women’s Hospital ### 1991377###Co-Author######Brigham and Women’s Hospital###Co-Author: Alexander Cervone – Brigham and Women’s Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Presenting Author: Katie R. Mollan, MS (she/her/hers) – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Daniel Westreich – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1358642###Co-Author######Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Daniel Westreich – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Brian W. Pence, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1359480###Co-Author###Professor###Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Brian W. Pence, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Agatha Bula – UNC Project-Malawi, Lilongwe, Malawi ### 1991206###Co-Author######UNC Project-Malawi, Lilongwe, Malawi###Co-Author: Agatha Bula – UNC Project-Malawi, Lilongwe, Malawi
### @@@ Clara Lemani – UNC Project-Malawi, Lilongwe, Malawi ### 1991207###Co-Author######UNC Project-Malawi, Lilongwe, Malawi###Co-Author: Clara Lemani – UNC Project-Malawi, Lilongwe, Malawi
### @@@ John Chapola – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1991208###Co-Author######Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: John Chapola – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Jennifer Winston – School of Medicine, University of North Carolina at Chapel Hill ### 1991209###Co-Author######School of Medicine, University of North Carolina at Chapel Hill###Co-Author: Jennifer Winston – School of Medicine, University of North Carolina at Chapel Hill
### @@@ Karen Diepstra, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1991205###Co-Author###PhD student###Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Karen Diepstra, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Jill Hagey – School of Medicine, University of North Carolina at Chapel Hill ### 1991254###Co-Author######School of Medicine, University of North Carolina at Chapel Hill###Co-Author: Jill Hagey – School of Medicine, University of North Carolina at Chapel Hill
### @@@ Sam Phiri – The Lighthouse Trust, Lilongwe, Malawi ### 1991210###Co-Author######The Lighthouse Trust, Lilongwe, Malawi###Co-Author: Sam Phiri – The Lighthouse Trust, Lilongwe, Malawi
### @@@ Jane Chiwoko – The Lighthouse Trust, Lilongwe, Malawi ### 1991255###Co-Author######The Lighthouse Trust, Lilongwe, Malawi###Co-Author: Jane Chiwoko – The Lighthouse Trust, Lilongwe, Malawi
### @@@ Mina Hosseinipour – School of Medicine, University of North Carolina at Chapel Hill ### 1991211###Co-Author######School of Medicine, University of North Carolina at Chapel Hill###Co-Author: Mina Hosseinipour – School of Medicine, University of North Carolina at Chapel Hill
### @@@ Michael Hudgens, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1358428###Co-Author###Professor and Associate Chair###Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Michael Hudgens, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Mackenzie Cottrell – School of Pharmacy, University of North Carolina at Chapel Hill ### 1991212###Co-Author######School of Pharmacy, University of North Carolina at Chapel Hill###Co-Author: Mackenzie Cottrell – School of Pharmacy, University of North Carolina at Chapel Hill
### @@@ Jennifer Tang – School of Medicine, University of North Carolina at Chapel Hill ### 1991213###Co-Author######School of Medicine, University of North Carolina at Chapel Hill###Co-Author: Jennifer Tang – School of Medicine, University of North Carolina at Chapel Hill
###Presenting Author: Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Chih-Ying Tsai – Taiwan Drug Relief Foundation ### 1991541###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Chih-Ying Tsai – Taiwan Drug Relief Foundation
### @@@ Hsun-Yin Liang – Taiwan Drug Relief Foundation ### 1991619###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Hsun-Yin Liang – Taiwan Drug Relief Foundation
### @@@ Chih-Wan Lin – Taiwan Drug Relief Foundation ### 1991543###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Chih-Wan Lin – Taiwan Drug Relief Foundation
### @@@ Wei-I Huang – Taiwan Drug Relief Foundation ### 1360456###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Wei-I Huang – Taiwan Drug Relief Foundation
### @@@ Pi-Hui Chao – Taiwan Drug Relief Foundation ### 1360457###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Pi-Hui Chao – Taiwan Drug Relief Foundation
### @@@ Wen-Wen Chen – Taiwan Drug Relief Foundation ### 1360458###Co-Author######Taiwan Drug Relief Foundation###Co-Author: Wen-Wen Chen – Taiwan Drug Relief Foundation
### @@@ Meng-Yu Weng, MD, PhD – National Cheng Kung University Hospital-Department of Internal Medicine Division of Allergy Immunology and Rheumatology ### 1991649###Co-Author######National Cheng Kung University Hospital-Department of Internal Medicine Division of Allergy Immunology and Rheumatology###Co-Author: Meng-Yu Weng, MD, PhD – National Cheng Kung University Hospital-Department of Internal Medicine Division of Allergy Immunology and Rheumatology
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisPresenting Author: Jill E. Lavigne, PhD (she/her/hers) – St John Fisher University/Department of Veteran Affairs
### she/her/hers @@@ Kwan Hur, PhD – University of Chicago ### 1991611###Co-Author######University of Chicago###Co-Author: Kwan Hur, PhD – University of Chicago
### @@@ J. John Mann, MD, PhD – Columbia University ### 1991612###Co-Author######Columbia University###Co-Author: J. John Mann, MD, PhD – Columbia University
### @@@ Robert D. Gibbons, PhD – University of Chicago ### 1655958###Co-Author###Blum-Riese Professor###University of Chicago###Co-Author: Robert D. Gibbons, PhD – University of Chicago
###Presenting Author: Anne M. Butler, PhD, MS (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655835###Co-Author###Sr. programmer analyst###Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ John M. Sahrmann, MA – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1360452###Co-Author######Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: John M. Sahrmann, MA – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### @@@ Margaret A. Olsen, PhD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655837###Co-Author######Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Margaret A. Olsen, PhD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### @@@ Elizabeth A. Neuner, PharmD – Department of Pharmacy, Barnes-Jewish Hospital ### 1991271###Co-Author######Department of Pharmacy, Barnes-Jewish Hospital###Co-Author: Elizabeth A. Neuner, PharmD – Department of Pharmacy, Barnes-Jewish Hospital
### @@@ Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655836###Co-Author######Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
###Presenting Author: Mennatullah Hasan, PharmD – University of Rhode Island
### @@@ Todd Brothers, Pharm D, BCCCP, BCPS – University of Rhode Island College of Pharmacy ### 1657630###Co-Author###Clinical Assistant Professor of Pharmacy Practice###University of Rhode Island College of Pharmacy###Co-Author: Todd Brothers, Pharm D, BCCCP, BCPS – University of Rhode Island College of Pharmacy
### @@@ Kristina Ward, PharmD, BCPS – University of Rhode Island ### 1359533###Co-Author###Clinical Professor and Vice Chair of Pharmacy Practice###University of Rhode Island###Co-Author: Kristina Ward, PharmD, BCPS – University of Rhode Island
### @@@ Xuerong Wen, PhD – University of Rhode Island ### 1062526###Co-Author###Assistant Professor###University of Rhode Island###Co-Author: Xuerong Wen, PhD – University of Rhode Island
###Presenting Author: Sophia R. Newcomer, PhD, MPH (she/her/hers) – University of Montana Center for Population Health Research
### she/her/hers @@@ Sarah Michels, MPH – University of Montana Center for Population Health Research ### 1991575###Co-Author###Epidemiology Specialist###University of Montana Center for Population Health Research###Co-Author: Sarah Michels, MPH – University of Montana Center for Population Health Research
### @@@ Alexandria N. Albers, MPH, MS – University of Montana ### 1991576###Co-Author###Graduate Research Assistant###University of Montana###Co-Author: Alexandria N. Albers, MPH, MS – University of Montana
### @@@ Rain E. Freeman – University of South Florida ### 1991577###Co-Author######University of South Florida###Co-Author: Rain E. Freeman – University of South Florida
### @@@ Christina L. Clarke, MS – Kaiser Permanente Colorado Institute for Health Research ### 1991578###Co-Author###Biostatistician III###Kaiser Permanente Colorado Institute for Health Research###Co-Author: Christina L. Clarke, MS – Kaiser Permanente Colorado Institute for Health Research
### @@@ Matthew Daley, MD – Kaiser Permanente Colorado ### 1660998###Co-Author######Kaiser Permanente Colorado###Co-Author: Matthew Daley, MD – Kaiser Permanente Colorado
### @@@ Jason M. Glanz, PhD, MS – Institute for Health Research, Kaiser Permanente ### 1655767###Co-Author###Senior Research Investigator###Institute for Health Research, Kaiser Permanente###Co-Author: Jason M. Glanz, PhD, MS – Institute for Health Research, Kaiser Permanente
###Presenting Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ David Merola – Aetion, Inc ### 1991593###Co-Author######Aetion, Inc###Co-Author: David Merola – Aetion, Inc
### @@@ Yinzhu Jin, MPH (she/her/hers) – Brigham and Women's Hospital ### 1062667###Co-Author###Research Specialist###Brigham and Women's Hospital###Co-Author: Yinzhu Jin, MPH (she/her/hers) – Brigham and Women's Hospital
### she/her/hers @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Joyce Lii – Brigham and Women’s Hospital ### 1991502###Co-Author######Brigham and Women’s Hospital###Co-Author: Joyce Lii – Brigham and Women’s Hospital
### @@@ Jun Liu – Brigham and Women’s Hospital ### 1659307###Co-Author######Brigham and Women’s Hospital###Co-Author: Jun Liu – Brigham and Women’s Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Presenting Author: Stephen S. Johnston, PhD – Johnson & Johnson
### @@@ Pranjal Tewari, BE – Mu Sigma ### 1655748###Co-Author######Mu Sigma###Co-Author: Pranjal Tewari, BE – Mu Sigma
### @@@ Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson ### 1088172###Co-Author###VP, MedTech Epidemiology and Real-World Data Sciences###Office of the Chief Medical Officer, Johnson & Johnson###Co-Author: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
###Presenting Author: Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Songhee Kim – School of Pharmacy, Sungkyunkwan University, South Korea ### 1991644###Co-Author######School of Pharmacy, Sungkyunkwan University, South Korea###Co-Author: Songhee Kim – School of Pharmacy, Sungkyunkwan University, South Korea
### @@@ Seok Jin Kim, MD, PhD – Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea ### 1991645###Co-Author###Professor###Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea###Co-Author: Seok Jin Kim, MD, PhD – Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc.
### @@@ Samantha St Laurent – Moderna, Inc. ### 1991173###Co-Author######Moderna, Inc.###Co-Author: Samantha St Laurent – Moderna, Inc.
### @@@ Vaishali Khamamkar – Moderna, Inc. ### 1991451###Co-Author######Moderna, Inc.###Co-Author: Vaishali Khamamkar – Moderna, Inc.
### @@@ Walter Straus – Moderna, Inc. ### 1991452###Co-Author######Moderna, Inc.###Co-Author: Walter Straus – Moderna, Inc.
### @@@ Veronica Urdaneta – Moderna, Inc. ### 1991216###Co-Author######Moderna, Inc.###Co-Author: Veronica Urdaneta – Moderna, Inc.
### @@@ Magalie Emilebacker – Moderna, Inc. ### 1991174###Co-Author######Moderna, Inc.###Co-Author: Magalie Emilebacker – Moderna, Inc.
### @@@ Katherine E. Mues – Aetion, Inc. ### 1655854###Co-Author######Aetion, Inc.###Co-Author: Katherine E. Mues – Aetion, Inc.
### @@@ Christopher Bush, MPH (he/him/his) – Aetion, Inc. ### 1655850###Co-Author###Sr. Scientist ###Aetion, Inc.###Co-Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hersPresenting Author: Michael Andrew Webster-Clark, PharmD, PhD – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health
### @@@ Jessie Edwards, PhD MSPH – University of North Carolina ### 1358533###Co-Author######University of North Carolina###Co-Author: Jessie Edwards, PhD MSPH – University of North Carolina
### @@@ Rachael Ross – University of North Carolina ### 1991596###Co-Author######University of North Carolina###Co-Author: Rachael Ross – University of North Carolina
###Presenting Author: Jordan Guillot, PharmD, PhD (he/him/his) – Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, 06516, USA
### he/him/his @@@ Amy C. Justice, MD, PhD – VA Connecticut Healthcare System ### 1360015###Co-Author######VA Connecticut Healthcare System###Co-Author: Amy C. Justice, MD, PhD – VA Connecticut Healthcare System
### @@@ Kirsha Gordon – VA Connecticut Healthcare System, West Haven, CT, 06516, USA ### 1991618###Co-Author######VA Connecticut Healthcare System, West Haven, CT, 06516, USA###Co-Author: Kirsha Gordon – VA Connecticut Healthcare System, West Haven, CT, 06516, USA
### @@@ Melissa Skanderson, MSW – Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, 06516, USA ### 1360003###Co-Author###Data Scientist###Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, 06516, USA###Co-Author: Melissa Skanderson, MSW – Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, 06516, USA
### @@@ Antoine Pariente, MD, PhD – Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France ### 1358005###Co-Author######Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France###Co-Author: Antoine Pariente, MD, PhD – Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France
### @@@ Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France ### 1358001###Co-Author######Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France###Co-Author: Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, F-33000 Bordeaux, France
### @@@ Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine ### 1062599###Co-Author###Assistant Professor###London School of Hygiene & Tropical Medicine###Co-Author: Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine
###Co-Moderator: Alec Walker, MD, DrPH (he/him/his) – Harvard TH Chan School of Public Health
### he/him/his @@@ Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit ### 1359017###Co-Moderator###Head of Epidemiology and Research###Drug Safety Research Unit###Co-Moderator: Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit
### he/him/hisPresenting Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
### @@@ SiHyun Cho – Department of Obstetrics and Gynecology, Gangnam Severance Hospital, College of Medicine, Yonsei University ### 1991341###Co-Author######Department of Obstetrics and Gynecology, Gangnam Severance Hospital, College of Medicine, Yonsei University###Co-Author: SiHyun Cho – Department of Obstetrics and Gynecology, Gangnam Severance Hospital, College of Medicine, Yonsei University
### @@@ Jung Ryeol Lee – Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital ### 1991343###Co-Author######Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital###Co-Author: Jung Ryeol Lee – Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital
### @@@ JaeYen Song – Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea ### 1991344###Co-Author######Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea###Co-Author: JaeYen Song – Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea
### @@@ Eunsun Lim, MS – Department of Health Convergence, Ewha Womans University ### 1063363###Co-Author###PhD Student###Department of Health Convergence, Ewha Womans University###Co-Author: Eunsun Lim, MS – Department of Health Convergence, Ewha Womans University
### @@@ Joong Shin Park, MD, PhD – Department of Obstetrics and Gynecology, Seoul National University College of Medicine ### 1991342###Co-Author###Chairman###Department of Obstetrics and Gynecology, Seoul National University College of Medicine###Co-Author: Joong Shin Park, MD, PhD – Department of Obstetrics and Gynecology, Seoul National University College of Medicine
### @@@ Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1660178###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###Co-Author: Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
###Presenting Author: Lisa Lundberg – Department of Microbiology and Immunology, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659122###Co-Author######Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Yiyi Xu, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991226###Co-Author###Researcher###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Yiyi Xu, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Jari Martikainen – Bioinformatics and Data Centre, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991257###Co-Author######Bioinformatics and Data Centre, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Jari Martikainen – Bioinformatics and Data Centre, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Ailiana Santosa – School of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358953###Co-Author######School of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Ailiana Santosa – School of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358955###Co-Author######Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Huiqi Li, PhD (he/him/his) – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659121###Co-Author###Researcher###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Huiqi Li, PhD (he/him/his) – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### he/him/his @@@ Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Co-Author###Prof. of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991229###Co-Author######School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###Co-Author: Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
###Presenting Author: Che-Yuan (Joey) Wu, BSc (he/him/his) – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
### he/him/his @@@ Carina Iskander – ICES, Toronto, Ontario, Canada ### 1991463###Co-Author######ICES, Toronto, Ontario, Canada###Co-Author: Carina Iskander – ICES, Toronto, Ontario, Canada
### @@@ Christa Wang – ICES, Toronto, Ontario, Canada ### 1991473###Co-Author######ICES, Toronto, Ontario, Canada###Co-Author: Christa Wang – ICES, Toronto, Ontario, Canada
### @@@ Lisa Y. Xiong – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada ### 1991474###Co-Author######Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada###Co-Author: Lisa Y. Xiong – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
### @@@ Baiju R. Shah, MD, PhD – ICES, Toronto, Ontario, Canada ### 1302770###Co-Author######ICES, Toronto, Ontario, Canada###Co-Author: Baiju R. Shah, MD, PhD – ICES, Toronto, Ontario, Canada
### @@@ Jodi D. Edwards – University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada ### 1991475###Co-Author######University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada###Co-Author: Jodi D. Edwards – University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada
### @@@ Moira K. Kapral, MD MSc – ICES, Toronto, Ontario, Canada ### 1991476###Co-Author######ICES, Toronto, Ontario, Canada###Co-Author: Moira K. Kapral, MD MSc – ICES, Toronto, Ontario, Canada
### @@@ Nathan Herrmann – Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada ### 1991478###Co-Author######Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada###Co-Author: Nathan Herrmann – Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
### @@@ Krista L. Lanctôt – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada ### 1991484###Co-Author######Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada###Co-Author: Krista L. Lanctôt – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
### @@@ Hugo Cogo-Moreira – Faculty of Education, ICT, and Learning, Østfold University College, Halden, Norway ### 1991485###Co-Author######Faculty of Education, ICT, and Learning, Østfold University College, Halden, Norway###Co-Author: Hugo Cogo-Moreira – Faculty of Education, ICT, and Learning, Østfold University College, Halden, Norway
### @@@ Bradley J. MacIntosh – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada ### 1991486###Co-Author######Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada###Co-Author: Bradley J. MacIntosh – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada
### @@@ Jennifer S. Rabin – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada ### 1991487###Co-Author######Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada###Co-Author: Jennifer S. Rabin – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada
### @@@ Sandra E. Black – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada ### 1991490###Co-Author######Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada###Co-Author: Sandra E. Black – Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada
### @@@ Refik Saskin – ICES, Toronto, Ontario, Canada ### 1991491###Co-Author######ICES, Toronto, Ontario, Canada###Co-Author: Refik Saskin – ICES, Toronto, Ontario, Canada
### @@@ Walter Swardfager – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada ### 1991492###Co-Author######Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada###Co-Author: Walter Swardfager – Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
###Lead Speaker: Amie Goodin, PhD, MPP – University of Florida
### @@@ Vicki Osborne, PhD (she/her/hers) – GW Pharmaceuticals, part of Jazz Pharmaceuticals ### 1991407###Speaker###Associate Director, Pharmacoepidemiology###GW Pharmaceuticals, part of Jazz Pharmaceuticals###Speaker: Vicki Osborne, PhD (she/her/hers) – GW Pharmaceuticals, part of Jazz Pharmaceuticals
### she/her/hers @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Speaker###Director###PEPI Consultancy Limited###Speaker: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Speaker###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###Speaker: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Catherine Cohet, PhD (she/her/hers) – European Medicines Agency ### 1655442###Speaker###Pharmacoepidemiology/RWE Senior Specialist###European Medicines Agency###Speaker: Catherine Cohet, PhD (she/her/hers) – European Medicines Agency
### she/her/hers @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Speaker###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
### @@@ David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration ### 1655443###Speaker###Acting Deputy Director, Office of Pharmacovigilance and Epidemiology###U.S. Food and Drug Administration###Speaker: David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1062523###Speaker###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Speaker: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Simone P. Pinheiro, ScD MSc – AbbVie ### 1991351###Speaker###Head, PECOE/global epi###AbbVie###Speaker: Simone P. Pinheiro, ScD MSc – AbbVie
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Speaker###Chief Scientific Officer###Optum Epidemiology###Speaker: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ K. Arnold Chan, MD, ScD, FISPE – National Taiwan University ### 1358385###Speaker###Professor###National Taiwan University###Speaker: K. Arnold Chan, MD, ScD, FISPE – National Taiwan University
### @@@ Joshua D. Brown, PharmD, PhD – Pfizer, Inc. ### 1062827###Speaker###Associate Professor###Pfizer, Inc.###Speaker: Joshua D. Brown, PharmD, PhD – Pfizer, Inc.
### @@@ Stanley A. Edlavitch, PhD, MA (he/him/his) – UMKC ### 1655662###Speaker###Professor###UMKC###Speaker: Stanley A. Edlavitch, PhD, MA (he/him/his) – UMKC
### he/him/his @@@ Hugh H. Tilson, MD, DrPH – UNC Gillings School of Global Public Health ### 1655663###Speaker###Adjunct Professor###UNC Gillings School of Global Public Health###Speaker: Hugh H. Tilson, MD, DrPH – UNC Gillings School of Global Public Health
###Lead Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Speaker###Assistant professor###Syddansk Universitet###Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
### @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Speaker###Assistant Professor###University of North Carolina at Chapel Hill###Speaker: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute ### 1655998###Speaker###Associate Director###Registry of Senior Australians, South Australian Health and Medical Research Institute###Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute
###Presenting Author: Jeffrey R. Curtis, MD, MS, MPH (he/him/his) – University of Alabama at Birmingham
### he/him/his @@@ Lixia zhang – Scipher Medicine Corporation ### 1991730###Co-Author######Scipher Medicine Corporation###Co-Author: Lixia zhang – Scipher Medicine Corporation
### @@@ Johanna Withers – Scipher Medicine Corporation ### 1991731###Co-Author######Scipher Medicine Corporation###Co-Author: Johanna Withers – Scipher Medicine Corporation
### @@@ Sam Asgarian, MD MBA – Scipher Medicine Corporation ### 1991732###Co-Author###Chief Medical Officer###Scipher Medicine Corporation###Co-Author: Sam Asgarian, MD MBA – Scipher Medicine Corporation
###Lead Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Harriet Dickinson, MPhil, PhD – Gilead ### 1991252###Speaker###RWE Director###Gilead###Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Orla M. Doyle, PhD, BEng – Novartis ### 1088162###Speaker###Director Data Science###Novartis###Speaker: Orla M. Doyle, PhD, BEng – Novartis
### @@@ Dana Y. Teltsch, PhD, MSc – Takeda ### 1088160###Speaker###Global Medical Evidence###Takeda###Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
### @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hersPresenting Author: Kathleen M. Andersen, PhD (she/her/hers) – Pfizer
### she/her/hers @@@ Farid L. Khan – Pfizer ### 1991187###Co-Author######Pfizer###Co-Author: Farid L. Khan – Pfizer
### @@@ Peter W. Park – Pfizer ### 1991188###Co-Author######Pfizer###Co-Author: Peter W. Park – Pfizer
### @@@ Timothy L. Wiemken, PhD – Pfizer ### 1991189###Co-Author###Senior Director, Global Clinical Epidemiology###Pfizer###Co-Author: Timothy L. Wiemken, PhD – Pfizer
### @@@ Birol Emir, PhD – Pfizer Inc ### 1991190###Co-Author######Pfizer Inc###Co-Author: Birol Emir, PhD – Pfizer Inc
### @@@ Deepa Malhotra, MS, MBA – Pfizer ### 1657486###Co-Author###Senior Director, Global RWE Lead, Vaccines###Pfizer###Co-Author: Deepa Malhotra, MS, MBA – Pfizer
### @@@ Tuka Alhanai – Ghamut Corporation ### 1991191###Co-Author######Ghamut Corporation###Co-Author: Tuka Alhanai – Ghamut Corporation
### @@@ Mohammad Ghassemi – Ghamut Corporation ### 1991192###Co-Author######Ghamut Corporation###Co-Author: Mohammad Ghassemi – Ghamut Corporation
### @@@ Leah J. McGrath, PhD – Pfizer ### 1659611###Co-Author###Senior Director, Vaccines RWE###Pfizer###Co-Author: Leah J. McGrath, PhD – Pfizer
###Presenting Author: Elyse M. Miller, MPH (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health ### 1046824###Co-Author###Associate Professor###UNC Chapel Hill Gillings School of Global Public Health###Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hersPresenting Author: Anaïs Havet, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Clara Bouvard, MSc (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991153###Co-Author###Biostatistician###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###Co-Author: Clara Bouvard, MSc (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### she/her/hers @@@ Aurélie Moskal, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991154###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###Co-Author: Aurélie Moskal, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Marc Chanelière, MD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France ### 1991155###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France###Co-Author: Marc Chanelière, MD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France
### @@@ Jérôme Massardier, MD – Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France ### 1991156###Co-Author######Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France###Co-Author: Jérôme Massardier, MD – Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France
### @@@ Bénédicte Lebrun-Vignes, MD – Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France ### 1991157###Co-Author######Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France###Co-Author: Bénédicte Lebrun-Vignes, MD – Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France
### @@@ Annie Pierre E. JONVILLE-BERA, MD – Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France ### 1991158###Co-Author###physician, head of department###Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France###Co-Author: Annie Pierre E. JONVILLE-BERA, MD – Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France
### @@@ Cécile Payet, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 1991159###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###Co-Author: Cécile Payet, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 1991160###Co-Author###Deputy head of the health data department of the Hospices Civils de Lyon###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###Co-Author: Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
###Co-Author: Jenny Alderden – Boise State
### @@@ Jace Johnny – University of Utah ### 1991742###Co-Author######University of Utah###Co-Author: Jace Johnny – University of Utah
### @@@ Andy Wilson, PhD – Parexel ### 1093652###Presenting Author###Head of Innovative RWD Analytics###Parexel###Presenting Author: Andy Wilson, PhD – Parexel
###Lead Speaker: Sina Noshad – Genesis Research
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Speaker###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/his @@@ Asieh Golozar, MD PhD MHS MPH – Odysseus Data Services Inc. ### 1062692###Speaker###VP, Global Head of Data Science ###Odysseus Data Services Inc.###Speaker: Asieh Golozar, MD PhD MHS MPH – Odysseus Data Services Inc.
### @@@ Susan A. Oliveria, ScD, MPH, FISPE – PPD, a part of Thermo Fisher Scientific ### 1991428###Speaker###Vice-President, Global Head Epidemiology and Scientific Affairs###PPD, a part of Thermo Fisher Scientific###Speaker: Susan A. Oliveria, ScD, MPH, FISPE – PPD, a part of Thermo Fisher Scientific
###Presenting Author: Azza Shoaibi, PhD, MPH – Janssen Research & Development
### @@@ Gowtham Rao – Janssen Research & Development ### 1360293###Co-Author######Janssen Research & Development###Co-Author: Gowtham Rao – Janssen Research & Development
### @@@ Joel N. Swerdel, PhD MS MPH (he/him/his) – Janssen Pharmaceuticals, Inc. ### 1659127###Co-Author###Director###Janssen Pharmaceuticals, Inc.###Co-Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Janssen Pharmaceuticals, Inc.
### he/him/his @@@ Ruth Namuyinga – Janssen RND ### 1994081###Co-Author######Janssen RND###Co-Author: Ruth Namuyinga – Janssen RND
### @@@ Santhi Mantravadi – Janssen RND ### 1994083###Co-Author######Janssen RND###Co-Author: Santhi Mantravadi – Janssen RND
### @@@ Brigitte Schaufelberger – Janssen RND ### 1994084###Co-Author######Janssen RND###Co-Author: Brigitte Schaufelberger – Janssen RND
### @@@ Nancy Parker, MD – Janssen RND ### 1994085###Co-Author######Janssen RND###Co-Author: Nancy Parker, MD – Janssen RND
### @@@ Eva De la torre – Janssen RND ### 1994086###Co-Author######Janssen RND###Co-Author: Eva De la torre – Janssen RND
### @@@ Susan Sabol – Janssen RND ### 1994087###Co-Author######Janssen RND###Co-Author: Susan Sabol – Janssen RND
### @@@ Evan Minty, MD MSc – University of Calgary ### 1994080###Co-Author###Clinical Assistant Professor###University of Calgary###Co-Author: Evan Minty, MD MSc – University of Calgary
### @@@ Dmytro Dymshyts – Janssen RND ### 1994088###Co-Author######Janssen RND###Co-Author: Dmytro Dymshyts – Janssen RND
### @@@ Amy Purrington – Janssen RND ### 1994082###Co-Author######Janssen RND###Co-Author: Amy Purrington – Janssen RND
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###Presenting Author: Jonas Walheim, PhD (he/him/his) – Bristol Myers Squibb
### he/him/his @@@ Nives Rombini – Bristol Myers Squibb ### 1991169###Co-Author######Bristol Myers Squibb###Co-Author: Nives Rombini – Bristol Myers Squibb
### @@@ Kim Van Naarden Braun, PhD – Bristol Myers Squibb ### 1991168###Co-Author###Senior Scientific Director###Bristol Myers Squibb###Co-Author: Kim Van Naarden Braun, PhD – Bristol Myers Squibb
###Presenting Author: Paige D. Wartko, PhD, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Sharon Fuller, BA – Kaiser Permanente Washington Health Research Institute ### 1360112###Co-Author###Programmer###Kaiser Permanente Washington Health Research Institute###Co-Author: Sharon Fuller, BA – Kaiser Permanente Washington Health Research Institute
### @@@ Anne M. Butler, PhD, MS (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1062638###Co-Author###Assistant Professor###Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Anne M. Butler, PhD, MS (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ Susan M. Shortreed, PhD, MS – Kaiser Permanente Washington Health Research Institute ### 1360508###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Susan M. Shortreed, PhD, MS – Kaiser Permanente Washington Health Research Institute
### @@@ Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655836###Co-Author######Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### @@@ Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center ### 1359344###Co-Author###Associate Professor###Department of Obstetrics and Gynecology, Vanderbilt University Medical Center###Co-Author: Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center
### @@@ Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655835###Co-Author###Sr. programmer analyst###Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###Co-Author: Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ Sandra McAteer – Department of Epidemiology, University of Washington, Seattle, WA, USA ### 1991533###Co-Author######Department of Epidemiology, University of Washington, Seattle, WA, USA###Co-Author: Sandra McAteer – Department of Epidemiology, University of Washington, Seattle, WA, USA
### @@@ Robin Garcia, MPH – Kaiser Permanente Washington Health Research Institute ### 1991241###Co-Author######Kaiser Permanente Washington Health Research Institute###Co-Author: Robin Garcia, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
###Presenting Author: Samantha B. Shapiro, MSc, BSc – McGill University
### @@@ Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada ### 1397870###Co-Author######The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada###Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###Co-Author: Laurent Azoulay, PhD – McGill University
###Presenting Author: Richeek Pradhan, MD, MS, PhD (he/him/his) – Harvard Medical School and Brigham and Women's Hospital
### he/him/his @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###Co-Author: Laurent Azoulay, PhD – McGill University
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
###Presenting Author: Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Co-Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Eric Wang, PharmD – Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University/ Daiichi Sankyo, Inc.
### @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hers @@@ Stephen Crystal, Ph.D. – Rutgers University ### 1358692###Co-Author###Board of Governors Professor###Rutgers University###Co-Author: Stephen Crystal, Ph.D. – Rutgers University
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Co-Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###Presenting Author: Yinzhu Jin, MPH (she/her/hers) – Brigham and Women's Hospital
### she/her/hers @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Co-Moderator: Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers) – RTI Health Solutions
### she/her/hers @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Moderator###Senior Epidemiologist###Optum Epidemiology###Co-Moderator: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hersCo-Moderator: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Co-Moderator###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Moderator: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/hisPresenting Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/his @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC University###Co-Author: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Maria de Ridder – Erasmus University Medical Center ### 1360078###Co-Author######Erasmus University Medical Center###Co-Author: Maria de Ridder – Erasmus University Medical Center
### @@@ Carlen Reyes Reyes – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1655367###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlen Reyes Reyes – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Talita Duarte-Salles, PhD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991455###Co-Author######Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Talita Duarte-Salles, PhD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Co-Author###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###Co-Author: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Co-Author###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hersCo-Moderator: Ursula Kirchmayer, MPH, FISPE – Department of Epidemiology, Lazio Regional Health Service, Rome
### @@@ Cécile Droz-Perroteau – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France ### 1358269###Co-Moderator######Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France###Co-Moderator: Cécile Droz-Perroteau – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
###Presenting Author: Paula Rios, MD PhD (she/her/hers) – EPI-PHARE
### she/her/hers @@@ Philippe Herlemont – EPI-PHARE ### 1991683###Co-Author######EPI-PHARE###Co-Author: Philippe Herlemont – EPI-PHARE
### @@@ Patricia Fauque – Université Bourgogne Franche-Comté - INSERM UMR1231, Dijon, France ### 1991686###Co-Author######Université Bourgogne Franche-Comté - INSERM UMR1231, Dijon, France###Co-Author: Patricia Fauque – Université Bourgogne Franche-Comté - INSERM UMR1231, Dijon, France
### @@@ Brigitte Lacour – French national registry of childhood cancer ### 1991688###Co-Author######French national registry of childhood cancer###Co-Author: Brigitte Lacour – French national registry of childhood cancer
### @@@ Pierre Jouannet – Université Paris-Cité ### 1991689###Co-Author######Université Paris-Cité###Co-Author: Pierre Jouannet – Université Paris-Cité
### @@@ Alain Weill – EPI-PHARE ### 1358499###Co-Author######EPI-PHARE###Co-Author: Alain Weill – EPI-PHARE
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE
### @@@ Jacqueline Clavel – INSERM U1153 EPICEA université Paris-Cité ### 1991690###Co-Author######INSERM U1153 EPICEA université Paris-Cité###Co-Author: Jacqueline Clavel – INSERM U1153 EPICEA université Paris-Cité
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###Co-Author: Rosemary Dray-Spira – EPI-PHARE
###Presenting Author: Núria Mercadé Besora (she/her/hers) – IDIAP Jordi Gol
### she/her/hers @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360486###Co-Author###PhD student###Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### she/her/hers @@@ Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya ### 1358939###Co-Author###Professor and Researcher###Universitat Politècnica de Catalunya###Co-Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/hisPresenting Author: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/his @@@ Marzan A. Khan, MPH – Brown University School of Public Health ### 1991632###Co-Author######Brown University School of Public Health###Co-Author: Marzan A. Khan, MPH – Brown University School of Public Health
### @@@ Melissa R. Pfeiffer, MPH – Center for Injury Research and Prevention, Children’s Hospital of Philadelphia ### 1991633###Co-Author######Center for Injury Research and Prevention, Children’s Hospital of Philadelphia###Co-Author: Melissa R. Pfeiffer, MPH – Center for Injury Research and Prevention, Children’s Hospital of Philadelphia
### @@@ Seth A. Margolis, PhD – Rhode Island Hospital ### 1991634###Co-Author######Rhode Island Hospital###Co-Author: Seth A. Margolis, PhD – Rhode Island Hospital
### @@@ Brian R. Ott, MD – Rhode Island Hospital ### 1359378###Co-Author######Rhode Island Hospital###Co-Author: Brian R. Ott, MD – Rhode Island Hospital
### @@@ Allison E. Curry, PhD – Center for Injury Research and Prevention, Children’s Hospital of Philadelphia ### 1991635###Co-Author######Center for Injury Research and Prevention, Children’s Hospital of Philadelphia###Co-Author: Allison E. Curry, PhD – Center for Injury Research and Prevention, Children’s Hospital of Philadelphia
### @@@ Nina R. Joyce, PhD – Brown University School of Public Health ### 1991636###Co-Author######Brown University School of Public Health###Co-Author: Nina R. Joyce, PhD – Brown University School of Public Health
###Presenting Author: Edouard L. Fu, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655332###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Dae Kim – Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School ### 1655334###Co-Author######Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School###Co-Author: Dae Kim – Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Julianna Mastrorilli – Brigham and Women’s Hospital ### 1659305###Co-Author######Brigham and Women’s Hospital###Co-Author: Julianna Mastrorilli – Brigham and Women’s Hospital
### @@@ Alexander Cervone – Brigham and Women’s Hospital ### 1991377###Co-Author######Brigham and Women’s Hospital###Co-Author: Alexander Cervone – Brigham and Women’s Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###Presenting Author: Hsin-Yi Huang, PhD, BCCCP (she/her/hers) – School of Pharmacy, National Taiwan University, Taipei, Taiwan
### she/her/hers @@@ Chi-Chuan Wang, PhD – School of Pharmacy, National Taiwan University, Taipei, Taiwan ### 1063211###Co-Author###Associate Professor###School of Pharmacy, National Taiwan University, Taipei, Taiwan###Co-Author: Chi-Chuan Wang, PhD – School of Pharmacy, National Taiwan University, Taipei, Taiwan
### @@@ Yee-Jen Wu, MS – Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan ### 1991453###Co-Author###Clinical Pharmacist###Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan###Co-Author: Yee-Jen Wu, MS – Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan
### @@@ Chien-Chih Wu, MS – Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan ### 1991454###Co-Author###Section head of Emergency Pharmacy###Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan###Co-Author: Chien-Chih Wu, MS – Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan
### @@@ Ling-Ya Huang, MS – School of Pharmacy, National Taiwan University, Taipei, Taiwan ### 1359422###Co-Author###Research Assistant###School of Pharmacy, National Taiwan University, Taipei, Taiwan###Co-Author: Ling-Ya Huang, MS – School of Pharmacy, National Taiwan University, Taipei, Taiwan
###Co-Moderator: Xiaojuan Li, PhD (she/her/hers) – Harvard Medical School
### she/her/hers @@@ Ya-Hui Yu, PhD – Georgia State University ### 1659578###Co-Moderator###Assistant Professor ###Georgia State University###Co-Moderator: Ya-Hui Yu, PhD – Georgia State University
###Co-Moderator: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Moderator###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Moderator: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisPresenting Author: Rachel Ogilvie, PhD, MPH – Optum Epidemiology
### @@@ J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Co-Author###Director, Epidemiology###RTI Health Solutions###Co-Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Yixin Jiao – Acumen, LLC ### 1991146###Co-Author######Acumen, LLC###Co-Author: Yixin Jiao – Acumen, LLC
### @@@ Ron J. Parambi, MBBS, MPH – Optum Epidemiology ### 1991121###Co-Author###Senior Epidemiology Analyst###Optum Epidemiology###Co-Author: Ron J. Parambi, MBBS, MPH – Optum Epidemiology
### @@@ Jie Deng – Optum Epidemiology ### 1991126###Co-Author######Optum Epidemiology###Co-Author: Jie Deng – Optum Epidemiology
### @@@ Michael Miller – Optum Epidemiology ### 1991127###Co-Author######Optum Epidemiology###Co-Author: Michael Miller – Optum Epidemiology
### @@@ Jennifer Song, MA, MURP – Optum Epidemiology ### 1360471###Co-Author###Senior Epidemiology Analyst###Optum Epidemiology###Co-Author: Jennifer Song, MA, MURP – Optum Epidemiology
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Co-Author###Health Statistician###US Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Lisa Weatherby – Optum Epidemiology ### 1991128###Co-Author######Optum Epidemiology###Co-Author: Lisa Weatherby – Optum Epidemiology
### @@@ Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Co-Author###Epidemiologist###Optum Epidemiology###Co-Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Grace Yang – OptumServe ### 1659346###Co-Author######OptumServe###Co-Author: Grace Yang – OptumServe
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Alison Tse Kawai – RTI Health Solutions ### 1095195###Co-Author###Director, Epidemiology###RTI Health Solutions###Co-Author: Alison Tse Kawai – RTI Health Solutions
### @@@ An-Chi Lo – Acumen, LLC ### 1358511###Co-Author######Acumen, LLC###Co-Author: An-Chi Lo – Acumen, LLC
### @@@ Kathryn Matuska, BA – Acumen LLC ### 1659336###Co-Author###Data and Policy Analyst###Acumen LLC###Co-Author: Kathryn Matuska, BA – Acumen LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Co-Author###Senior Research Manager###Acumen, LLC###Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration ### 1991147###Co-Author###Epidemiologist###US Food and Drug Administration###Co-Author: Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson, PhD – FDA/CBER
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Yoganand Chillarige, MPA – Acumen, LLC ### 1655508###Co-Author###Research Manager###Acumen, LLC###Co-Author: Yoganand Chillarige, MPA – Acumen, LLC
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
###Presenting Author: Ousseny Zerbo, PhD – Kaiser Permanente Northern California, Vaccine Study Center
### @@@ Joan Bartlett – Kaiser Permanente Northern California Vaccine Study Center ### 1991435###Co-Author######Kaiser Permanente Northern California Vaccine Study Center###Co-Author: Joan Bartlett – Kaiser Permanente Northern California Vaccine Study Center
### @@@ Bruce Fireman – kaiser ### 1655762###Co-Author###Biostatistician###kaiser###Co-Author: Bruce Fireman – kaiser
### @@@ Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1655535###Co-Author###Data Manager###Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###Co-Author: Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### @@@ Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1655534###Co-Author###Research Manager###Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###Co-Author: Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### she/her/hers @@@ Kathleen L. Dooling, MD, MPH – CDC ### 1991436###Co-Author###Medical Officer###CDC###Co-Author: Kathleen L. Dooling, MD, MPH – CDC
### @@@ Jonathan Duffy – U.S. Centers for Disease Control and Prevention ### 1991437###Co-Author######U.S. Centers for Disease Control and Prevention###Co-Author: Jonathan Duffy – U.S. Centers for Disease Control and Prevention
### @@@ Jason M. Glanz, PhD, MS – Institute for Health Research, Kaiser Permanente ### 1655767###Co-Author###Senior Research Investigator###Institute for Health Research, Kaiser Permanente###Co-Author: Jason M. Glanz, PhD, MS – Institute for Health Research, Kaiser Permanente
### @@@ Allison Naleway – Center for Health Research, Kaiser Permanente Northwest ### 1655765###Co-Author######Center for Health Research, Kaiser Permanente Northwest###Co-Author: Allison Naleway – Center for Health Research, Kaiser Permanente Northwest
### @@@ James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute ### 1655536###Co-Author######Marshfield Clinic Research Institute###Co-Author: James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute
### @@@ Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1062961###Co-Author######Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###Co-Author: Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
###Presenting Author: Jia-Chian Hu, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan ### 1062628###Co-Author###Pharmacist###Keelung Chang Gung Memorial Hospital, Keelung, Taiwan###Co-Author: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan. ### 1991536###Co-Author###Research fellow###Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.###Co-Author: Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Kuan-Hung Liu, MD – Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. ### 1991615###Co-Author######Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.###Co-Author: Kuan-Hung Liu, MD – Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisPresenting Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Phyo Than T. Htoo, MD, PhD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655331###Co-Author###Research Fellow###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Phyo Than T. Htoo, MD, PhD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655332###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1991320###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1991321###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1360567###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany ### 1655588###Co-Author######Lilly Deutschland GmbH, Bad Homburg, Germany###Co-Author: Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany
### @@@ Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA ### 1360566###Co-Author######MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA###Co-Author: Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
### @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hersCo-Author: Thanh Phuong Pham Nguyen, PharmD, MBA, MSCE – University of Pennsylvania
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine ### 1359957###Co-Author###Professor of Epidemiology###University of Pennsylvania Perelman School of Medicine###Co-Author: Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine
### @@@ Colleen M. Brensinger, M.S. – Perelman School of Medicine at the University of Pennsylvania ### 1357964###Co-Author###Senior Biostatistician###Perelman School of Medicine at the University of Pennsylvania###Co-Author: Colleen M. Brensinger, M.S. – Perelman School of Medicine at the University of Pennsylvania
### @@@ Warren Bilker, Ph.D. – Faculty ### 1656004###Co-Author######Faculty###Co-Author: Warren Bilker, Ph.D. – Faculty
### @@@ Laura M. Dember, MD – University of Pennsylvania School of Medicine ### 1991592###Co-Author###Professor of Medicine and Epidemiology###University of Pennsylvania School of Medicine###Co-Author: Laura M. Dember, MD – University of Pennsylvania School of Medicine
### @@@ Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania ### 1357966###Presenting Author###Assistant Professor of Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Presenting Author: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Allison W. Willis, MD, MS – University of Pennsylvania Perelman School of Medicine ### 1358082###Co-Author######University of Pennsylvania Perelman School of Medicine###Co-Author: Allison W. Willis, MD, MS – University of Pennsylvania Perelman School of Medicine
### @@@ Charles E. Leonard, PharmD, MSCE, FISPE (he/him/his) – University of Pennsylvania ### 1096939###Co-Author###Assistant Professor of Epidemiology###University of Pennsylvania###Co-Author: Charles E. Leonard, PharmD, MSCE, FISPE (he/him/his) – University of Pennsylvania
### he/him/hisPresenting Author: Dongwon Yoon, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Seng Chan You, MD, PhD – Yonsei University College of Medicine ### 1991646###Co-Author######Yonsei University College of Medicine###Co-Author: Seng Chan You, MD, PhD – Yonsei University College of Medicine
### @@@ Soo-Mee Bang – Division of Hemato-Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea ### 1991647###Co-Author######Division of Hemato-Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea###Co-Author: Soo-Mee Bang – Division of Hemato-Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Lead Speaker: Gretchen Bandoli, PhD MPH MBA – University of California San Diego
### @@@ Erin Delker, PhD MPH (she/her/hers) – University of California San Diego ### 1991442###Speaker###Post doctoral researcher###University of California San Diego###Speaker: Erin Delker, PhD MPH (she/her/hers) – University of California San Diego
### she/her/hers @@@ Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659932###Speaker###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Speaker: Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Speaker###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###Speaker: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
### @@@ Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center ### 1359344###Speaker###Associate Professor###Department of Obstetrics and Gynecology, Vanderbilt University Medical Center###Speaker: Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center
###Presenting Author: Mehdi NajafZadeh, PhD – Medidata AI
### @@@ Akiko Shimamura – Medidata AI, Medidata Solutions ### 1991507###Co-Author###Vice President###Medidata AI, Medidata Solutions###Co-Author: Akiko Shimamura – Medidata AI, Medidata Solutions
### @@@ Ben McConnochie – Medidata ### 1991509###Co-Author###Director of Strategic Development###Medidata###Co-Author: Ben McConnochie – Medidata
### @@@ Jimmy Polewaczyk – Medidata AI, Medidata Solutions ### 1991510###Co-Author######Medidata AI, Medidata Solutions###Co-Author: Jimmy Polewaczyk – Medidata AI, Medidata Solutions
### @@@ Sevtap Demirci – Medidata AI, Medidata Solutions ### 1991511###Co-Author######Medidata AI, Medidata Solutions###Co-Author: Sevtap Demirci – Medidata AI, Medidata Solutions
### @@@ Aniketh Talwai – Medidata AI, Medidata Solutions ### 1991512###Co-Author######Medidata AI, Medidata Solutions###Co-Author: Aniketh Talwai – Medidata AI, Medidata Solutions
### @@@ Amir Ahmed – Medidata AI, Medidata Solutions ### 1991508###Co-Author######Medidata AI, Medidata Solutions###Co-Author: Amir Ahmed – Medidata AI, Medidata Solutions
###Lead Speaker: Wenzhen Ge, PhD (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Speaker###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Speaker: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/his @@@ Bingcao Wu, PhD, MS – Janssen Scientific Affairs, LLC ### 1991414###Speaker###Group Director, Real-World Value and Evidence###Janssen Scientific Affairs, LLC###Speaker: Bingcao Wu, PhD, MS – Janssen Scientific Affairs, LLC
### @@@ Paul J. Spin, PhD (he/him/his) – Eversana Life Science Services, LLC ### 1991497###Speaker###Director, Biostatistics###Eversana Life Science Services, LLC###Speaker: Paul J. Spin, PhD (he/him/his) – Eversana Life Science Services, LLC
### he/him/his @@@ K. Arnold Chan, MD, ScD, FISPE – National Taiwan University ### 1358385###Speaker###Professor###National Taiwan University###Speaker: K. Arnold Chan, MD, ScD, FISPE – National Taiwan University
### @@@ Catherine C. Lerro, PhD, MPH (she/her/hers) – Oncology Center of Excellence, US Food and Drug Administration ### 1993800###Speaker###Epidemiologist###Oncology Center of Excellence, US Food and Drug Administration###Speaker: Catherine C. Lerro, PhD, MPH (she/her/hers) – Oncology Center of Excellence, US Food and Drug Administration
### she/her/hersCo-Author: Oksana Pugach, PhD – CorEvitas, LLC
### @@@ Kristin M. Sheffield, PhD – Eli Lilly and Company ### 1655417###Co-Author###Research Advisor - Value Evidence and Outcomes###Eli Lilly and Company###Co-Author: Kristin M. Sheffield, PhD – Eli Lilly and Company
### @@@ Anita M. Loughlin, PhD – CorEvitas, LLC ### 1655416###Co-Author###Former Senior Director of Epidemiology###CorEvitas, LLC###Co-Author: Anita M. Loughlin, PhD – CorEvitas, LLC
### @@@ Mingyang Shan, PhD – Eli Lilly and Company ### 1359337###Co-Author###Senior Research Scientist###Eli Lilly and Company###Co-Author: Mingyang Shan, PhD – Eli Lilly and Company
### @@@ Douglas Faries – Eli Lilly and Company ### 1991465###Co-Author######Eli Lilly and Company###Co-Author: Douglas Faries – Eli Lilly and Company
### @@@ Carla Roberts-Toler – CorEvitas, LLC ### 1991466###Co-Author######CorEvitas, LLC###Co-Author: Carla Roberts-Toler – CorEvitas, LLC
### @@@ Paul Lakin, MS – CorEvitas, LLC ### 1655419###Co-Author###Biostatistician II###CorEvitas, LLC###Co-Author: Paul Lakin, MS – CorEvitas, LLC
### @@@ Zhanglin Lin Cui, PhD – Eli Lilly and Company ### 1655421###Co-Author###Sr. Director###Eli Lilly and Company###Co-Author: Zhanglin Lin Cui, PhD – Eli Lilly and Company
### @@@ Leslie R. Harrold, MD, MPH – CorEvitas, LLC ### 1655424###Co-Author###Chief Scientific Officer###CorEvitas, LLC###Co-Author: Leslie R. Harrold, MD, MPH – CorEvitas, LLC
### @@@ Heather Litman, PhD – CorEvitas, LLC ### 1655423###Presenting Author###Vice President of Biostatistics###CorEvitas, LLC###Presenting Author: Heather Litman, PhD – CorEvitas, LLC
###Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Presenting Author###Health Statistician###US Food and Drug Administration###Presenting Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Yoganand Chillarige, MPA – Acumen, LLC ### 1655508###Co-Author###Research Manager###Acumen, LLC###Co-Author: Yoganand Chillarige, MPA – Acumen, LLC
### @@@ Rose Do – Acumen, LLC ### 1991326###Co-Author######Acumen, LLC###Co-Author: Rose Do – Acumen, LLC
### @@@ Mao Hu – Acumen, LLC ### 1655532###Co-Author######Acumen, LLC###Co-Author: Mao Hu – Acumen, LLC
### @@@ Yixin Jiao – Acumen, LLC ### 1991146###Co-Author######Acumen, LLC###Co-Author: Yixin Jiao – Acumen, LLC
### @@@ Andrew Kwist, MPH – Acumen, LLC ### 1991410###Co-Author######Acumen, LLC###Co-Author: Andrew Kwist, MPH – Acumen, LLC
### @@@ Arnstein Lindaas – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###Co-Author: Arnstein Lindaas – Acumen, LLC
### @@@ Rowan McEvoy, B.S. – Acumen, LLC ### 1991408###Co-Author######Acumen, LLC###Co-Author: Rowan McEvoy, B.S. – Acumen, LLC
### @@@ Michelle Ondari, MSPH – Acumen LLC ### 1991411###Co-Author######Acumen LLC###Co-Author: Michelle Ondari, MSPH – Acumen LLC
### @@@ Shruti Parulekar – Acumen LLC ### 1991412###Co-Author######Acumen LLC###Co-Author: Shruti Parulekar – Acumen LLC
### @@@ Xiangyu Shi – Acumen, LLC ### 1991273###Co-Author######Acumen, LLC###Co-Author: Xiangyu Shi – Acumen, LLC
### @@@ Jing Wang – Acumen, LLC ### 1991406###Co-Author######Acumen, LLC###Co-Author: Jing Wang – Acumen, LLC
### @@@ Kathryn Matuska, BA – Acumen LLC ### 1659336###Co-Author###Data and Policy Analyst###Acumen LLC###Co-Author: Kathryn Matuska, BA – Acumen LLC
### @@@ Yun Lu, PhD – US Food and Drug Administration ### 1659299###Co-Author###Mathematical Statistician###US Food and Drug Administration###Co-Author: Yun Lu, PhD – US Food and Drug Administration
### @@@ Joyce Obidi, PhD – US. Food and Drug Administration ### 1358853###Co-Author###Health Scientist###US. Food and Drug Administration###Co-Author: Joyce Obidi, PhD – US. Food and Drug Administration
### @@@ Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc ### 1991413###Co-Author###Director, Global Safety Epidemiology###Moderna, Inc###Co-Author: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc
### she/her/hers @@@ Jeffery A. Kelman – Centers for Medicare and Medicaid Services ### 1358531###Co-Author######Centers for Medicare and Medicaid Services###Co-Author: Jeffery A. Kelman – Centers for Medicare and Medicaid Services
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson, PhD – FDA/CBER
###Presenting Author: Yu-Seon Jung, PharmD, PhD – Chung-Ang University
### @@@ Yeo-Jin Song – Department of Rheumatology, Hanyang University for Rheumatic Disease ### 1657504###Co-Author######Department of Rheumatology, Hanyang University for Rheumatic Disease###Co-Author: Yeo-Jin Song – Department of Rheumatology, Hanyang University for Rheumatic Disease
### @@@ Jihyun Keum – Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Korea ### 1991534###Co-Author######Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Korea###Co-Author: Jihyun Keum – Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Korea
### @@@ Soo-Kyung Cho – Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea ### 1657503###Co-Author######Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea###Co-Author: Soo-Kyung Cho – Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea
### @@@ Yoon-Kyoung Sung – Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea ### 1657505###Co-Author######Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea###Co-Author: Yoon-Kyoung Sung – Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Korea
### @@@ Sun-Young Jung, PhD – College of Pharmacy, Chung-Ang University, Korea ### 1302752###Co-Author###Associate Professor###College of Pharmacy, Chung-Ang University, Korea###Co-Author: Sun-Young Jung, PhD – College of Pharmacy, Chung-Ang University, Korea
###Co-Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA ### 1046829###Co-Moderator###Vice president and Global Head of Epidemiology###IQVIA###Co-Moderator: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
###Presenting Author: Ahhyung Choi, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1063055###Co-Author###Research Professor###School of Pharmacy, Sungkyunkwan University, South Korea###Co-Author: Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Co-Moderator: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University ### 1063128###Co-Moderator###Assistant Professor###Dalhousie University###Co-Moderator: Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University
### she/her/hersPresenting Author: Jenny Dimakos, BSc (she/her/hers) – Department of Medicine, McGill University, Montreal, QC, Canada
### she/her/hers @@@ Ying Cui – Lady Davis Institute ### 1358290###Co-Author###Research Assistant###Lady Davis Institute###Co-Author: Ying Cui – Lady Davis Institute
### @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Co-Author###Associate Professor###McGill University###Co-Author: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358292###Co-Author###Associate Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Co-Author###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###Co-Author: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/hisLead Speaker: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
### @@@ Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson ### 1046821###Speaker###Vice President and Global Head of Epidemiology###Johnson & Johnson###Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
###Presenting Author: Asieh Golozar, MD PhD MHS MPH – Odysseus Data Services Inc.
### @@@ Martin Lavallee, PhD – Odysseus Data Services Inc. ### 1991296###Co-Author###Data Scientist###Odysseus Data Services Inc.###Co-Author: Martin Lavallee, PhD – Odysseus Data Services Inc.
### @@@ Anna Ostropolets, MD, PhD – Odysseus Data Services ### 1991561###Co-Author######Odysseus Data Services###Co-Author: Anna Ostropolets, MD, PhD – Odysseus Data Services
### @@@ M. Ines Neves, PhD – IQVIA, Real-World Solutions, Durham, North Carolina ### 1659695###Co-Author###Data Scientist###IQVIA, Real-World Solutions, Durham, North Carolina###Co-Author: M. Ines Neves, PhD – IQVIA, Real-World Solutions, Durham, North Carolina
### @@@ Priyamvada Desai, MS – Stanford University School of Medicine ### 1991565###Co-Author###Research Manager###Stanford University School of Medicine###Co-Author: Priyamvada Desai, MS – Stanford University School of Medicine
### @@@ Thomas Falconer – Columbia University ### 1655449###Co-Author######Columbia University###Co-Author: Thomas Falconer – Columbia University
### @@@ Scott L. DuVall, PhD (he/him/his) – Department of Veterans Affairs ### 1655448###Co-Author###VINCI Director###Department of Veterans Affairs###Co-Author: Scott L. DuVall, PhD (he/him/his) – Department of Veterans Affairs
### he/him/his @@@ Michael E. Matheny, MD, MS, MPH – Vanderbilt University Medical Center ### 1655452###Co-Author###Professor of Biomedical Informatics###Vanderbilt University Medical Center###Co-Author: Michael E. Matheny, MD, MS, MPH – Vanderbilt University Medical Center
### @@@ Marc A. Suchard – UCLA ### 1360254###Co-Author######UCLA###Co-Author: Marc A. Suchard – UCLA
### @@@ Christian Reich, MD – The OHDSI Center at the Roux Institute, Northeastern University, Portland, ME, USA ### 1991566###Co-Author###Professor of Practice###The OHDSI Center at the Roux Institute, Northeastern University, Portland, ME, USA###Co-Author: Christian Reich, MD – The OHDSI Center at the Roux Institute, Northeastern University, Portland, ME, USA
###Co-Author: Lina Titievsky, PhD, MPH (she/her/hers) – GSK
### she/her/hers @@@ Janna Manjelievskaia, PhD, MPH – Merative ### 1991356###Co-Author###Research Leader###Merative###Co-Author: Janna Manjelievskaia, PhD, MPH – Merative
### @@@ Katherine L. Ender, MD, MS – Vertex Pharmaceuticals ### 1991357###Co-Author###Associate Medical Director, Clinical Development###Vertex Pharmaceuticals###Co-Author: Katherine L. Ender, MD, MS – Vertex Pharmaceuticals
### @@@ Daoyuan Shi – Vertex Pharmaceuticals ### 1991358###Co-Author######Vertex Pharmaceuticals###Co-Author: Daoyuan Shi – Vertex Pharmaceuticals
### @@@ Timothy Lillehaugen, MPH – Merative ### 1991359###Co-Author######Merative###Co-Author: Timothy Lillehaugen, MPH – Merative
### @@@ Timothy Beukelman – Vertex Pharmaceuticals ### 1991360###Presenting Author######Vertex Pharmaceuticals###Presenting Author: Timothy Beukelman – Vertex Pharmaceuticals
###Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers @@@ Hythem Sidky, PhD – AstraZeneca ### 1658937###Speaker###Director, Data Science & AI###AstraZeneca###Speaker: Hythem Sidky, PhD – AstraZeneca
### @@@ Anne-Marie Meyer, PhD – National Cancer Institute (NCI) ### 1991735###Speaker###RWD Expert###National Cancer Institute (NCI)###Speaker: Anne-Marie Meyer, PhD – National Cancer Institute (NCI)
### @@@ Jennifer S. Fusco (she/her/hers) – Epividian ### 1991734###Speaker###President###Epividian###Speaker: Jennifer S. Fusco (she/her/hers) – Epividian
### she/her/hersPresenting Author: Siu Chung Andrew Yuen, MPharm (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Adrienne YL Chan, MPH – Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands ### 1063197###Co-Author###PhD Candidate###Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands###Co-Author: Adrienne YL Chan, MPH – Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands
### @@@ Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK ### 1063024###Co-Author######Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK###Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Author###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###Co-Author: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/hisPresenting Author: Julie A. Schmidt, MSc, DPhil (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers @@@ Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1657893###Co-Author###MSPH, PhD###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1659144###Co-Author######Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Per Damkier, MD, PhD – Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark ### 1358430###Co-Author###Professor, consultant###Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark###Co-Author: Per Damkier, MD, PhD – Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark
### @@@ Søren Feddersen – Department of Clinical Research, University of Southern Denmark, Odense, Denmark ### 1659676###Co-Author###Biochemist, assistant Professor, MSc, PhD###Department of Clinical Research, University of Southern Denmark, Odense, Denmark###Co-Author: Søren Feddersen – Department of Clinical Research, University of Southern Denmark, Odense, Denmark
### @@@ Stephen Hamilton-Dutoit – Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark ### 1991393###Co-Author######Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark###Co-Author: Stephen Hamilton-Dutoit – Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark
### @@@ Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark ### 1358744###Co-Author######Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark###Co-Author: Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
### @@@ Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA USA ### 1358745###Co-Author###Professor and Chair###Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA USA###Co-Author: Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA USA
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1358742###Co-Author###Associate Professor###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hersCo-Moderator: Kenneth Hornbuckle, DVM, PhD – Eli Lilly and Company
### @@@ Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1360157###Co-Moderator###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Moderator: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Christine E. Hallgreen, PhD – Copenhagen Centre for Regulatory Science, University of Copenhagen ### 1062920###Co-Moderator###Associate professor###Copenhagen Centre for Regulatory Science, University of Copenhagen###Co-Moderator: Christine E. Hallgreen, PhD – Copenhagen Centre for Regulatory Science, University of Copenhagen
###Presenting Author: Odile Sheehy, MSc (she/her/hers) – Research Centre - CHU Sainte-Justine
### she/her/hers @@@ Sherif Eltonsy, PhD – University of Manitoba ### 1357974###Co-Author###Assistant Professor###University of Manitoba###Co-Author: Sherif Eltonsy, PhD – University of Manitoba
### @@@ Steven Hawken, PhD – Ottawa Hospital Research Institute ### 1991313###Co-Author###Senior Scientist###Ottawa Hospital Research Institute###Co-Author: Steven Hawken, PhD – Ottawa Hospital Research Institute
### @@@ Padma Kaul, PhD, PhD – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept ### 1991314###Co-Author###Professor###University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept###Co-Author: Padma Kaul, PhD, PhD – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept
### @@@ Brandace Winquist – University of Saskatchewan ### 1991328###Co-Author######University of Saskatchewan###Co-Author: Brandace Winquist – University of Saskatchewan
### @@@ Olesya Barrett – Alberta Health Services, AHS Data & Analytics ### 1991315###Co-Author######Alberta Health Services, AHS Data & Analytics###Co-Author: Olesya Barrett – Alberta Health Services, AHS Data & Analytics
### @@@ Anamaria Savu – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept ### 1991316###Co-Author###Biostatistician###University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept###Co-Author: Anamaria Savu – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept
### @@@ Roxana Dragan – University of Manitoba ### 1991317###Co-Author######University of Manitoba###Co-Author: Roxana Dragan – University of Manitoba
### @@@ Michael Pugliese, MSc – OHRI (ICES uOttawa) ### 1991318###Co-Author###Research analysts###OHRI (ICES uOttawa)###Co-Author: Michael Pugliese, MSc – OHRI (ICES uOttawa)
### @@@ Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE ### 1358207###Co-Author###Professor of medicine ###McGill University, Dept. of Medicine and CORE###Co-Author: Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE
### @@@ Jessica Gorgui, PhD (she/her/hers) – Research Centre - CHU Sainte-Justine ### 1991319###Co-Author###Pharmacoepidemiologist###Research Centre - CHU Sainte-Justine###Co-Author: Jessica Gorgui, PhD (she/her/hers) – Research Centre - CHU Sainte-Justine
### she/her/hers @@@ Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal ### 1302804###Co-Author###Professor Researcher###University of Montreal###Co-Author: Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal
### she/her/hersCo-Moderator: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis
### she/her/hers @@@ Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute ### 1061396###Co-Moderator###VP Epidemiology###Research Triangle Institute###Co-Moderator: Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute
###Presenting Author: Phyo Than T. Htoo, MD, PhD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655578###Co-Author###Senior Research Specialist ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA ### 1360566###Co-Author######MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA###Co-Author: Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1991321###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1360567###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany ### 1655588###Co-Author######Lilly Deutschland GmbH, Bad Homburg, Germany###Co-Author: Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany
### @@@ Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655332###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hersPresenting Author: Yujia Li, MS – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
### @@@ Hui Shao – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy ### 1991119###Co-Author######Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy###Co-Author: Hui Shao – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
### @@@ Yi Guo – Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida ### 1991480###Co-Author######Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida###Co-Author: Yi Guo – Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida
### @@@ Yongkang Zhang, PhD – Department of Population Health Sciences, Weill Medical College of Cornell University ### 1991481###Co-Author###Assistant Professor###Department of Population Health Sciences, Weill Medical College of Cornell University###Co-Author: Yongkang Zhang, PhD – Department of Population Health Sciences, Weill Medical College of Cornell University
### @@@ Vivian Fonseca – School of Medicine, Tulane University ### 1991482###Co-Author######School of Medicine, Tulane University###Co-Author: Vivian Fonseca – School of Medicine, Tulane University
### @@@ Lizheng Shi – School of Public Health and Tropical Medicine, Tulane University ### 1991483###Co-Author######School of Public Health and Tropical Medicine, Tulane University###Co-Author: Lizheng Shi – School of Public Health and Tropical Medicine, Tulane University
### @@@ Jiang Bian – University of Florida ### 1658680###Co-Author######University of Florida###Co-Author: Jiang Bian – University of Florida
### @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Serena Jingchuan Guo – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy ### 1659293###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy###Co-Author: Serena Jingchuan Guo – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
###Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill, Department of Epidemiology
### @@@ Virginia Pate, MS – UNC Chapel Hill Gillings School of Global Public Health ### 1358426###Co-Author###Analyst###UNC Chapel Hill Gillings School of Global Public Health###Co-Author: Virginia Pate, MS – UNC Chapel Hill Gillings School of Global Public Health
### @@@ John Buse, MD – UNC Chapel Hill School of Medicine ### 1991568###Co-Author######UNC Chapel Hill School of Medicine###Co-Author: John Buse, MD – UNC Chapel Hill School of Medicine
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### he/him/hisPresenting Author: Joe B.B Silva, ScM (he/him/his) – Brown University School of Public Health
### he/him/his @@@ Chanelle J. Howe, PhD – Brown University School of Public Health ### 1660183###Co-Author###Associate Professor###Brown University School of Public Health###Co-Author: Chanelle J. Howe, PhD – Brown University School of Public Health
### @@@ John W. Jackson, PhD – Johns Hopkins Bloomberg School of Public Health ### 1393299###Co-Author###Assistant Professor###Johns Hopkins Bloomberg School of Public Health###Co-Author: John W. Jackson, PhD – Johns Hopkins Bloomberg School of Public Health
### @@@ Melissa R. Riester, PharmD – Brown University School of Public Health ### 1302727###Co-Author###Research Scientist###Brown University School of Public Health###Co-Author: Melissa R. Riester, PharmD – Brown University School of Public Health
### @@@ Barbara H. Bardenheier, PhD – Brown University School of Public Health ### 1302731###Co-Author###Assistant Professor###Brown University School of Public Health###Co-Author: Barbara H. Bardenheier, PhD – Brown University School of Public Health
### @@@ Liou Xu, PhD – National Minority Quality Forum ### 1991179###Co-Author######National Minority Quality Forum###Co-Author: Liou Xu, PhD – National Minority Quality Forum
### @@@ Gary Puckrein, PhD – National Minority Quality Forum ### 1991180###Co-Author######National Minority Quality Forum###Co-Author: Gary Puckrein, PhD – National Minority Quality Forum
### @@@ Robertus van Aalst, PhD – Sanofi ### 1302730###Co-Author###Lead, Vaccine Epidemiology and Modeling###Sanofi###Co-Author: Robertus van Aalst, PhD – Sanofi
### @@@ Matthew M. Loiacono, PhD – Sanofi ### 1302734###Co-Author###Medical Evidence Generation Lead###Sanofi###Co-Author: Matthew M. Loiacono, PhD – Sanofi
### @@@ Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health ### 1302736###Co-Author###Associate Professor###Brown University School of Public Health###Co-Author: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/hisPresenting Author: Noelle M. Cocoros, DSc, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ John G. Connolly, ScD – Harvard Pilgrim Health Care Institute ### 1063038###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute###Co-Author: John G. Connolly, ScD – Harvard Pilgrim Health Care Institute
### @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Co-Author###Senior Epidemiologist###US Food and Drug Administration###Co-Author: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania ### 1655454###Co-Author######Perelman School of Medicine at the University of Pennsylvania###Co-Author: Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Terese DeFor – HealthPartners Institute ### 1655455###Co-Author######HealthPartners Institute###Co-Author: Terese DeFor – HealthPartners Institute
### @@@ Djeneba Audrey Djibo, PhD – CVS Health ### 1655293###Co-Author###Lead Director - Epidemiology###CVS Health###Co-Author: Djeneba Audrey Djibo, PhD – CVS Health
### @@@ Laura B. Harrington, PhD, MPH – Kaiser Permanente Washington Health Research Institute ### 1360510###Co-Author###Assistant Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Laura B. Harrington, PhD, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1359984###Co-Author###Research Analyst II###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine ### 1359957###Co-Author###Professor of Epidemiology###University of Pennsylvania Perelman School of Medicine###Co-Author: Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine
### @@@ Rebecca Hubbard, Ph.D. – University of Pennsylvania ### 1655438###Co-Author###Professor###University of Pennsylvania###Co-Author: Rebecca Hubbard, Ph.D. – University of Pennsylvania
### @@@ Maria Kempner, BA – Harvard Pilgrim Health Care Institute ### 1360312###Co-Author###Senior Research Analyst###Harvard Pilgrim Health Care Institute###Co-Author: Maria Kempner, BA – Harvard Pilgrim Health Care Institute
### @@@ Jennifer Kuntz, PhD – Kaiser Permanente Northwest Center for Health Research ### 1359348###Co-Author######Kaiser Permanente Northwest Center for Health Research###Co-Author: Jennifer Kuntz, PhD – Kaiser Permanente Northwest Center for Health Research
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health Clinical Trial Services###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services
### @@@ Jolene Mosley – Harvard Pilgrim Health Care Institute ### 1655461###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Jolene Mosley – Harvard Pilgrim Health Care Institute
### @@@ Pamala A. Pawloski, PharmD, BCOP, FCCP – HealthPartners Institute ### 1358149###Co-Author###Senior Research Investigator###HealthPartners Institute###Co-Author: Pamala A. Pawloski, PharmD, BCOP, FCCP – HealthPartners Institute
### @@@ Andrew Petrone, MPH – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA ### 1359985###Co-Author###Lead SAS Programmer/Analyst###Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA###Co-Author: Andrew Petrone, MPH – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Allyson Pishko – University of Pennsylvania ### 1655462###Co-Author######University of Pennsylvania###Co-Author: Allyson Pishko – University of Pennsylvania
### @@@ Meighan Rogers Driscoll – Harvard Pilgrim Health Care Institute ### 1655463###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Meighan Rogers Driscoll – Harvard Pilgrim Health Care Institute
### @@@ Claudia Steiner, MD MPH – Kaiser Permanente Colorado Institute for Health Research ### 1655464###Co-Author######Kaiser Permanente Colorado Institute for Health Research###Co-Author: Claudia Steiner, MD MPH – Kaiser Permanente Colorado Institute for Health Research
### @@@ Yunping Zhou – Humana Healthcare Research, Inc. ### 1655465###Co-Author######Humana Healthcare Research, Inc.###Co-Author: Yunping Zhou – Humana Healthcare Research, Inc.
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Co-Author###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Co-Author: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/hisIntroducer/Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Stephen B. Thomas, PhD (he/him/his) – University of Maryland School of Public Health ### 2033612###Speaker###Professor, Health Policy and Management###University of Maryland School of Public Health###Speaker: Stephen B. Thomas, PhD (he/him/his) – University of Maryland School of Public Health
### he/him/his @@@ Paula Braveman, MD, MPH (she/her/hers) – University of California San Francisco ### 2033613###Speaker###Professor, Family Community Medicine###University of California San Francisco###Speaker: Paula Braveman, MD, MPH (she/her/hers) – University of California San Francisco
### she/her/hers @@@ Sieta de Vries, PhD (she/her/hers) – Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen ### 1063125###Speaker###Researcher###Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen###Speaker: Sieta de Vries, PhD (she/her/hers) – Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen
### she/her/hersLead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
### @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Speaker###Director of Observational Research###Amgen, Inc.###Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Speaker###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Speaker###Associate Director for Science###US Food and Drug Administration###Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hersPresenting Author: Sudhir Venkatesan, MPH, PhD – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics
### @@@ Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK ### 1360359###Co-Author######Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK###Co-Author: Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK
###Presenting Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Malcolm Maclure, PhD – University of British Colombia ### 1655849###Co-Author###Professor###University of British Colombia###Co-Author: Malcolm Maclure, PhD – University of British Colombia
### @@@ Suzanne M. Cadarette, PhD – University of Toronto, Toronto, Canada ### 1358519###Co-Author###Associate Professor###University of Toronto, Toronto, Canada###Co-Author: Suzanne M. Cadarette, PhD – University of Toronto, Toronto, Canada
### @@@ Joseph Delaney, PhD – University of Manitoba ### 1359102###Co-Author###Associate Professor###University of Manitoba###Co-Author: Joseph Delaney, PhD – University of Manitoba
### @@@ Heather J. Whitaker – Public Health England ### 1360253###Co-Author###Senior Statistician###Public Health England###Co-Author: Heather J. Whitaker – Public Health England
### @@@ Nicole L. Pratt, FISPE – University of South Australia ### 1358335###Co-Author######University of South Australia###Co-Author: Nicole L. Pratt, FISPE – University of South Australia
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/hisPresenting Author: Sarah R. Hoffman, PhD, MS, MPH (she/her/hers) – Carelon Research
### she/her/hers @@@ Francesca Kolitsopoulos, MPH – Pfizer, Inc., New York, NY, USA ### 1358445###Co-Author######Pfizer, Inc., New York, NY, USA###Co-Author: Francesca Kolitsopoulos, MPH – Pfizer, Inc., New York, NY, USA
### @@@ Aziza Jamal-Allial, PhD, MS – Carelon Research ### 1062683###Co-Author###Research Scientist of Epidemiology###Carelon Research###Co-Author: Aziza Jamal-Allial, PhD, MS – Carelon Research
### @@@ Keith Wilner – Pfizer ### 1659545###Co-Author######Pfizer###Co-Author: Keith Wilner – Pfizer
### @@@ Cynthia Senerchia, RN, MS – Optum ### 1658028###Co-Author###Vice President###Optum###Co-Author: Cynthia Senerchia, RN, MS – Optum
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ James Harnett, PharmD, MS – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1655631###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: James Harnett, PharmD, MS – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
###Presenting Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Romin Pajouheshnia, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1063167###Co-Author###Assistant Professor (formerly)###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Romin Pajouheshnia, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht ### 1655741###Co-Author###Postdoctoral researcher###Julius Global Health, University Medical Center Utrecht###Co-Author: Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands ### 1991418###Co-Author###PhD candidate###Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands###Co-Author: Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands
### @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1062523###Co-Author###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
###Presenting Author: Anthony Chen, BSc, MSc (he/him/his) – University of Nottingham
### he/him/his @@@ Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1991171###Co-Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### he/him/his @@@ Isla S. Mackenzie, PhD – University of Dundee ### 1991526###Co-Author###Professor###University of Dundee###Co-Author: Isla S. Mackenzie, PhD – University of Dundee
### @@@ Allan D. Struthers, MD – University of Dundee ### 1991527###Co-Author###Professor###University of Dundee###Co-Author: Allan D. Struthers, MD – University of Dundee
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Author###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###Co-Author: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/hisPresenting Author: Kyle Johnson, MSc – Mcgill University Department of Epidemiology, Biostatistics, and Occupational Health
### @@@ Sarah Beradid – Lady Davis Institute ### 1991427###Co-Author######Lady Davis Institute###Co-Author: Sarah Beradid – Lady Davis Institute
### @@@ James M. Brophy, MD, PhD – McGill University ### 1359484###Co-Author######McGill University###Co-Author: James M. Brophy, MD, PhD – McGill University
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358292###Co-Author###Associate Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
###Presenting Author: Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research
### he/him/his @@@ Marieke T. Blom, PhD – Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice ### 1659198###Co-Author######Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice###Co-Author: Marieke T. Blom, PhD – Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice
### @@@ Karin M.A Swart, PhD – PHARMO Institute for Drug Outcomes Research ### 1358327###Co-Author###Senior Researcher###PHARMO Institute for Drug Outcomes Research###Co-Author: Karin M.A Swart, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research ### 1062554###Co-Author###Head of PHARMO Research###PHARMO Institute for Drug Outcomes Research###Co-Author: Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Sharon Remmelzwaal – Amsterdam UMC location Vrije Universiteit Amsterdam, department of General Practice ### 1991363###Co-Author######Amsterdam UMC location Vrije Universiteit Amsterdam, department of General Practice###Co-Author: Sharon Remmelzwaal – Amsterdam UMC location Vrije Universiteit Amsterdam, department of General Practice
### @@@ Petra JM Elders, MD PhD – dpt of General Practice, Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice ### 1360375###Co-Author###Professor of General Practice###dpt of General Practice, Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice###Co-Author: Petra JM Elders, MD PhD – dpt of General Practice, Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice
### @@@ Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1657462###Co-Author###Professor in Pharmaco-epidemiology and Healthcare Optimization, Director of the PHARMO Institute###PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###Co-Author: Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
###Presenting Author: Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health
### @@@ Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA ### 1358097###Co-Author###Assistant Professor###Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA###Co-Author: Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
### @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Co-Author###Assistant Professor###University of Toronto###Co-Author: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego ### 1658462###Co-Author###Associate Professor###Division of Clinical Pharmacy, University of California San Diego###Co-Author: Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego
### @@@ Walid Gellad, MD MPH – Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine ### 1358100###Co-Author###Professor of Medicine###Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine###Co-Author: Walid Gellad, MD MPH – Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine
### @@@ Lisa Maillart, PhD – Department of Industrial Engineering, University of Pittsburgh Swanson School of Engineering ### 1991464###Co-Author###Professor###Department of Industrial Engineering, University of Pittsburgh Swanson School of Engineering###Co-Author: Lisa Maillart, PhD – Department of Industrial Engineering, University of Pittsburgh Swanson School of Engineering
### @@@ Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh ### 1360024###Co-Author###Professor###University of Pittsburgh###Co-Author: Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh
### she/her/hersPresenting Author: Xi Xiong, Msc – The University of Hong Kong
### @@@ David Tak Wai Lui – University of Hong Kong ### 1993248###Co-Author######University of Hong Kong###Co-Author: David Tak Wai Lui – University of Hong Kong
### @@@ Matthew Shing Hin Chung – University of Hong Kong ### 1993249###Co-Author######University of Hong Kong###Co-Author: Matthew Shing Hin Chung – University of Hong Kong
### @@@ Ivan Chi Ho Au – University of Hong Kong ### 1993250###Co-Author######University of Hong Kong###Co-Author: Ivan Chi Ho Au – University of Hong Kong
### @@@ Francisco Tsz Tsun Lai – University of Hong Kong ### 1657436###Co-Author######University of Hong Kong###Co-Author: Francisco Tsz Tsun Lai – University of Hong Kong
### @@@ Eric Yuk Fai Wan – The University of Hong Kong ### 1358937###Co-Author######The University of Hong Kong###Co-Author: Eric Yuk Fai Wan – The University of Hong Kong
### @@@ Celine Sze Ling Chui, PhD – University of Hong Kong ### 1093237###Co-Author###Assistant Professor###University of Hong Kong###Co-Author: Celine Sze Ling Chui, PhD – University of Hong Kong
### @@@ Xue Li, PhD – The University of Hong Kong ### 1358457###Co-Author###Assistant Professor###The University of Hong Kong###Co-Author: Xue Li, PhD – The University of Hong Kong
### @@@ Franco Wing Tak Cheng – The University of Hong Kong ### 1991863###Co-Author######The University of Hong Kong###Co-Author: Franco Wing Tak Cheng – The University of Hong Kong
### @@@ Ching‐Lung Cheung, PhD (he/him/his) – University of Hong Kong ### 1358271###Co-Author###Associate Professor###University of Hong Kong###Co-Author: Ching‐Lung Cheung, PhD (he/him/his) – University of Hong Kong
### he/him/his @@@ Esther Wai Yin Chan – The University of Hong Kong ### 1358455###Co-Author######The University of Hong Kong###Co-Author: Esther Wai Yin Chan – The University of Hong Kong
### @@@ Chi Ho Lee – University of Hong Kong ### 1993251###Co-Author######University of Hong Kong###Co-Author: Chi Ho Lee – University of Hong Kong
### @@@ Yu Cho Woo – University of Hong Kong ### 1993252###Co-Author######University of Hong Kong###Co-Author: Yu Cho Woo – University of Hong Kong
### @@@ Kathryn Choon Beng Tan – University of Hong Kong ### 1993253###Co-Author######University of Hong Kong###Co-Author: Kathryn Choon Beng Tan – University of Hong Kong
### @@@ Carlos King Ho K. Wong – University of Hong Kong ### 1358585###Co-Author######University of Hong Kong###Co-Author: Carlos King Ho K. Wong – University of Hong Kong
### @@@ Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong ### 1358232###Co-Author###Head of Department of Pharmacology and Pharmacy###The University of Hong Kong###Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong
### he/him/hisPresenting Author: Wenzhen Ge, PhD (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Alexi Archambault, PhD, MPH – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1658114###Co-Author###Sr. Manager, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Alexi Archambault, PhD, MPH – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Thomas E. Delea – Policy Analysis Inc (PAI), Cambridge, MA ### 1991467###Co-Author######Policy Analysis Inc (PAI), Cambridge, MA###Co-Author: Thomas E. Delea – Policy Analysis Inc (PAI), Cambridge, MA
### @@@ Karen Rodriguez Lorenc – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1658117###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Karen Rodriguez Lorenc – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ James Harnett, PharmD, MS – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1655631###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: James Harnett, PharmD, MS – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Aaron P. Moynahan, Masters degree – Policy Analysis Inc (PAI), Cambridge, MA ### 1991468###Co-Author###Senior programmer analyist###Policy Analysis Inc (PAI), Cambridge, MA###Co-Author: Aaron P. Moynahan, Masters degree – Policy Analysis Inc (PAI), Cambridge, MA
### @@@ Derek Weycker, Ph.D. – Policy Analysis Inc (PAI), Cambridge, MA ### 1991469###Co-Author######Policy Analysis Inc (PAI), Cambridge, MA###Co-Author: Derek Weycker, Ph.D. – Policy Analysis Inc (PAI), Cambridge, MA
### @@@ Yariv Houvras – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1991470###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Yariv Houvras – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Glenn S. Kroog, MD – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1658118###Co-Author###Executive Director###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Glenn S. Kroog, MD – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Ning Wu, PhD – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360274###Co-Author###Director of Health Economics and Outcomes Research###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Ning Wu, PhD – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Co-Author###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/his @@@ Qiufei Ma – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1991471###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Qiufei Ma – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### @@@ Sikander Ailawadhi – Mayo Clinic ### 1991472###Co-Author######Mayo Clinic###Co-Author: Sikander Ailawadhi – Mayo Clinic
###Presenting Author: Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Co-Author######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Co-Author: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###Co-Author: Seanna Vine – Brigham and Women's Hospital
###Presenting Author: Wajd Alkabbani, MSc – University of Waterloo
### @@@ Colleen J. Maxwell, PhD – University of Waterloo ### 1655899###Co-Author###Professor###University of Waterloo###Co-Author: Colleen J. Maxwell, PhD – University of Waterloo
### @@@ Ruth Ann Marrie, MD, PhD – University of Manitoba ### 1358111###Co-Author######University of Manitoba###Co-Author: Ruth Ann Marrie, MD, PhD – University of Manitoba
### @@@ Suzanne Tyas – University of Waterloo ### 1655900###Co-Author######University of Waterloo###Co-Author: Suzanne Tyas – University of Waterloo
### @@@ Iliana Lega – University of Toronto ### 1655357###Co-Author######University of Toronto###Co-Author: Iliana Lega – University of Toronto
### @@@ John-Michael Gamble, PhD – University of Waterloo ### 1302773###Co-Author###Clinical Associate Professor; Associate Director, Graduate Studies and Research###University of Waterloo###Co-Author: John-Michael Gamble, PhD – University of Waterloo
###Presenting Author: Hamid Mahmoudpour, PharmD, PhD (he/him/his) – Global Epidemiology, the healthcare business of Merck KGaA, Darmstadt, Germany
### he/him/his @@@ Craig Knott – Health Data Insight CIC; NHS Digital, Leeds, UK ### 1991494###Co-Author######Health Data Insight CIC; NHS Digital, Leeds, UK###Co-Author: Craig Knott – Health Data Insight CIC; NHS Digital, Leeds, UK
### @@@ Amerah Amin – Health Outcomes, Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA ### 1658449###Co-Author######Health Outcomes, Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA###Co-Author: Amerah Amin – Health Outcomes, Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA
### @@@ Emmanuelle Boutmy, Msc, PhD – Global Epidemiology, the healthcare business of Merck KGaA, Darmstadt, Germany ### 1360043###Co-Author###Associate Director Biostatistics###Global Epidemiology, the healthcare business of Merck KGaA, Darmstadt, Germany###Co-Author: Emmanuelle Boutmy, Msc, PhD – Global Epidemiology, the healthcare business of Merck KGaA, Darmstadt, Germany
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Co-Author###Head of Real World Evidence###European Medicines Agency###Co-Author: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
###Lead Speaker: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Jodi B. Segal, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine ### 1302718###Speaker###Professor###Johns Hopkins University School of Medicine###Speaker: Jodi B. Segal, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
### she/her/hers @@@ Madhav Thambisetty, MD, PhD – Clinical and Translational Neuroscience Section, National Institute on Aging, National Institutes of Health ### 1991535###Speaker######Clinical and Translational Neuroscience Section, National Institute on Aging, National Institutes of Health###Speaker: Madhav Thambisetty, MD, PhD – Clinical and Translational Neuroscience Section, National Institute on Aging, National Institutes of Health
###Lead Speaker: Jennifer Gerber, PhD, MSc – GlaxoSmithKline
### @@@ Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc. ### 1359188###Speaker###Senior Director###Infectious Disease Epidemiology, Moderna Therapeutics Inc.###Speaker: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
### he/him/his @@@ Henok Tadesse Ayele, PhD – Merck & Co., Inc. ### 1062670###Speaker###Pricnicipal Scientist###Merck & Co., Inc.###Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
### @@@ Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA ### 1659297###Speaker###Associate Director ###Office of Vaccines Research and Review, CBER/FDA###Speaker: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
### @@@ Robert T. Chen, MA, MD, FISPE – Brighton Collaboration ### 1088150###Speaker###Scientific Director###Brighton Collaboration###Speaker: Robert T. Chen, MA, MD, FISPE – Brighton Collaboration
### @@@ Joanne Wu, ScD (she/her/hers) – Pfizer Inc ### 1993416###Speaker###Associate Director, Epidemiology###Pfizer Inc###Speaker: Joanne Wu, ScD (she/her/hers) – Pfizer Inc
### she/her/hers @@@ Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc ### 1991413###Speaker###Director, Global Safety Epidemiology###Moderna, Inc###Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc
### she/her/hers @@@ Deshayne B. Fell – University of Ottawa ### 1062677###Speaker###Dr. ###University of Ottawa###Speaker: Deshayne B. Fell – University of Ottawa
### @@@ Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA ### 1655874###Speaker###Associate Professor###University of San Francisco, San Francisco CA, USA###Speaker: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA
### she/her/hers @@@ Leah J. McGrath, PhD – Pfizer ### 1659611###Speaker###Senior Director, Vaccines RWE###Pfizer###Speaker: Leah J. McGrath, PhD – Pfizer
### @@@ Christopher G. Prener, PhD – Pfizer, Inc ### 1991415###Speaker###Director, Vaccines RWE Biocurator Scientist###Pfizer, Inc###Speaker: Christopher G. Prener, PhD – Pfizer, Inc
###Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers @@@ Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062592###Speaker###Associate Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Speaker: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Speaker###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Mugdha Gokhale, PhD – Pfizer ### 1088166###Speaker###Director, Value & Evidence###Pfizer###Speaker: Mugdha Gokhale, PhD – Pfizer
### @@@ Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062525###Speaker###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Speaker: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### he/him/his @@@ Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet ### 1932107###Speaker###Postdoctoral Researcher###Karolinska Institutet###Speaker: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet
### she/her/hersCo-Author: Marina G. Birck, Pharmacist, MSc, PhD (she/her/hers) – Research Institute of the McGill University Health Centre
### she/her/hers @@@ Autumn Neville – Research Institute of the McGill University Health Centre ### 1991323###Co-Author######Research Institute of the McGill University Health Centre###Co-Author: Autumn Neville – Research Institute of the McGill University Health Centre
### @@@ Louise Pilote, MD, MPH, PhD, FRCPC – Research Institute of the McGill University Health Centre ### 1360026###Co-Author######Research Institute of the McGill University Health Centre###Co-Author: Louise Pilote, MD, MPH, PhD, FRCPC – Research Institute of the McGill University Health Centre
### @@@ Erik Youngson, Mr, MMath, P.Stat – Alberta Strategy for Patient Oriented Research ### 1991324###Co-Author###Associate Director###Alberta Strategy for Patient Oriented Research###Co-Author: Erik Youngson, Mr, MMath, P.Stat – Alberta Strategy for Patient Oriented Research
### @@@ James A. King – Alberta Strategy for Patient Oriented Research ### 1991325###Co-Author######Alberta Strategy for Patient Oriented Research###Co-Author: James A. King – Alberta Strategy for Patient Oriented Research
### @@@ Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal ### 1302804###Co-Author###Professor Researcher###University of Montreal###Co-Author: Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal
### she/her/hers @@@ Sherif Eltonsy, PhD – University of Manitoba ### 1357974###Co-Author###Assistant Professor###University of Manitoba###Co-Author: Sherif Eltonsy, PhD – University of Manitoba
### @@@ Cristiano S. Moura – Research Institute of the McGill University Health Centre ### 1062600###Co-Author######Research Institute of the McGill University Health Centre###Co-Author: Cristiano S. Moura – Research Institute of the McGill University Health Centre
### @@@ Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE ### 1358207###Presenting Author###Professor of medicine ###McGill University, Dept. of Medicine and CORE###Presenting Author: Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE
###Co-Author: Wilhelmine Meeraus, PhD – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK
### @@@ Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK ### 1360359###Co-Author######Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK###Co-Author: Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK
### @@@ Eduardo Conde-Sousa – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK ### 1991345###Co-Author######Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK###Co-Author: Eduardo Conde-Sousa – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK
### @@@ Andrew Lee – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Cambridge, UK ### 1991346###Co-Author######Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Cambridge, UK###Co-Author: Andrew Lee – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Cambridge, UK
### @@@ Abigail Postema – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK ### 1991347###Co-Author######Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK###Co-Author: Abigail Postema – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK
### @@@ Andre Santa Maria – Evidence Generation, AstraZeneca, São Paulo, Brazil ### 1991348###Co-Author######Evidence Generation, AstraZeneca, São Paulo, Brazil###Co-Author: Andre Santa Maria – Evidence Generation, AstraZeneca, São Paulo, Brazil
### @@@ Bárbara Emoingt Furtado, MD, MBA – Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, São Paulo, Brazil ### 1991349###Co-Author###International Associate Medical Director Vaccines & Immune###Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, São Paulo, Brazil###Co-Author: Bárbara Emoingt Furtado, MD, MBA – Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, São Paulo, Brazil
### @@@ Claudia Corte – Evidence Generation, AstraZeneca, São Paulo, Brazil ### 1991350###Co-Author######Evidence Generation, AstraZeneca, São Paulo, Brazil###Co-Author: Claudia Corte – Evidence Generation, AstraZeneca, São Paulo, Brazil
### @@@ Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden ### 1358658###Co-Author######Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden###Co-Author: Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden
### @@@ Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK ### 1658805###Presenting Author###Senior Director, Epidemiology###Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK###Presenting Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK
###Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Tarry Ahuja, PhD (he/him/his) – Canadian Agency for Drugs and Technologies in Health ### 1991598###Speaker###Director, Post-Market Drug Evaluation###Canadian Agency for Drugs and Technologies in Health###Speaker: Tarry Ahuja, PhD (he/him/his) – Canadian Agency for Drugs and Technologies in Health
### he/him/his @@@ Melissa Kampman, PhD (she/her/hers) – Health Canada ### 1991542###Speaker###Manager, Data Analytics and Real-world Evidence Division###Health Canada###Speaker: Melissa Kampman, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration ### 1655443###Speaker###Acting Deputy Director, Office of Pharmacovigilance and Epidemiology###U.S. Food and Drug Administration###Speaker: David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Speaker###Associate Professor###McGill University###Speaker: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/hisLead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Lead Speaker###Assistant professor###Syddansk Universitet###Lead Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
### @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Speaker###Assistant Professor###University of Toronto###Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Speaker###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
### @@@ Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university ### 1358174###Speaker###Professor###Uppsala university###Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university
### he/him/hisLead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Dana Y. Teltsch, PhD, MSc – Takeda ### 1088160###Lead Speaker###Global Medical Evidence###Takeda###Lead Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
### @@@ Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG ### 1088161###Speaker###Director TA Methodology Statistician RWE ###Boehringer Ingelheim Pharma GmbH & Co. KG###Speaker: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
### @@@ Orla M. Doyle, PhD, BEng – Novartis ### 1088162###Speaker###Director Data Science###Novartis###Speaker: Orla M. Doyle, PhD, BEng – Novartis
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hersCo-Author: Mallika L. Mundkur, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Co-Author###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Qin Ryan, MD, PhD – Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991373###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Qin Ryan, MD, PhD – Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Rosanna Setse, MD, PhD – Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991374###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Rosanna Setse, MD, PhD – Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Presenting Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Presenting Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Meredith Epperson – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991460###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Meredith Epperson – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1359984###Co-Author###Research Analyst II###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ James Marshall, MPH – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1358682###Co-Author###Research Analyst III###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: James Marshall, MPH – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Elizabeth K. Sirasonian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1657942###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Elizabeth K. Sirasonian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Emma C. Whited – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991461###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Emma C. Whited – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Michael D. Blum, MD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991375###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Michael D. Blum, MD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hersCo-Author: Thomas Delvin, MD – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health,Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Sofie D. Egsgaard, MSPH (she/her/hers) – University of Southern Denmark ### 1991402###Co-Author###PhD-Student###University of Southern Denmark###Co-Author: Sofie D. Egsgaard, MSPH (she/her/hers) – University of Southern Denmark
### she/her/hers @@@ Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark ### 1358299###Co-Author###MD###Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark###Co-Author: Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Presenting Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Presenting Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/his @@@ Martin Torp Rahbek, MD – University of Southern Denmark/Department of Public Health ### 1991403###Co-Author######University of Southern Denmark/Department of Public Health###Co-Author: Martin Torp Rahbek, MD – University of Southern Denmark/Department of Public Health
###Presenting Author: Jenna Wong, PhD – Harvard Medical School & Harvard Pilgrim Health Care Institute
### @@@ Suzanne M. Bertisch, MD, MPH – Harvard Medical School & Brigham and Women's Hospital ### 1991681###Co-Author######Harvard Medical School & Brigham and Women's Hospital###Co-Author: Suzanne M. Bertisch, MD, MPH – Harvard Medical School & Brigham and Women's Hospital
### @@@ Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 1358101###Co-Author######Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###Co-Author: Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
###Co-Moderator: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Co-Moderator###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###Co-Moderator: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/hisPresenting Author: Justin Bohn, ScD – Johnson & Johnson
### @@@ James P. Gilbert, PhD – Janssen Research & Development ### 1659757###Co-Author###Manager of Epidemiology Analytics###Janssen Research & Development###Co-Author: James P. Gilbert, PhD – Janssen Research & Development
### @@@ Christopher Knoll – Johnson & Johnson ### 1991162###Co-Author######Johnson & Johnson###Co-Author: Christopher Knoll – Johnson & Johnson
### @@@ David M. Kern, PhD, MS – Janssen Research & Development ### 1062834###Co-Author###Sr. Director, Epidemiology###Janssen Research & Development###Co-Author: David M. Kern, PhD, MS – Janssen Research & Development
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###Co-Moderator: Jessica M. Franklin, PhD (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Co-Moderator###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###Co-Moderator: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
###Lead Speaker: Jamie Geier, PhD (she/her/hers) – Novartis
### she/her/hers @@@ Kui Huang, PhD, MPH – Pfizer, Inc. ### 1359236###Speaker###Senior Director###Pfizer, Inc.###Speaker: Kui Huang, PhD, MPH – Pfizer, Inc.
### @@@ Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA ### 1063298###Speaker###Category Lead, Safety Evidence for Regulators###IQVIA###Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
### @@@ Quazi Ataher, MHS, MBBS, PhD – CSL Behring, King of Prussia, PA, USA ### 1089193###Speaker###Head of Clinical Epidemiology###CSL Behring, King of Prussia, PA, USA###Speaker: Quazi Ataher, MHS, MBBS, PhD – CSL Behring, King of Prussia, PA, USA
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hersCo-Moderator: Marleen Van Gelder, PhD (she/her/hers) – Radboud university medical center
### she/her/hers @@@ Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University ### 1061395###Co-Moderator###Associate professor###Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University###Co-Moderator: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
### @@@ Lawrence Rasouliyan, MPH – OMNY Health ### 1359580###Co-Moderator###Head, Biostatistics & Data Science###OMNY Health###Co-Moderator: Lawrence Rasouliyan, MPH – OMNY Health
### @@@ Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine ### 1062599###Co-Moderator###Assistant Professor###London School of Hygiene & Tropical Medicine###Co-Moderator: Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine
###Co-Moderator: Jessica Jalbert, PhD (she/her/hers) – Regeneron
### she/her/hers @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Moderator###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Moderator: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Co-Moderator######Food and Drug Administration###Co-Moderator: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Leo J. Russo, PhD – Pfizer ### 1658914###Co-Moderator###VP, Global Medical Epidemiology###Pfizer###Co-Moderator: Leo J. Russo, PhD – Pfizer
###Co-Moderator: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Kourtney Davis, PhD MSPH FISPE (she/her/hers) – Janssen Research & Development ### 1292361###Co-Moderator###Vice President###Janssen Research & Development###Co-Moderator: Kourtney Davis, PhD MSPH FISPE (she/her/hers) – Janssen Research & Development
### she/her/hers @@@ Rachel E. Sobel, DrPH, FISPE (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1991877###Co-Moderator###Executive Director, Head of Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###Co-Moderator: Rachel E. Sobel, DrPH, FISPE (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Co-Moderator###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###Co-Moderator: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
###Co-Author: Debra Fromer – Hackensack University Medical Center, Hackensack, NJ, USA
### @@@ Wendy Y. Cheng, PhD, MPH – Analysis Group, Inc. ### 1991195###Co-Author######Analysis Group, Inc.###Co-Author: Wendy Y. Cheng, PhD, MPH – Analysis Group, Inc.
### @@@ Chi Gao, MS, ScD – Analysis Group, Inc., Boston, MA, USA ### 1991196###Co-Author######Analysis Group, Inc., Boston, MA, USA###Co-Author: Chi Gao, MS, ScD – Analysis Group, Inc., Boston, MA, USA
### @@@ Malena Mahendran, MSc – Analysis Group, Inc., Boston, MA, USA ### 1991197###Co-Author######Analysis Group, Inc., Boston, MA, USA###Co-Author: Malena Mahendran, MSc – Analysis Group, Inc., Boston, MA, USA
### @@@ Annalise Hilts – Analysis Group, Inc., Boston, MA, USA ### 1991198###Co-Author######Analysis Group, Inc., Boston, MA, USA###Co-Author: Annalise Hilts – Analysis Group, Inc., Boston, MA, USA
### @@@ Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA ### 1359083###Presenting Author###Chief Epidemiologist and Managing Principal###Analysis Group, Inc., Boston, MA, USA###Presenting Author: Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA
### she/her/hers @@@ Ashish V. Joshi, PhD – GSK, Collegeville, PA, USA ### 1991199###Co-Author######GSK, Collegeville, PA, USA###Co-Author: Ashish V. Joshi, PhD – GSK, Collegeville, PA, USA
### @@@ Aruni Mulgirigama – GSK, Surrey, UK ### 1991200###Co-Author######GSK, Surrey, UK###Co-Author: Aruni Mulgirigama – GSK, Surrey, UK
### @@@ Fanny S. Mitrani-Gold, MPH (she/her/hers) – GSK ### 1991193###Co-Author###Director of Epidemiology, Infectious Diseases###GSK###Co-Author: Fanny S. Mitrani-Gold, MPH (she/her/hers) – GSK
### she/her/hersPresenting Author: Felix Wittström, MD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1062759###Co-Author###Researcher###Centre for Pharmacoepidemiology, Karolinska Institutet###Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1360547###Co-Author###Senior Researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hers @@@ Marie Bendix – Karolinska Institutet ### 1991302###Co-Author######Karolinska Institutet###Co-Author: Marie Bendix – Karolinska Institutet
### @@@ Mette Bliddal, PhD – University of Southern Denmark ### 1062809###Co-Author###Associate professor###University of Southern Denmark###Co-Author: Mette Bliddal, PhD – University of Southern Denmark
### @@@ Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki ### 1360036###Co-Author###Professor###Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki###Co-Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
### @@@ Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1358190###Co-Author###Associate professor###Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###Co-Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1358376###Co-Author######Clinical Epidemiology Division, Karolinska Institutet###Co-Author: Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Co-Author###Assistant professor###Syddansk Universitet###Co-Author: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
### @@@ Helga Zoega – University of New South Wales - Sydney ### 1358124###Co-Author###Associate professor/professor###University of New South Wales - Sydney###Co-Author: Helga Zoega – University of New South Wales - Sydney
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet###Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
###Co-Moderator: Emily S. Brouwer, PhD – University of Kentucky College of Pharmacy
### @@@ Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal ### 1302804###Co-Moderator###Professor Researcher###University of Montreal###Co-Moderator: Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal
### she/her/hersPresenting Author: Theresa Burkard, PhD (she/her/hers) – ETH Zurich
### she/her/hers @@@ Enriqueta Vallejo-Yagüe – ETH Zurich ### 1085673###Co-Author###PhD Candidate###ETH Zurich###Co-Author: Enriqueta Vallejo-Yagüe – ETH Zurich
### @@@ Kim Lauper – Geneva University Hospitals ### 1993260###Co-Author######Geneva University Hospitals###Co-Author: Kim Lauper – Geneva University Hospitals
### @@@ Axel Finckh – Geneva University Hospitals ### 1358408###Co-Author######Geneva University Hospitals###Co-Author: Axel Finckh – Geneva University Hospitals
### @@@ Thomas Hügle, PhD – Lausanne University Hospital ### 1358769###Co-Author######Lausanne University Hospital###Co-Author: Thomas Hügle, PhD – Lausanne University Hospital
### @@@ Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland ### 1358409###Co-Author###Assistant Professor###Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland###Co-Author: Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
###Presenting Author: Samuel Hawley, DPhil, MSc – University of Bristol
### @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Gulraj Matharu – University of Bristol ### 1991571###Co-Author######University of Bristol###Co-Author: Gulraj Matharu – University of Bristol
### @@@ Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Andrew Judge – University of Bristol ### 1991572###Co-Author######University of Bristol###Co-Author: Andrew Judge – University of Bristol
### @@@ Michael Whitehouse – University of Bristol ### 1991573###Co-Author######University of Bristol###Co-Author: Michael Whitehouse – University of Bristol
###Presenting Author: Qing Liu, MD – Karolinska Institutet
### @@@ Xinchen Wang – Karolinska Institutet ### 1991604###Co-Author######Karolinska Institutet###Co-Author: Xinchen Wang – Karolinska Institutet
### @@@ Lars Engstrand – Karolinska Institutet ### 1991605###Co-Author######Karolinska Institutet###Co-Author: Lars Engstrand – Karolinska Institutet
### @@@ Omid Sadr-Azodi – Karolinska Institutet ### 1991606###Co-Author######Karolinska Institutet###Co-Author: Omid Sadr-Azodi – Karolinska Institutet
### @@@ Katja Fall – Karolinska Institutet ### 1991607###Co-Author######Karolinska Institutet###Co-Author: Katja Fall – Karolinska Institutet
### @@@ Nele Brusselaers – Karolinska Institutet ### 1991608###Co-Author######Karolinska Institutet###Co-Author: Nele Brusselaers – Karolinska Institutet
###Co-Moderator: Macarius M. Donneyong, PhD – The Ohio State University
### @@@ Eileen E. Ming, MPH, ScD, FISPE (she/her/hers) – Epi Excellence LLC ### 1409662###Co-Moderator###Founder & CEO###Epi Excellence LLC###Co-Moderator: Eileen E. Ming, MPH, ScD, FISPE (she/her/hers) – Epi Excellence LLC
### she/her/hersCo-Moderator: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Chioma S. Ejekam, MPH, MSc, FMCPH (she/her/hers) – University of Lagos ### 1062966###Co-Moderator###Dr(Mrs)###University of Lagos###Co-Moderator: Chioma S. Ejekam, MPH, MSc, FMCPH (she/her/hers) – University of Lagos
### she/her/hersCo-Author: Jenny Guadamuz, PhD – Flatiron Health
### @@@ Xiaoliang Wang, PhD, MPH (she/her/hers) – Flatiron Health ### 1991383###Co-Author###Senior Quantitative Scientist###Flatiron Health###Co-Author: Xiaoliang Wang, PhD, MPH (she/her/hers) – Flatiron Health
### she/her/hers @@@ Ivy Altomare – Flatiron Health ### 1991384###Co-Author######Flatiron Health###Co-Author: Ivy Altomare – Flatiron Health
### @@@ Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California ### 1655507###Presenting Author###Adjunct Associate Professor###University of Southern California###Presenting Author: Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California
### he/him/hisLead Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA ### 1993856###Speaker###Director, Epidemiology###IQVIA###Speaker: Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA
### she/her/hers @@@ David Maislin – Biomedical Statistical Consulting ### 1761991###Speaker###Managing Partner###Biomedical Statistical Consulting###Speaker: David Maislin – Biomedical Statistical Consulting
### @@@ Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson ### 1088172###Speaker###VP, MedTech Epidemiology and Real-World Data Sciences###Office of the Chief Medical Officer, Johnson & Johnson###Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
###Lead Speaker: Jennifer Christian, PharmD,PhD, FISPE (she/her/hers) – TargetRWE
### she/her/hers @@@ Priscilla Velentgas, MS, PhD (she/her/hers) – Merck ### 2015422###Lead Speaker###Senior Principal Scientist###Merck###Lead Speaker: Priscilla Velentgas, MS, PhD (she/her/hers) – Merck
### she/her/hers @@@ Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC ### 1088317###Speaker###Founder and President###CERobs Consulting, LLC###Speaker: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
### @@@ Anne Trontell, MPH, MD (she/her/hers) – Patient Centered Outcomes Research Institute ### 1088318###Speaker###Associate Director, Clinical Effectiveness and Decision Science###Patient Centered Outcomes Research Institute###Speaker: Anne Trontell, MPH, MD (she/her/hers) – Patient Centered Outcomes Research Institute
### she/her/hers @@@ Jay Park, PhD (he/him/his) – Core Clinical Sciences ### 2100923###Speaker###Scientific Lead###Core Clinical Sciences###Speaker: Jay Park, PhD (he/him/his) – Core Clinical Sciences
### he/him/his @@@ Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE ### 1991710###Speaker###Director, Epidemiology###Target RWE###Speaker: Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE
### she/her/hersPresenting Author: Caitlin N. Dodd, PhD (she/her/hers) – Panalgo
### she/her/hers @@@ Elsie Divinagracia, MPH – Panalgo ### 1991661###Co-Author######Panalgo###Co-Author: Elsie Divinagracia, MPH – Panalgo
### @@@ Gally Reznor, MPH – Panalgo ### 1991662###Co-Author###Senior Analytic Consultant###Panalgo###Co-Author: Gally Reznor, MPH – Panalgo
### @@@ Michael J. Munsell, PhD – Panalgo ### 1661018###Co-Author###Director of Research###Panalgo###Co-Author: Michael J. Munsell, PhD – Panalgo
###Co-Moderator: Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
### @@@ Yea-Huei Kao Yang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358574###Co-Moderator###Professor###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Moderator: Yea-Huei Kao Yang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
###Lead Speaker: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Speaker######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Speaker: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Speaker###Professor of Epidemiology###Harvard University###Speaker: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Speaker######Brigham and Women's Hospital, Harvard Medical School###Speaker: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Presenting Author: Qingqing Hu, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, China
### @@@ Yuqin Cao – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China ### 1991537###Co-Author######Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China###Co-Author: Yuqin Cao – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
### @@@ Yuan Zhou, MMed – Johnson & Johnson Medical (Shanghai) LTD, Shanghai, China ### 1658453###Co-Author######Johnson & Johnson Medical (Shanghai) LTD, Shanghai, China###Co-Author: Yuan Zhou, MMed – Johnson & Johnson Medical (Shanghai) LTD, Shanghai, China
### @@@ Chengqiang Li – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China ### 1991538###Co-Author######Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China###Co-Author: Chengqiang Li – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
### @@@ Yajie Zhang – zhangyajieryan@163.com ### 1991539###Co-Author######zhangyajieryan@163.com###Co-Author: Yajie Zhang – zhangyajieryan@163.com
### @@@ Yongjing Zhang, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson ### 1358341###Co-Author######Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson###Co-Author: Yongjing Zhang, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson
### @@@ Hong Qiu, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson ### 1358342###Co-Author######Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson###Co-Author: Hong Qiu, PhD – Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson
### @@@ Hecheng Li – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China ### 1991540###Co-Author######Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China###Co-Author: Hecheng Li – Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
###Co-Author: Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht
### @@@ Svetlana V. Belitser – Utrecht University ### 1655669###Co-Author######Utrecht University###Co-Author: Svetlana V. Belitser – Utrecht University
### @@@ Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1655571###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###Co-Author: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Fabio Riefolo, PhD – Teamit Institute ### 1657346###Co-Author###Medical Writer###Teamit Institute###Co-Author: Fabio Riefolo, PhD – Teamit Institute
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Patricia García-Poza – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain ### 1655701###Co-Author######Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain###Co-Author: Patricia García-Poza – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain
### @@@ Mar Martín Pérez – Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1063260###Co-Author###PhD###Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain###Co-Author: Mar Martín Pérez – Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Juan José Carreras – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health). ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health).###Co-Author: Juan José Carreras – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health).
### @@@ Elisa Correcher-Martínez – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991142###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Elisa Correcher-Martínez – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Arantxa Urchueguía, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991141###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Arantxa Urchueguía, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Patrick C. Souverein, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Patrick C. Souverein, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands ### 1991418###Co-Author###PhD candidate###Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands###Co-Author: Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands
### @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT ### 1360173###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT###Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
### @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine, London###Co-Author: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1062523###Co-Author###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Presenting Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Presenting Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
###Presenting Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Christopher Bush, MPH (he/him/his) – Aetion, Inc. ### 1655850###Co-Author###Sr. Scientist ###Aetion, Inc.###Co-Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Katherine E. Mues – Aetion, Inc. ### 1655854###Co-Author######Aetion, Inc.###Co-Author: Katherine E. Mues – Aetion, Inc.
### @@@ Deesha A. Patel, MS (she/her/hers) – Aetion, Inc. ### 1655851###Co-Author###Senior Scientist###Aetion, Inc.###Co-Author: Deesha A. Patel, MS (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Victoria Cooley – Aetion, Inc. ### 1991444###Co-Author######Aetion, Inc.###Co-Author: Victoria Cooley – Aetion, Inc.
### @@@ Sahar Syed – Aetion, Inc. ### 1397917###Co-Author###Scientific Analyst###Aetion, Inc.###Co-Author: Sahar Syed – Aetion, Inc.
### @@@ Shaina Desai, MPH – Aetion, Inc. ### 1991445###Co-Author######Aetion, Inc.###Co-Author: Shaina Desai, MPH – Aetion, Inc.
### @@@ Brent Arakaki – Aetion, Inc. ### 1991446###Co-Author######Aetion, Inc.###Co-Author: Brent Arakaki – Aetion, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc.
### @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
###Presenting Author: Janet K. Sluggett, PhD (she/her/hers) – UniSA Allied Health & Human Performance, University of South Australia
### she/her/hers @@@ Tracy Air, M.Biostatistics – Registry of Senior Australians, South Australian Health and Medical Research Institute ### 1991378###Co-Author###Statistician###Registry of Senior Australians, South Australian Health and Medical Research Institute###Co-Author: Tracy Air, M.Biostatistics – Registry of Senior Australians, South Australian Health and Medical Research Institute
### @@@ Maria C. Inacio, PhD, MS, FAAG – Registry of Senior Australians, South Australian Health & Medical Research Institute ### 1655780###Co-Author###Director###Registry of Senior Australians, South Australian Health & Medical Research Institute###Co-Author: Maria C. Inacio, PhD, MS, FAAG – Registry of Senior Australians, South Australian Health & Medical Research Institute
### @@@ Catherine Lang – Registry of Senior Australians, South Australian Health & Medical Research Institute ### 1655999###Co-Author###Senior Data Officer/ Data Scientist###Registry of Senior Australians, South Australian Health & Medical Research Institute###Co-Author: Catherine Lang – Registry of Senior Australians, South Australian Health & Medical Research Institute
### @@@ Stephanie A. Ward – Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales ### 1991379###Co-Author######Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales###Co-Author: Stephanie A. Ward – Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales
### @@@ Susannah Ahern, MBBS, FRACMA, MBA, PhD – School of Public and Preventive Medicine, Monash University ### 1991380###Co-Author######School of Public and Preventive Medicine, Monash University###Co-Author: Susannah Ahern, MBBS, FRACMA, MBA, PhD – School of Public and Preventive Medicine, Monash University
### @@@ Xiaoping Lin – School of Public Health and Preventive Medicine, Monash University ### 1991381###Co-Author######School of Public Health and Preventive Medicine, Monash University###Co-Author: Xiaoping Lin – School of Public Health and Preventive Medicine, Monash University
### @@@ Kasey Wallis – School of Public Health and Preventive Medicine, Monash University ### 1991382###Co-Author######School of Public Health and Preventive Medicine, Monash University###Co-Author: Kasey Wallis – School of Public Health and Preventive Medicine, Monash University
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute ### 1655998###Co-Author###Associate Director###Registry of Senior Australians, South Australian Health and Medical Research Institute###Co-Author: Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute
###Presenting Author: Georgina A. Hughes, B.Pharm (Hons) B.PharmSc (she/her/hers) – UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia
### she/her/hers @@@ Maria C. Inacio, PhD, MS, FAAG – Registry of Senior Australians, South Australian Health & Medical Research Institute ### 1655780###Co-Author###Director###Registry of Senior Australians, South Australian Health & Medical Research Institute###Co-Author: Maria C. Inacio, PhD, MS, FAAG – Registry of Senior Australians, South Australian Health & Medical Research Institute
### @@@ Debra Rowett – UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia ### 1655474###Co-Author###Discipline Leader: Pharmacy External Relations###UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia###Co-Author: Debra Rowett – UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia
### @@@ Catherine Lang – Registry of Senior Australians, South Australian Health & Medical Research Institute ### 1655999###Co-Author###Senior Data Officer/ Data Scientist###Registry of Senior Australians, South Australian Health & Medical Research Institute###Co-Author: Catherine Lang – Registry of Senior Australians, South Australian Health & Medical Research Institute
### @@@ Robert N. Jorissen, PhD – Registry of Senior Australians, South Australian Health & Medical Research Institute, Adelaide, South Australia ### 1991289###Co-Author###Senior Research Fellow###Registry of Senior Australians, South Australian Health & Medical Research Institute, Adelaide, South Australia###Co-Author: Robert N. Jorissen, PhD – Registry of Senior Australians, South Australian Health & Medical Research Institute, Adelaide, South Australia
### @@@ Megan Corlis, RN – Australian Nursing and Midwifery Education Centre ### 1991290###Co-Author###Director - Education, Research & Aged Care###Australian Nursing and Midwifery Education Centre###Co-Author: Megan Corlis, RN – Australian Nursing and Midwifery Education Centre
### @@@ Janet K. Sluggett, PhD (she/her/hers) – UniSA Allied Health & Human Performance, University of South Australia ### 1656000###Co-Author###Enterprise Fellow###UniSA Allied Health & Human Performance, University of South Australia###Co-Author: Janet K. Sluggett, PhD (she/her/hers) – UniSA Allied Health & Human Performance, University of South Australia
### she/her/hersLead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ William G. Dixon, MD PhD – The University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###The University of Manchester###Speaker: William G. Dixon, MD PhD – The University of Manchester
### @@@ Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA ### 1063005###Speaker###Senior Scientist###UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA###Speaker: Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA
###Presenting Author: Chase D. Latour – UNC Gillings School of Global Public Health
### @@@ Clara E. Busse, MPH – Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1991130###Co-Author###Doctoral Candidate###Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Clara E. Busse, MPH – Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Mekhala V. Dissanayake, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1991131###Co-Author###PhD Candidate###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Mekhala V. Dissanayake, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Sara Z. Dejene, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1655238###Co-Author###PhD Candidate###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Sara Z. Dejene, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Andrea K. Knittel, MD, PhD, FACOG – Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill ### 1991132###Co-Author######Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill###Co-Author: Andrea K. Knittel, MD, PhD, FACOG – Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill
### @@@ Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659932###Co-Author###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Alan Kinlaw, PhD, MSPH – University of North Carolina at Chapel Hill ### 1659633###Co-Author###Assistant Professor###University of North Carolina at Chapel Hill###Co-Author: Alan Kinlaw, PhD, MSPH – University of North Carolina at Chapel Hill
###Presenting Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Yanning Wang, MS – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1358834###Co-Author###Graduate Student###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Yanning Wang, MS – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1358688###Co-Author###Graduate Student###Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School ### 1062542###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute/Harvard Medical School###Co-Author: Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School
### she/her/hers @@@ Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1657495###Co-Author###Graduate Assistant###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Sonja Rasmussen, MD – Department of Genetic Medicine, School of Medicine, Johns Hopkins University ### 1991648###Co-Author######Department of Genetic Medicine, School of Medicine, Johns Hopkins University###Co-Author: Sonja Rasmussen, MD – Department of Genetic Medicine, School of Medicine, Johns Hopkins University
###Presenting Author: Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark
### @@@ Morten Olesen – University of Southern Denmark ### 1357897###Co-Author######University of Southern Denmark###Co-Author: Morten Olesen – University of Southern Denmark
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Co-Author###Assistant professor###Syddansk Universitet###Co-Author: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
###Presenting Author: Alec Walker, MD, DrPH (he/him/his) – Harvard TH Chan School of Public Health
### he/him/his @@@ Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991331###Co-Author###Instructor###Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Maria C. Schneeweiss, MD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360208###Co-Author###Instructor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Maria C. Schneeweiss, MD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
###Presenting Author: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Lorenzo Trippa, PhD – Data Farber Cancer Institute ### 1991330###Co-Author######Data Farber Cancer Institute###Co-Author: Lorenzo Trippa, PhD – Data Farber Cancer Institute
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991331###Co-Author###Instructor###Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Punam Keller, PhD – Dartmouth College ### 1991332###Co-Author######Dartmouth College###Co-Author: Punam Keller, PhD – Dartmouth College
### @@@ Ted Robertson, MPA – ideas42 ### 1991333###Co-Author######ideas42###Co-Author: Ted Robertson, MPA – ideas42
### @@@ Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991334###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991335###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655660###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
###Presenting Author: Christopher Gravel, PhD (he/him/his) – School of Epidemiology and Public Health, University of Ottawa
### he/him/his @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Co-Author###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###Co-Author: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/hisPresenting Author: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Jeremy Brown, MSc – London School of Hygiene and Tropical Medicine ### 1062859###Co-Author###PhD student###London School of Hygiene and Tropical Medicine###Co-Author: Jeremy Brown, MSc – London School of Hygiene and Tropical Medicine
### @@@ Daniel R. Morales – Division of Population Health and Genomics, University of Dundee, Dundee, UK. ### 1991489###Co-Author######Division of Population Health and Genomics, University of Dundee, Dundee, UK.###Co-Author: Daniel R. Morales – Division of Population Health and Genomics, University of Dundee, Dundee, UK.
### @@@ Elizabeth Williamson, PhD – Department of Medical Statistics, London School of Hygiene and Tropical Medicine ### 1358765###Co-Author###Professor of Biostatistics and Health Data Science###Department of Medical Statistics, London School of Hygiene and Tropical Medicine###Co-Author: Elizabeth Williamson, PhD – Department of Medical Statistics, London School of Hygiene and Tropical Medicine
### @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine, London###Co-Author: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
###Lead Speaker: Madlen Gazarian, MBBBS (Hons1), MSc(ClinEpi), FRACP (she/her/hers) – Faculty of Medicine & Health, University of New South Wales, Sydney, 2052, Australia
### she/her/hers @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Speaker###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###Speaker: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/his @@@ Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia ### 1046820###Speaker###Professor###University of British Columbia###Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
### @@@ Emily F. Gorman, MLIS (she/her/hers) – University of Maryland, Baltimore ### 1659621###Speaker###Research and Education Librarian###University of Maryland, Baltimore###Speaker: Emily F. Gorman, MLIS (she/her/hers) – University of Maryland, Baltimore
### she/her/hers @@@ Lina Titievsky, PhD, MPH (she/her/hers) – GSK ### 1991172###Speaker###Senior Director, head of immunology and opportunistic epidemiology ###GSK###Speaker: Lina Titievsky, PhD, MPH (she/her/hers) – GSK
### she/her/hers @@@ Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital ### 1062665###Speaker###Associate Professor###Nationwide Children's Hospital###Speaker: Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Speaker###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Speaker: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
###Presenting Author: Nuvan Rathnayaka – TargetRWE
### @@@ Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE ### 1991710###Co-Author###Director, Epidemiology###Target RWE###Co-Author: Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE
### she/her/hersPresenting Author: Carla Y. Vossen, PhD – Syneos Health
### @@@ Jessica D. Albano, MPH, PhD – Syneos Health ### 1063360###Co-Author###VP Epidemiology, RWE###Syneos Health###Co-Author: Jessica D. Albano, MPH, PhD – Syneos Health
###Moderator: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
### @@@ Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency ### 1061402###Speaker###Dr.###European Medicines Agency###Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
### @@@ Stella Blackburn, MB BS MA MSc FRCP (edin) FISPE FFPM DLSHTM Dip Pharm Med – N/A ### 1397907###Speaker###N/A###N/A###Speaker: Stella Blackburn, MB BS MA MSc FRCP (edin) FISPE FFPM DLSHTM Dip Pharm Med – N/A
### @@@ Michael Wolf, PhD, MPH – Institute for Public Health and Medicine ### 2033614###Speaker###Associate Vice Chair for Research###Institute for Public Health and Medicine###Speaker: Michael Wolf, PhD, MPH – Institute for Public Health and Medicine
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Speaker###Senior DIrector###Evidera, Inc###Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Nicole Mittmann, PhD ### 2125315###Panelist#########Panelist: Nicole Mittmann, PhD
###Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.
### @@@ Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA ### 1046828###Speaker###Senior Advisor on RWE###US FDA###Speaker: Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA
### she/her/hers @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Speaker###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###Speaker: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/his @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics ### 1142411###Speaker###Team Lead, Science and Innovation Team###Office of Pediatric Therapeutics###Speaker: Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics
###Presenting Author: Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC
### @@@ Julia Phillippi – Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University ### 1991262###Co-Author######Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University###Co-Author: Julia Phillippi – Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University
### @@@ Alexandra Muhar, MD – Department of Pediatrics, Division of Neonatology, VUMC ### 1991263###Co-Author###Fellow###Department of Pediatrics, Division of Neonatology, VUMC###Co-Author: Alexandra Muhar, MD – Department of Pediatrics, Division of Neonatology, VUMC
### @@@ Aleksandra Polic – Department of Obstetrics and Gynecology, VUMC ### 1991264###Co-Author######Department of Obstetrics and Gynecology, VUMC###Co-Author: Aleksandra Polic – Department of Obstetrics and Gynecology, VUMC
### @@@ Ge Liu – Center for Precision Medicine, VUMC ### 1991265###Co-Author######Center for Precision Medicine, VUMC###Co-Author: Ge Liu – Center for Precision Medicine, VUMC
### @@@ Sarah Loch – Vanderbilt Center for Child Health Policy, VUMC ### 1991266###Co-Author######Vanderbilt Center for Child Health Policy, VUMC###Co-Author: Sarah Loch – Vanderbilt Center for Child Health Policy, VUMC
### @@@ Henry H. Ong, PhD – Center for Precision Medicine, VUMC ### 1991267###Co-Author######Center for Precision Medicine, VUMC###Co-Author: Henry H. Ong, PhD – Center for Precision Medicine, VUMC
### @@@ Wu-Chen Su – Center for Precision Medicine, VUMC ### 1991268###Co-Author######Center for Precision Medicine, VUMC###Co-Author: Wu-Chen Su – Center for Precision Medicine, VUMC
### @@@ Wei-Qi Wei – Center for Precision Medicine, Department of Biomedical Informatics, VUMC ### 1991269###Co-Author######Center for Precision Medicine, Department of Biomedical Informatics, VUMC###Co-Author: Wei-Qi Wei – Center for Precision Medicine, Department of Biomedical Informatics, VUMC
### @@@ Stephen W. Patrick, MD, MPHS, MS – Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC ### 1360466###Co-Author###Associate Professor of Pediatrics & Health Policy###Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC###Co-Author: Stephen W. Patrick, MD, MPHS, MS – Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC
###Presenting Author: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Elad Yom-Tov, PhD – Microsoft Research Labs ### 1991336###Co-Author######Microsoft Research Labs###Co-Author: Elad Yom-Tov, PhD – Microsoft Research Labs
### @@@ Punam Keller, PhD – Dartmouth College ### 1991332###Co-Author######Dartmouth College###Co-Author: Punam Keller, PhD – Dartmouth College
### @@@ Marie McDonnell, MD – Brigham and Women's Hospital, Endocrinology ### 1991337###Co-Author######Brigham and Women's Hospital, Endocrinology###Co-Author: Marie McDonnell, MD – Brigham and Women's Hospital, Endocrinology
### @@@ Katherine Crum – Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991338###Co-Author######Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Katherine Crum – Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Gauri Bhatkhande, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1991339###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Gauri Bhatkhande, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991334###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991335###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655660###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
###Lead Speaker: Darmendra Ramcharran, PhD, MPH – GSK
### @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Speaker######Food and Drug Administration###Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson ### 1088172###Speaker###VP, MedTech Epidemiology and Real-World Data Sciences###Office of the Chief Medical Officer, Johnson & Johnson###Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ William G. Dixon, MD PhD – The University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###The University of Manchester###Speaker: William G. Dixon, MD PhD – The University of Manchester
###Presenting Author: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University
### she/her/hers @@@ Amy Grant – Maritime SPOR Support Unit ### 1993625###Co-Author###Senior Health Policy Researcher###Maritime SPOR Support Unit###Co-Author: Amy Grant – Maritime SPOR Support Unit
### @@@ Alice Bruce, M.Sc. – Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit) ### 1993626###Co-Author###Research Assistant###Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit)###Co-Author: Alice Bruce, M.Sc. – Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit)
### @@@ Judith Fisher, BScPhm, PhD – Nova Scotia Department of Health and Wellness ### 1993633###Co-Author######Nova Scotia Department of Health and Wellness###Co-Author: Judith Fisher, BScPhm, PhD – Nova Scotia Department of Health and Wellness
### @@@ Katelyn M. Frizzell, MSc – Nova Scotia Health ### 1993629###Co-Author######Nova Scotia Health###Co-Author: Katelyn M. Frizzell, MSc – Nova Scotia Health
### @@@ Elizabeth Jeffers – Maritime SPOR SUPPORT Unit ### 1993630###Co-Author###Research Manager###Maritime SPOR SUPPORT Unit###Co-Author: Elizabeth Jeffers – Maritime SPOR SUPPORT Unit
### @@@ Rebecca D. Lawrence, BScPharm – Dalhousie University ### 1993632###Co-Author######Dalhousie University###Co-Author: Rebecca D. Lawrence, BScPharm – Dalhousie University
### @@@ Lihui Liu – MSSU ### 1994187###Co-Author###Senior Data Analyst###MSSU###Co-Author: Lihui Liu – MSSU
### @@@ Andrea Murphy – Dalhousie University ### 1993634###Co-Author######Dalhousie University###Co-Author: Andrea Murphy – Dalhousie University
### @@@ Ingrid Sketris, PharmD – Dalhousie University ### 1358680###Co-Author###Professor###Dalhousie University###Co-Author: Ingrid Sketris, PharmD – Dalhousie University
### @@@ Samuel A. Stewart, PhD – Dalhousie University ### 1092270###Co-Author###Associate Professor###Dalhousie University###Co-Author: Samuel A. Stewart, PhD – Dalhousie University
### @@@ Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University ### 1063128###Co-Author###Assistant Professor###Dalhousie University###Co-Author: Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University
### she/her/hers @@@ Lisa Woodill – Pharmacy Association of Nova Scotia ### 1993636###Co-Author###Director of Pharmacy Practice###Pharmacy Association of Nova Scotia###Co-Author: Lisa Woodill – Pharmacy Association of Nova Scotia
###Co-Moderator: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1655571###Co-Moderator###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###Co-Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hersLead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Speaker###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/hisModerator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Speaker######Food and Drug Administration###Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/hisLead Speaker: Amalia M. Issa, PhD, MPH, FISPE
### @@@ Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine ### 1086987###Lead Speaker###Associate Dean###University of Missouri School of Medicine###Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine
### @@@ Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida ### 1359594###Speaker###Professor of Epidemiology###University of Florida###Speaker: Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida
### @@@ Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC ### 1088169###Speaker###Professor of Precision Medicine in Respiratory Disease###Amsterdam UMC###Speaker: Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC
### she/her/hers @@@ Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia ### 1046820###Speaker###Professor###University of British Columbia###Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
###Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Lead Speaker###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 1062637###Speaker###Chief Science Officer###Uppsala Monitoring Centre###Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
### @@@ Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline ### 1063261###Speaker###Senior Director, Safety and Clinical Innovation###GlaxoSmithKline###Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline
### he/him/hisCo-Moderator: Nelson Pace, PhD, SM – AbbVie, Inc.
### @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Co-Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###Co-Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hersPresenting Author: Xuya(Rayna) Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health
### she/her/hers @@@ Hemalkumar B. Mehta, PhD, MS – Johns Hopkins Bloomberg School of Public Health ### 1093588###Co-Author###Assistant Professor###Johns Hopkins Bloomberg School of Public Health###Co-Author: Hemalkumar B. Mehta, PhD, MS – Johns Hopkins Bloomberg School of Public Health
### @@@ Jill Curran, MS – Johns Hopkins Bloomberg School of Public Health ### 1659092###Co-Author###Research Program Manager###Johns Hopkins Bloomberg School of Public Health###Co-Author: Jill Curran, MS – Johns Hopkins Bloomberg School of Public Health
### @@@ Brian T. Garibaldi – Johns Hopkins University School of Medicine ### 1302716###Co-Author###Associate Professor###Johns Hopkins University School of Medicine###Co-Author: Brian T. Garibaldi – Johns Hopkins University School of Medicine
### @@@ G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health ### 1991150###Co-Author###Professor of Epidemiology and Medicine###Johns Hopkins Bloomberg School of Public Health###Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health
###Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Speaker###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Speaker: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/his @@@ Jessica Jalbert, PhD (she/her/hers) – Regeneron ### 2015396###Speaker###Executive Director - HEOR-Epidemiology###Regeneron###Speaker: Jessica Jalbert, PhD (she/her/hers) – Regeneron
### she/her/hers @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Speaker###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
### @@@ Ximena Camacho, MMath (she/her/hers) – UNSW Sydney ### 1658324###Speaker###PhD candidate###UNSW Sydney###Speaker: Ximena Camacho, MMath (she/her/hers) – UNSW Sydney
### she/her/hers @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Speaker###Associate Director for Science###US Food and Drug Administration###Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Speaker###Senior Epidemiologist###US Food and Drug Administration###Speaker: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Olivier Humblet ### 2125427###Speaker#########Speaker: Olivier Humblet
###Presenting Author: Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark
### @@@ Mette Bliddal, PhD – University of Southern Denmark ### 1062809###Co-Author###Associate professor###University of Southern Denmark###Co-Author: Mette Bliddal, PhD – University of Southern Denmark
### @@@ Martin Thomsen Ernst – University of Southern Denmark ### 1358301###Co-Author######University of Southern Denmark###Co-Author: Martin Thomsen Ernst – University of Southern Denmark
### @@@ Rikke Wesselhoeft, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark ### 1062690###Co-Author###Associate Professor###Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark###Co-Author: Rikke Wesselhoeft, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### @@@ Kara G. Margolis, MD – New York University College of Dental Medicine ### 1991458###Co-Author###Associate Professor of Molecular Pathobiology and Pediatrics###New York University College of Dental Medicine###Co-Author: Kara G. Margolis, MD – New York University College of Dental Medicine
### @@@ Ardesheer Talati, PhD – Columbia University ### 1657812###Co-Author######Columbia University###Co-Author: Ardesheer Talati, PhD – Columbia University
###Presenting Author: Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 1084118###Co-Author###Manager###Janssen Research & Development, Johnson & Johnson###Co-Author: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School ### 1062542###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute/Harvard Medical School###Co-Author: Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School
### she/her/hers @@@ Sebastian Jugl, BPharm, RPh (he/him/his) – University of Florida ### 1063291###Co-Author###PhD Student###University of Florida###Co-Author: Sebastian Jugl, BPharm, RPh (he/him/his) – University of Florida
### he/him/his @@@ Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1657495###Co-Author###Graduate Assistant###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
###Presenting Author: Oliver Scholle, PhD – Leibniz Institute for Prevention Research and Epidemiology – BIPS
### @@@ Kathrin Jobski, PhD – Department of Health Services Research, Carl von Ossietzky University Oldenburg ### 1991250###Co-Author######Department of Health Services Research, Carl von Ossietzky University Oldenburg###Co-Author: Kathrin Jobski, PhD – Department of Health Services Research, Carl von Ossietzky University Oldenburg
### @@@ Jost Viebrock – Leibniz Institute for Prevention Research and Epidemiology – BIPS ### 1661022###Co-Author######Leibniz Institute for Prevention Research and Epidemiology – BIPS###Co-Author: Jost Viebrock – Leibniz Institute for Prevention Research and Epidemiology – BIPS
### @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###Presenting Author: Omar Mansour, MHS – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
### @@@ Rienna Russo – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States ### 1991716###Co-Author######Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States###Co-Author: Rienna Russo – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
### @@@ Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School ### 1062604###Co-Author###Research Fellow###Brigham and Women's Hospital/Harvard Medical School###Co-Author: Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
###Presenting Author: Donald R. Miller, ScD – EOS
### @@@ Guneet Jasuja, PhD – Center for Healthcare Organization and Implementation Research ### 1991718###Co-Author###Research Scientist###Center for Healthcare Organization and Implementation Research###Co-Author: Guneet Jasuja, PhD – Center for Healthcare Organization and Implementation Research
### @@@ Byron Aguilar, PhD – Geriatric Research Education and Clinical Center, VA Bedford Healthcare System ### 1991720###Co-Author###Research Scientist###Geriatric Research Education and Clinical Center, VA Bedford Healthcare System###Co-Author: Byron Aguilar, PhD – Geriatric Research Education and Clinical Center, VA Bedford Healthcare System
### @@@ Xuyang Li, BS – Department of Biomedical Engineering, Johns Hopkins University ### 1991721###Co-Author###Doctoral student###Department of Biomedical Engineering, Johns Hopkins University###Co-Author: Xuyang Li, BS – Department of Biomedical Engineering, Johns Hopkins University
### @@@ Ekaterina Shishova, PhD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell ### 1991722###Co-Author###Research Scientist###Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell###Co-Author: Ekaterina Shishova, PhD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell
### @@@ Dan Berlowitz, MPH MD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell ### 1991723###Co-Author###Chair and Professor###Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell###Co-Author: Dan Berlowitz, MPH MD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell
### @@@ Peter Morin, MD PhD – Department of Neurology, Boston University School of Medicine ### 1991724###Co-Author###Clinical Associate Professor###Department of Neurology, Boston University School of Medicine###Co-Author: Peter Morin, MD PhD – Department of Neurology, Boston University School of Medicine
### @@@ Maureen K. O'Conner, PsyD – Department of Neurology, Boston University School of Medicine ### 1991725###Co-Author###Assistant Professor###Department of Neurology, Boston University School of Medicine###Co-Author: Maureen K. O'Conner, PsyD – Department of Neurology, Boston University School of Medicine
### @@@ Andrew Nguyen, M.A. – VA Bedford Healthcare System ### 1991726###Co-Author###Research Associate###VA Bedford Healthcare System###Co-Author: Andrew Nguyen, M.A. – VA Bedford Healthcare System
### @@@ Cindy Christiansen, PhD – Goldman School of Dental Medicine, Boston University ### 1991727###Co-Author###Professor###Goldman School of Dental Medicine, Boston University###Co-Author: Cindy Christiansen, PhD – Goldman School of Dental Medicine, Boston University
### @@@ Raymond Zhang, MD PhD – Epidemiology, Biostatistics and Occupational Health, McGill University ### 1991728###Co-Author###Adjunct Professor###Epidemiology, Biostatistics and Occupational Health, McGill University###Co-Author: Raymond Zhang, MD PhD – Epidemiology, Biostatistics and Occupational Health, McGill University
### @@@ Amir Abbas Tahami Monfared, MD, PhD – Eisai Inc., USA ### 1991392###Co-Author###Executive Director###Eisai Inc., USA###Co-Author: Amir Abbas Tahami Monfared, MD, PhD – Eisai Inc., USA
### @@@ Quanwu Zhang, PhD – Eisai Inc., USA ### 1991391###Co-Author###Senior Director###Eisai Inc., USA###Co-Author: Quanwu Zhang, PhD – Eisai Inc., USA
### @@@ Weiming Xia, PhD – Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine ### 1991729###Co-Author###Professor###Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine###Co-Author: Weiming Xia, PhD – Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine
###Presenting Author: Janick Weberpals, RPh, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Co-Author###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Co-Author: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Pamela A. Shaw – Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA ### 1991182###Co-Author######Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA###Co-Author: Pamela A. Shaw – Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA
### @@@ Hana Lee, PhD – Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1655520###Co-Author######Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Hana Lee, PhD – Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Co-Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Co-Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/his @@@ Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 1358101###Co-Author######Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###Co-Author: Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ John G. Connolly, ScD – Harvard Pilgrim Health Care Institute ### 1063038###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute###Co-Author: John G. Connolly, ScD – Harvard Pilgrim Health Care Institute
### @@@ Kimberly J. Dandreo – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA ### 1991184###Co-Author######Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA###Co-Author: Kimberly J. Dandreo – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Luke Zabotka – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1659303###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Luke Zabotka – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Fang Tian – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1659617###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###Co-Author: Fang Tian – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1358274###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###Co-Author: Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Jie Li, PhD – US Food and Drug Administration ### 1062564###Co-Author###Associate Director for RWE at Office of Surveillance and Epidemiology, CDER###US Food and Drug Administration###Co-Author: Jie Li, PhD – US Food and Drug Administration
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Co-Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
###Lead Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Speaker###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hersLead Speaker: Echo Wang, DrPH, MSPH (she/her/hers) – Merck & Co. Inc.
### she/her/hers @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Randi Foraker, PhD, MA – Washington University School of Medicine ### 1655736###Speaker###Professor of Medicine###Washington University School of Medicine###Speaker: Randi Foraker, PhD, MA – Washington University School of Medicine
### @@@ Lucy Mosquera, MSc (she/her/hers) – Replica Analytics ### 2043844###Speaker###Sr Director Data Science###Replica Analytics###Speaker: Lucy Mosquera, MSc (she/her/hers) – Replica Analytics
### she/her/hers @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real World Evidence###European Medicines Agency###Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Khaled El Emam – Replica Analytics ### 1655739###Speaker######Replica Analytics###Speaker: Khaled El Emam – Replica Analytics
###Presenting Author: Mary Ellen Vajravelu, MD, MSHP (she/her/hers) – University of Pittsburgh School of Medicine
### she/her/hers @@@ Patricia Chu, MD – Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania ### 1991496###Co-Author######Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania###Co-Author: Patricia Chu, MD – Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
### @@@ David A. Frank, MPH – Department of Epidemiology, University of Pittsburgh School of Public Health ### 1991203###Co-Author###Student###Department of Epidemiology, University of Pittsburgh School of Public Health###Co-Author: David A. Frank, MPH – Department of Epidemiology, University of Pittsburgh School of Public Health
### @@@ Ravy K. Vajravelu, MD MSCE – Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System ### 1991214###Co-Author###Assistant Professor of Medicine###Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System###Co-Author: Ravy K. Vajravelu, MD MSCE – Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System
###Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
###Co-Author: Karolina Zebrowska – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Rosa C. Banuelos, PhD – Lumen Value & Access, Healthcare Consultancy Group ### 1657562###Co-Author###Senior Statistician###Lumen Value & Access, Healthcare Consultancy Group###Co-Author: Rosa C. Banuelos, PhD – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Evelyn J. Rizzo, MSc – Lumen Value & Access, Healthcare Consultancy Group ### 1657563###Co-Author###Consultant###Lumen Value & Access, Healthcare Consultancy Group###Co-Author: Evelyn J. Rizzo, MSc – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Kathy W. Belk, BA – Lumen Value & Access, Healthcare Consultancy Group ### 1657565###Co-Author###Vice President###Lumen Value & Access, Healthcare Consultancy Group###Co-Author: Kathy W. Belk, BA – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Gary Schneider, MSPH, ScD – Lumen Value & Access, Healthcare Consultancy Group ### 1991709###Presenting Author###VP, Real World Evidence, Analytics & Innovation###Lumen Value & Access, Healthcare Consultancy Group###Presenting Author: Gary Schneider, MSPH, ScD – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Koen Degeling, PhD – Lumen Value & Access, Healthcare Consultancy Group ### 1657564###Co-Author###Scientific Director & Decision-Analytic Modeling Lead###Lumen Value & Access, Healthcare Consultancy Group###Co-Author: Koen Degeling, PhD – Lumen Value & Access, Healthcare Consultancy Group
###Presenting Author: Xiaofeng Zhou, PhD – Pfizer Inc
### @@@ Ling Li – Kite ### 1358441###Co-Author###associate director RWE###Kite###Co-Author: Ling Li – Kite
### @@@ Scott P. Kelly, PhD – Pfizer Inc, Global Medical Epidemiology, New York, NY ### 1358440###Co-Author###Senior Director, Global Medical Epidemiology ###Pfizer Inc, Global Medical Epidemiology, New York, NY###Co-Author: Scott P. Kelly, PhD – Pfizer Inc, Global Medical Epidemiology, New York, NY
### @@@ Heidi Leister-Tebbe – Pfizer Inc ### 1991522###Co-Author######Pfizer Inc###Co-Author: Heidi Leister-Tebbe – Pfizer Inc
### @@@ Steven G. Terra – Pfizer Inc ### 1991523###Co-Author######Pfizer Inc###Co-Author: Steven G. Terra – Pfizer Inc
### @@@ Rongjun Shen – Pfizer Inc ### 1358103###Co-Author######Pfizer Inc###Co-Author: Rongjun Shen – Pfizer Inc
### @@@ Mark Cullen, MD – Independent Researcher ### 1991426###Co-Author######Independent Researcher###Co-Author: Mark Cullen, MD – Independent Researcher
### @@@ Michael Gaffney, PhD. – Pfizer Inc ### 1991524###Co-Author###Vice President, Statistics###Pfizer Inc###Co-Author: Michael Gaffney, PhD. – Pfizer Inc
### @@@ Leo J. Russo, PhD – Pfizer ### 1658914###Co-Author###VP, Global Medical Epidemiology###Pfizer###Co-Author: Leo J. Russo, PhD – Pfizer
###Lead Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
### @@@ Costel Chirila, PhD – RTI Health Solutions ### 1991622###Speaker###Director of Biostatistics###RTI Health Solutions###Speaker: Costel Chirila, PhD – RTI Health Solutions
### @@@ Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health ### 1360646###Speaker######CAUSALab, Harvard T.H. Chan School of Public Health###Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
### @@@ Jason A. Roy, PhD – Rutgers University School of Public Health ### 1360415###Speaker###Professor of Biostatistics###Rutgers University School of Public Health###Speaker: Jason A. Roy, PhD – Rutgers University School of Public Health
### @@@ Paul Kluetz – US Food and Drug Administration ### 1993681###Speaker######US Food and Drug Administration###Speaker: Paul Kluetz – US Food and Drug Administration
###Presenting Author: Albert Cid-Royo, PhDs – UMC Utrecht
### @@@ Roel JH Elbers – Department of Datascience & Biostatistics, University Medical Center Utrecht ### 1657471###Co-Author######Department of Datascience & Biostatistics, University Medical Center Utrecht###Co-Author: Roel JH Elbers – Department of Datascience & Biostatistics, University Medical Center Utrecht
### @@@ Ema Alsina – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1655797###Co-Author######Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Ema Alsina – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Vjola Hoxhaj, PharmD, MSc, PhD Candidate – Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1991500###Co-Author###PhD Candidate###Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Vjola Hoxhaj, PharmD, MSc, PhD Candidate – Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Contanza L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991498###Co-Author###Assistant Professor###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###Co-Author: Contanza L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### @@@ Fariba Ahmadizar, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1658676###Co-Author###Assistant Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Fariba Ahmadizar, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht ### 1655741###Co-Author###Postdoctoral researcher###Julius Global Health, University Medical Center Utrecht###Co-Author: Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Tiago Andres Vaz, PhD – Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991499###Co-Author###Scientific Programming Coordinator###Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands###Co-Author: Tiago Andres Vaz, PhD – Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands
###Co-Author: Jessie Torgersen, MD, MHS, MSCE – Perelman School of Medicine at the University of Pennsylvania
### @@@ Alyssa K. Mezochow, MD – Perelman School of Medicine at the University of Pennsylvania ### 1991580###Co-Author######Perelman School of Medicine at the University of Pennsylvania###Co-Author: Alyssa K. Mezochow, MD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Craig W. Newcomb, MS – Perelman School of Medicine at the University of Pennsylvania ### 1991581###Co-Author######Perelman School of Medicine at the University of Pennsylvania###Co-Author: Craig W. Newcomb, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania ### 1655454###Co-Author######Perelman School of Medicine at the University of Pennsylvania###Co-Author: Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine ### 1359957###Co-Author###Professor of Epidemiology###University of Pennsylvania Perelman School of Medicine###Co-Author: Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine
### @@@ Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine ### 1062599###Co-Author###Assistant Professor###London School of Hygiene & Tropical Medicine###Co-Author: Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine
### @@@ Lesley S. Park, PhD, MPH – Stanford University School of Medicine ### 1991582###Co-Author######Stanford University School of Medicine###Co-Author: Lesley S. Park, PhD, MPH – Stanford University School of Medicine
### @@@ Janet P. Tate, ScD – VA Connecticut Healthcare System ### 1359969###Co-Author###Associate Professor###VA Connecticut Healthcare System###Co-Author: Janet P. Tate, ScD – VA Connecticut Healthcare System
### @@@ Norbert Bräu, MD – James J. Peters VA Medical Center ### 1991583###Co-Author######James J. Peters VA Medical Center###Co-Author: Norbert Bräu, MD – James J. Peters VA Medical Center
### @@@ Debika Bhattacharya, MD – VA Greater Los Angeles Healthcare System ### 1991584###Co-Author######VA Greater Los Angeles Healthcare System###Co-Author: Debika Bhattacharya, MD – VA Greater Los Angeles Healthcare System
### @@@ Joseph K. Lim, MD – Yale University School of Medicine ### 1991585###Co-Author######Yale University School of Medicine###Co-Author: Joseph K. Lim, MD – Yale University School of Medicine
### @@@ Jason A. Roy, PhD – Rutgers University School of Public Health ### 1360415###Co-Author###Professor of Biostatistics###Rutgers University School of Public Health###Co-Author: Jason A. Roy, PhD – Rutgers University School of Public Health
### @@@ Tamar H. Taddei, MD – VA Connecticut Healthcare System ### 1991586###Co-Author######VA Connecticut Healthcare System###Co-Author: Tamar H. Taddei, MD – VA Connecticut Healthcare System
### @@@ Amy C. Justice, MD, PhD – VA Connecticut Healthcare System ### 1360015###Co-Author######VA Connecticut Healthcare System###Co-Author: Amy C. Justice, MD, PhD – VA Connecticut Healthcare System
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Presenting Author###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Presenting Author: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/hisLead Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Laura Hester, PhD – Janssen R&D, LLC ### 1063349###Speaker###Director###Janssen R&D, LLC###Speaker: Laura Hester, PhD – Janssen R&D, LLC
### @@@ Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
### @@@ Jie Li, PhD – US Food and Drug Administration ### 1062564###Speaker###Associate Director for RWE at Office of Surveillance and Epidemiology, CDER###US Food and Drug Administration###Speaker: Jie Li, PhD – US Food and Drug Administration
###Presenting Author: Christopher G. Prener, PhD – Pfizer, Inc
### @@@ Eva Jodar – Pfizer, S.L.U. ### 1991416###Co-Author######Pfizer, S.L.U.###Co-Author: Eva Jodar – Pfizer, S.L.U.
### @@@ Jessica Presa, MD – Pfizer, Inc ### 1991417###Co-Author###Medical lead###Pfizer, Inc###Co-Author: Jessica Presa, MD – Pfizer, Inc
### @@@ Sarah Willis, PhD – Pfizer, Inc ### 1991419###Co-Author######Pfizer, Inc###Co-Author: Sarah Willis, PhD – Pfizer, Inc
### @@@ Katharina Schley – Pfizer Pharma GmbH ### 1991420###Co-Author######Pfizer Pharma GmbH###Co-Author: Katharina Schley – Pfizer Pharma GmbH
###Co-Author: Mark Hoogendoorn, BSc – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Babs Fabriek, PhD – Dutch Medicines Evaluation Board ### 1991695###Co-Author######Dutch Medicines Evaluation Board###Co-Author: Babs Fabriek, PhD – Dutch Medicines Evaluation Board
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1063247###Presenting Author###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Presenting Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### he/him/hisLead Speaker: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis
### she/her/hers @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Speaker###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
###Presenting Author: Nana A. Ansah, MBChB,MSc – Navrongo Health Research Centre
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Samuel T. Oladokun – Navrongo Health Research Centre ### 1991365###Co-Author######Navrongo Health Research Centre###Co-Author: Samuel T. Oladokun – Navrongo Health Research Centre
### @@@ Enyonam Duah – NAVRONGO HEALTH RESEARCH CENTRE ### 1991366###Co-Author######NAVRONGO HEALTH RESEARCH CENTRE###Co-Author: Enyonam Duah – NAVRONGO HEALTH RESEARCH CENTRE
### @@@ Patrick Ansah, MD – Navrongo Health Research Centre ### 1991367###Co-Author######Navrongo Health Research Centre###Co-Author: Patrick Ansah, MD – Navrongo Health Research Centre
### @@@ Abraham R. Oduro, MD,PhD – Research and Development Division,Ghana Health Service ### 1991368###Co-Author###Director###Research and Development Division,Ghana Health Service###Co-Author: Abraham R. Oduro, MD,PhD – Research and Development Division,Ghana Health Service
### @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
###Presenting Author: Rachael DiSantostefano (she/her/hers) – Janssen Research & Development
### she/her/hers @@@ Gwenda Simons, MA, PhD – Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. ### 1360048###Co-Author###Research Fellow###Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.###Co-Author: Gwenda Simons, MA, PhD – Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
### @@@ Matthias Englbrecht, PhD – Freelance Data Scientist ### 1991116###Co-Author######Freelance Data Scientist###Co-Author: Matthias Englbrecht, PhD – Freelance Data Scientist
### @@@ Jennifer Humphreys – University of Manchester ### 1991117###Co-Author######University of Manchester###Co-Author: Jennifer Humphreys – University of Manchester
### @@@ Ian Bruce – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK ### 1359376###Co-Author######Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK###Co-Author: Ian Bruce – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
### @@@ Karin Schölin Bywall, PhD – School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden ### 1991118###Co-Author######School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden###Co-Author: Karin Schölin Bywall, PhD – School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden
### @@@ Christine Radawski – Eli Lilly and Company ### 1360050###Co-Author######Eli Lilly and Company###Co-Author: Christine Radawski – Eli Lilly and Company
### @@@ Karim Raza – University of Birmingham, UK ### 1360051###Co-Author######University of Birmingham, UK###Co-Author: Karim Raza – University of Birmingham, UK
### @@@ Marie Falahee, BSc PhD – University of Birmingham ### 1360047###Co-Author###Lecturer in Behavioural Rheumatology###University of Birmingham###Co-Author: Marie Falahee, BSc PhD – University of Birmingham
### @@@ Jorien Veldwijk – Erasmus School of Health Policy & Management, Erasmus University Rotterdam ### 1360052###Co-Author######Erasmus School of Health Policy & Management, Erasmus University Rotterdam###Co-Author: Jorien Veldwijk – Erasmus School of Health Policy & Management, Erasmus University Rotterdam
###Lead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Lead Speaker###Senior DIrector###Evidera, Inc###Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
### @@@ Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago ### 1046822###Speaker###Dean and Professor, Parkinson School of Health Sciences and Public Health###Loyola University Chicago###Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
### @@@ Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 1084118###Speaker###Manager###Janssen Research & Development, Johnson & Johnson###Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Rania Mouchantaf, PhD (she/her/hers) – Health Canada ### 2016534###Speaker###A/Executive Director###Health Canada###Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
###Presenting Author: Soulmaz Fazeli Farsani, PharmD, Msc, PhD – Boehringer Ingelheim International GmbH
### @@@ kristy Iglay – CERobs Consulting, LLC ### 1991175###Co-Author######CERobs Consulting, LLC###Co-Author: kristy Iglay – CERobs Consulting, LLC
### @@@ Ling Zhang – Boehringer Ingelheim ### 1991176###Co-Author######Boehringer Ingelheim###Co-Author: Ling Zhang – Boehringer Ingelheim
### @@@ Christian Niyonkuru – Boehringer Ingelheim ### 1660102###Co-Author######Boehringer Ingelheim###Co-Author: Christian Niyonkuru – Boehringer Ingelheim
### @@@ Laurieann Nessralla – Boehringer Ingelheim ### 1991177###Co-Author######Boehringer Ingelheim###Co-Author: Laurieann Nessralla – Boehringer Ingelheim
### @@@ Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC ### 1088317###Co-Author###Founder and President###CERobs Consulting, LLC###Co-Author: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
###Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ahhyung Choi, PharmD – School of Pharmacy, Sungkyunkwan University ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University###Co-Author: Ahhyung Choi, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991599###Co-Author######Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###Co-Author: Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Won Suk Choi, MD, PhD – Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea ### 1991736###Co-Author######Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea###Co-Author: Won Suk Choi, MD, PhD – Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea
### @@@ Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea ### 1991610###Co-Author######Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea###Co-Author: Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Karin M.A Swart, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Brenda N. Baak, MSc – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1991329###Co-Author###Researcher and PhD Student###PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###Co-Author: Brenda N. Baak, MSc – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
### @@@ Louise Lemmens – PHARMO Institute for Drug Outcomes Research ### 1358900###Co-Author######PHARMO Institute for Drug Outcomes Research###Co-Author: Louise Lemmens – PHARMO Institute for Drug Outcomes Research
### @@@ Fernie J. Penning-van Beest – PHARMO Institute for Drug Outcomes Research ### 1358902###Co-Author######PHARMO Institute for Drug Outcomes Research###Co-Author: Fernie J. Penning-van Beest – PHARMO Institute for Drug Outcomes Research
### @@@ Camilla Bengtsson – IQVIA ### 1991396###Co-Author######IQVIA###Co-Author: Camilla Bengtsson – IQVIA
### @@@ Muriel Lobier – IQVIA ### 1991397###Co-Author######IQVIA###Co-Author: Muriel Lobier – IQVIA
### @@@ Fabian Hoti – IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland ### 1657594###Co-Author###Director, Biostatistics###IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland###Co-Author: Fabian Hoti – IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland
### @@@ Dina Vojinovic – IQVIA ### 1991398###Co-Author######IQVIA###Co-Author: Dina Vojinovic – IQVIA
### @@@ Lindy van Burk – AstraZeneca ### 1991399###Co-Author######AstraZeneca###Co-Author: Lindy van Burk – AstraZeneca
### @@@ Kirsty Rhodes – AstraZeneca ### 1657793###Co-Author######AstraZeneca###Co-Author: Kirsty Rhodes – AstraZeneca
### @@@ Sami Simons – Maastricht University Medical Center ### 1991400###Co-Author######Maastricht University Medical Center###Co-Author: Sami Simons – Maastricht University Medical Center
### @@@ Clementine Nordon, MD, PhD – AstraZeneca ### 1657794###Co-Author###Director###AstraZeneca###Co-Author: Clementine Nordon, MD, PhD – AstraZeneca
### @@@ Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1657462###Co-Author###Professor in Pharmaco-epidemiology and Healthcare Optimization, Director of the PHARMO Institute###PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###Co-Author: Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
###Presenting Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Laura K Seppälä – Tampere University Hospital, Tampere, Finland ### 1991291###Co-Author######Tampere University Hospital, Tampere, Finland###Co-Author: Laura K Seppälä – Tampere University Hospital, Tampere, Finland
### @@@ Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1900337###Co-Author###Researcher###PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Marie Hargreave – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1991292###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark###Co-Author: Marie Hargreave – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Caroline H Hemmingsen – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1991293###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark###Co-Author: Caroline H Hemmingsen – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Sarah Hjorth – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1062541###Co-Author######PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Sarah Hjorth – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Susanne K Kjaer – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark ### 1991294###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark###Co-Author: Susanne K Kjaer – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
### @@@ Lina S Mørch – Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1093592###Co-Author######Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark###Co-Author: Lina S Mørch – Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Ulrika Nörby – Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden ### 1991295###Co-Author######Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden###Co-Author: Ulrika Nörby – Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden
### @@@ Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
###Co-Author: Stéphane Le Vu – EPI-PHARE (ANSM/CNAM)
### @@@ Marion Bertrand – EPI-PHARE (ANSM/CNAM) ### 1359610###Co-Author###MSc###EPI-PHARE (ANSM/CNAM)###Co-Author: Marion Bertrand – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE ### 1360499###Presenting Author###PhD, PharmD, MPH###EPI-PHARE###Presenting Author: Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE
### he/him/his @@@ Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM) ### 1360145###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###Co-Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE (ANSM/CNAM) ### 1360500###Co-Author######EPI-PHARE (ANSM/CNAM)###Co-Author: Jérôme Drouin – EPI-PHARE (ANSM/CNAM)
### @@@ Laura Semenzato – EPI-PHARE (ANSM/CNAM) ### 1360498###Co-Author######EPI-PHARE (ANSM/CNAM)###Co-Author: Laura Semenzato – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill – EPI-PHARE ### 1358499###Co-Author######EPI-PHARE###Co-Author: Alain Weill – EPI-PHARE
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###Co-Author: Rosemary Dray-Spira – EPI-PHARE
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE
###Presenting Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA ### 1991170###Co-Author###Research Fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA###Co-Author: C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA
### he/him/his @@@ Nazleen F. Khan, PhD – Merck ### 1063044###Co-Author######Merck###Co-Author: Nazleen F. Khan, PhD – Merck
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###Co-Author: Seanna Vine – Brigham and Women's Hospital
### @@@ Heba H. Edrees, PharmD – Brigham and Women's Hospital ### 1359849###Co-Author######Brigham and Women's Hospital###Co-Author: Heba H. Edrees, PharmD – Brigham and Women's Hospital
### @@@ Julianna Mastrorilli – Brigham and Women’s Hospital ### 1659305###Co-Author######Brigham and Women’s Hospital###Co-Author: Julianna Mastrorilli – Brigham and Women’s Hospital
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Co-Author######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Co-Author: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Presenting Author: Dana Alsugeir, Msc. PharmD. – University college london
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Matthew Adesuyan, MPharm – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom. ### 1657300###Co-Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.###Co-Author: Matthew Adesuyan, MPharm – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.
### @@@ Vikram Talaulikar – University college london hospitals ### 1991544###Co-Author######University college london hospitals###Co-Author: Vikram Talaulikar – University college london hospitals
### @@@ Ruth Brauer, PhD – University College London ### 1062558###Co-Author###Lecturer in Pharmacoepidemiology###University College London###Co-Author: Ruth Brauer, PhD – University College London
###Co-Author: Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hers @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health###Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health
### @@@ Hein Stigum – University of Oslo ### 1991298###Co-Author######University of Oslo###Co-Author: Hein Stigum – University of Oslo
### @@@ Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1063219###Co-Author###Senior researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###Co-Author: Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1062759###Co-Author###Researcher###Centre for Pharmacoepidemiology, Karolinska Institutet###Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet###Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Jennifer Hutcheon – University of British Columbia ### 1991299###Co-Author######University of British Columbia###Co-Author: Jennifer Hutcheon – University of British Columbia
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1360547###Presenting Author###Senior Researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###Presenting Author: Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hersPresenting Author: Therese Johansson – Department of Immunology, Genetics and Pathology, Uppsala University
### @@@ Philip Fowler, PhD – Department of Statistics ### 1991386###Co-Author######Department of Statistics###Co-Author: Philip Fowler, PhD – Department of Statistics
### @@@ Alkistis Skalkidou – Department of Women's and Children's Health ### 1991387###Co-Author######Department of Women's and Children's Health###Co-Author: Alkistis Skalkidou – Department of Women's and Children's Health
### @@@ Weronica E. Ek, PhD – Department of immunology, genetics and pathology ### 1991388###Co-Author###Associate Professor###Department of immunology, genetics and pathology###Co-Author: Weronica E. Ek, PhD – Department of immunology, genetics and pathology
### @@@ Torgny Karlsson – Department of Immunology, Genetics and Pathology, Uppsala University ### 1991166###Co-Author###Researcher###Department of Immunology, Genetics and Pathology, Uppsala University###Co-Author: Torgny Karlsson – Department of Immunology, Genetics and Pathology, Uppsala University
### @@@ Åsa Johansson, PhD – Department of Immunology, Genetics and Pathology, Uppsala University ### 1991165###Co-Author###Associate professor###Department of Immunology, Genetics and Pathology, Uppsala University###Co-Author: Åsa Johansson, PhD – Department of Immunology, Genetics and Pathology, Uppsala University
###Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Heejun Son, MD – Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea ### 1991600###Co-Author######Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea###Co-Author: Heejun Son, MD – Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
### @@@ Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea ### 1991601###Co-Author######Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea###Co-Author: Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
### @@@ Sun Wook Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991602###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###Co-Author: Sun Wook Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
###Co-Moderator: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
### she/her/hers @@@ Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration ### 1360167###Co-Moderator###Deputy Director for Safety###US Food and Drug Administration###Co-Moderator: Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration
### she/her/hersCo-Author: Mao Hu – Acumen, LLC
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Yuhui Feng, MS – Acumen LLC ### 1991518###Co-Author######Acumen LLC###Co-Author: Yuhui Feng, MS – Acumen LLC
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Presenting Author###Health Statistician###US Food and Drug Administration###Presenting Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Elizabeth R. Smith – Acumen, LLC ### 1659094###Co-Author######Acumen, LLC###Co-Author: Elizabeth R. Smith – Acumen, LLC
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research ### 1062536###Co-Author###Sr. Director, Safety & Epidemiology###Carelon Research###Co-Author: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
### he/him/his @@@ Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration ### 1991147###Co-Author###Epidemiologist###US Food and Drug Administration###Co-Author: Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Mahasweta Mitra, MPH – Acumen,LLC ### 1991405###Co-Author###Data and Policy Analyst###Acumen,LLC###Co-Author: Mahasweta Mitra, MPH – Acumen,LLC
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Alex Secora, PhD – IQVIA ### 1991253###Co-Author######IQVIA###Co-Author: Alex Secora, PhD – IQVIA
### @@@ Joyce Obidi, PhD – US. Food and Drug Administration ### 1358853###Co-Author###Health Scientist###US. Food and Drug Administration###Co-Author: Joyce Obidi, PhD – US. Food and Drug Administration
### @@@ Jing Wang – Acumen, LLC ### 1991406###Co-Author######Acumen, LLC###Co-Author: Jing Wang – Acumen, LLC
### @@@ Jennifer Song, MA, MURP – Optum Epidemiology ### 1360471###Co-Author###Senior Epidemiology Analyst###Optum Epidemiology###Co-Author: Jennifer Song, MA, MURP – Optum Epidemiology
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health Clinical Trial Services###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services
### @@@ Djeneba Audrey Djibo, PhD – CVS Health ### 1655293###Co-Author###Lead Director - Epidemiology###CVS Health###Co-Author: Djeneba Audrey Djibo, PhD – CVS Health
### @@@ Rowan McEvoy, B.S. – Acumen, LLC ### 1991408###Co-Author######Acumen, LLC###Co-Author: Rowan McEvoy, B.S. – Acumen, LLC
### @@@ Rose Do – Acumen, LLC ### 1991326###Co-Author######Acumen, LLC###Co-Author: Rose Do – Acumen, LLC
### @@@ Yoganand Chillarige, MPA – Acumen, LLC ### 1655508###Co-Author###Research Manager###Acumen, LLC###Co-Author: Yoganand Chillarige, MPA – Acumen, LLC
### @@@ Robin Clifford, MS – Optum Epidemiology ### 1358796###Co-Author######Optum Epidemiology###Co-Author: Robin Clifford, MS – Optum Epidemiology
### @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson, PhD – FDA/CBER
###Co-Moderator: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/his @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Co-Moderator###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Moderator: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hersPresenting Author: Heehyun Won, MS – Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
### @@@ Jeong Ah Kim – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1991667###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###Co-Author: Jeong Ah Kim – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
### @@@ Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University ### 1062838###Co-Author###Ph.D. student###Department of Health Convergence, Ewha Womans University###Co-Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
### @@@ Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1660178###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###Co-Author: Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
###Presenting Author: Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### she/her/hers @@@ James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute ### 1655536###Co-Author######Marshfield Clinic Research Institute###Co-Author: James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute
### @@@ Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1655535###Co-Author###Data Manager###Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###Co-Author: Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### @@@ Kayla E. Hanson, MPH – Marshfield Clinic Research Institute ### 1655763###Co-Author######Marshfield Clinic Research Institute###Co-Author: Kayla E. Hanson, MPH – Marshfield Clinic Research Institute
### @@@ Bruce Fireman – kaiser ### 1655762###Co-Author###Biostatistician###kaiser###Co-Author: Bruce Fireman – kaiser
### @@@ Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1062961###Co-Author######Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###Co-Author: Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
###Lead Speaker: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Speaker###Associate Professor###Department of Medical Informatics, Erasmus MC University###Speaker: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Speaker###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Speaker: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
### @@@ Andrej Segec, MPharm MSc (he/him/his) – European Medicines Agency ### 1658869###Speaker###Scientific administrator###European Medicines Agency###Speaker: Andrej Segec, MPharm MSc (he/him/his) – European Medicines Agency
### he/him/his @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Speaker######Johnson & Johnson###Speaker: Patrick B. Ryan, PhD – Johnson & Johnson
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Speaker###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###Speaker: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real World Evidence###European Medicines Agency###Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Gianmario Candore, MSc – Bayer AG ### 1659477###Speaker###Partnerships Senior Manager###Bayer AG###Speaker: Gianmario Candore, MSc – Bayer AG
###Presenting Author: Marta Alcalde-Herraiz – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358612###Co-Author###DPhil Candidate & Research Assistant###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Danielle Newby, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1991362###Co-Author###Postdoctoral researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Danielle Newby, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya ### 1358939###Co-Author###Professor and Researcher###Universitat Politècnica de Catalunya###Co-Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
### she/her/hers @@@ Dipender Gill – Imperial College London ### 1655602###Co-Author######Imperial College London###Co-Author: Dipender Gill – Imperial College London
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/hisCo-Moderator: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Hiraku Kumamaru, MD, ScD – Graduate School of Medicine, The University of Tokyo ### 1658910###Co-Moderator###Associate Professor###Graduate School of Medicine, The University of Tokyo###Co-Moderator: Hiraku Kumamaru, MD, ScD – Graduate School of Medicine, The University of Tokyo
###Presenting Author: Saad Hanif Abbasi, PhD. student – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/his @@@ Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark ### 1062967###Co-Author###Professor of clinical pharmacology###University of Southern Denmark###Co-Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Martin Thomsen Ernst – University of Southern Denmark ### 1358301###Co-Author######University of Southern Denmark###Co-Author: Martin Thomsen Ernst – University of Southern Denmark
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
###Presenting Author: Vikas Kumar, MD, MS – OMNY Health
### @@@ Lawrence Rasouliyan, MPH – OMNY Health ### 1359580###Co-Author###Head, Biostatistics & Data Science###OMNY Health###Co-Author: Lawrence Rasouliyan, MPH – OMNY Health
### @@@ Amanda G. Althoff, MS – OMNY Health ### 1659852###Co-Author###Senior Data Scientist###OMNY Health###Co-Author: Amanda G. Althoff, MS – OMNY Health
### @@@ Stella Chang, MPH – OMNY Health ### 1991733###Co-Author###Senior Vice President, Customer Success###OMNY Health###Co-Author: Stella Chang, MPH – OMNY Health
### @@@ Stacey Long, MS – OMNY Health ### 1359578###Co-Author###Chief Strategy Officer###OMNY Health###Co-Author: Stacey Long, MS – OMNY Health
###Presenting Author: Adrian Martinez-De la Torre, PhD – Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
### @@@ Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland ### 1358409###Co-Author###Assistant Professor###Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland###Co-Author: Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/hisLead Speaker: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Speaker###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Speaker###Professor###London School of Hygiene & Tropical Medicine, London###Speaker: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Speaker###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Speaker: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Speaker###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Speaker: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Caroline Morton, MRCGP MSc BMedSci MbChb – Queen Mary University of London ### 1991556###Speaker###Senior Clinical Research Fellow###Queen Mary University of London###Speaker: Caroline Morton, MRCGP MSc BMedSci MbChb – Queen Mary University of London
### @@@ Jennifer R. Popovic, DVM – GSK ### 1991567###Speaker###Senior Director###GSK###Speaker: Jennifer R. Popovic, DVM – GSK
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
###Presenting Author: Caroline Korves, ScD (she/her/hers) – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### she/her/hers @@@ Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA ### 1659297###Co-Author###Associate Director ###Office of Vaccines Research and Review, CBER/FDA###Co-Author: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
### @@@ Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991423###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991424###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ Jeremy Smith, MS – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991425###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###Co-Author: Jeremy Smith, MS – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1655356###Co-Author###Associate director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Yinong Young-Xu, ScD, MS, MA – Veterans Affairs Medical Center, White River Junction, VT, USA ### 1659630###Co-Author###Director, Clinical Epidemiology Program###Veterans Affairs Medical Center, White River Junction, VT, USA###Co-Author: Yinong Young-Xu, ScD, MS, MA – Veterans Affairs Medical Center, White River Junction, VT, USA
###Presenting Author: Xunming Sun, PhD (she/her/hers) – Pfizer Inc.
### she/her/hers @@@ Yun Gu, PhD – Pfizer Inc. at the time of this work ### 1991439###Co-Author######Pfizer Inc. at the time of this work###Co-Author: Yun Gu, PhD – Pfizer Inc. at the time of this work
### @@@ Steven Arkin, MD – Pfizer Inc. ### 1655415###Co-Author###Vice-President Rare Hematology Clinical Research###Pfizer Inc.###Co-Author: Steven Arkin, MD – Pfizer Inc.
### @@@ Stephen E. Schachterle, PhD – Pfizer Inc. ### 1657348###Co-Author###Senior Director###Pfizer Inc.###Co-Author: Stephen E. Schachterle, PhD – Pfizer Inc.
### @@@ Xiaofeng Zhou, PhD – Pfizer Inc ### 1062976###Co-Author###Sr. Director###Pfizer Inc###Co-Author: Xiaofeng Zhou, PhD – Pfizer Inc
### @@@ Thomas Edwards, MS – Panalgo Inc. ### 1991440###Co-Author######Panalgo Inc.###Co-Author: Thomas Edwards, MS – Panalgo Inc.
### @@@ Shannon Marraffino, MD – Pfizer Inc. ### 1991441###Co-Author######Pfizer Inc.###Co-Author: Shannon Marraffino, MD – Pfizer Inc.
###Presenting Author: Lockwood Taylor, PhD – IQVIA
### @@@ Marie-Laure Kürzinger, MSc – Sanofi ### 1657665###Co-Author######Sanofi###Co-Author: Marie-Laure Kürzinger, MSc – Sanofi
### @@@ Ruben Hermans, PhD – IQVIA ### 1991623###Co-Author######IQVIA###Co-Author: Ruben Hermans, PhD – IQVIA
### @@@ Bernadette Dwan, BSc MPHARM MPSI – IQVIA ### 1991624###Co-Author###Product Strategy lead###IQVIA###Co-Author: Bernadette Dwan, BSc MPHARM MPSI – IQVIA
### @@@ Priyanka Chhikara, Rph, MBA – Sanofi ### 1991625###Co-Author######Sanofi###Co-Author: Priyanka Chhikara, Rph, MBA – Sanofi
### @@@ Xinyu Li – Sanofi Inc ### 1991626###Co-Author######Sanofi Inc###Co-Author: Xinyu Li – Sanofi Inc
### @@@ Sreenivas Thummisetti, MBBS, Ph.D – Sanofi ### 1991627###Co-Author###Global Safety Officer, Sanofi###Sanofi###Co-Author: Sreenivas Thummisetti, MBBS, Ph.D – Sanofi
### @@@ Sandrine Colas, PhD – Sanofi ### 1991628###Co-Author###Pharmacoepidemiologist###Sanofi###Co-Author: Sandrine Colas, PhD – Sanofi
### @@@ Marielle Duverne, n/a – sanofi ### 1991629###Co-Author###Pharmacovigilance Scientist###sanofi###Co-Author: Marielle Duverne, n/a – sanofi
### @@@ Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi ### 1094012###Co-Author###VP and Global Head###Epidemiology & Benefit - Risk Evaluation, Sanofi###Co-Author: Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi
###Presenting Author: David M. Kern, PhD, MS – Janssen Research & Development
### @@@ Steven S. Smugar – Janssen R&D ### 1991370###Co-Author######Janssen R&D###Co-Author: Steven S. Smugar – Janssen R&D
### @@@ Azza Shoaibi, PhD, MPH – Janssen Research & Development ### 1360292###Co-Author###Associate director ###Janssen Research & Development###Co-Author: Azza Shoaibi, PhD, MPH – Janssen Research & Development
### @@@ Patrina Muller, RN, MPH &TM – Janssen R&D ### 1991372###Co-Author###Manager Safety Analysis Scientist###Janssen R&D###Co-Author: Patrina Muller, RN, MPH &TM – Janssen R&D
### @@@ Anthony G. Sena, BA – Janssen R&D ### 1360294###Co-Author###Director - Observational Health Data Analytics###Janssen R&D###Co-Author: Anthony G. Sena, BA – Janssen R&D
### @@@ Martijn Schuemie – Janssen R&D ### 1657738###Co-Author######Janssen R&D###Co-Author: Martijn Schuemie – Janssen R&D
### @@@ James P. Gilbert, PhD – Janssen Research & Development ### 1659757###Co-Author###Manager of Epidemiology Analytics###Janssen Research & Development###Co-Author: James P. Gilbert, PhD – Janssen Research & Development
### @@@ Mitchell M. Conover, PhD – Janssen R&D ### 1658363###Co-Author###Associate Director, Observational Health Data Analytics###Janssen R&D###Co-Author: Mitchell M. Conover, PhD – Janssen R&D
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###Presenting Author: Julie A. Schmidt, MSc, DPhil (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers @@@ Kirsten M. Woolpert – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1661021###Co-Author###PhD Student###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Kirsten M. Woolpert – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1657893###Co-Author###MSPH, PhD###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1659144###Co-Author######Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark ### 1358744###Co-Author######Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark###Co-Author: Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1358742###Co-Author###Associate Professor###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hersPresenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Co-Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Yunha Noh, PharmD, PhD – McGill University ### 1062651###Co-Author######McGill University###Co-Author: Yunha Noh, PharmD, PhD – McGill University
### @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Dong Hyun Sinn, MD, PhD – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991737###Co-Author######Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###Co-Author: Dong Hyun Sinn, MD, PhD – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991599###Co-Author######Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###Co-Author: Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###Co-Author: Laurent Azoulay, PhD – McGill University
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Co-Author###Associate Professor###McGill University###Co-Author: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Yi Li, MS (she/her/hers) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University
### she/her/hers @@@ Tibor Schuster, PhD – Department of Family Medicine, McGill University ### 1093618###Co-Author######Department of Family Medicine, McGill University###Co-Author: Tibor Schuster, PhD – Department of Family Medicine, McGill University
### @@@ Kazuki Yoshida, MD, MPH, ScD – OM1, Inc. ### 1991516###Co-Author######OM1, Inc.###Co-Author: Kazuki Yoshida, MD, MPH, ScD – OM1, Inc.
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/hisPresenting Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### he/him/his @@@ Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK ### 1063024###Co-Author######Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK###Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
###Presenting Author: William Henley – University of Exeter
### @@@ Adam J. Streeter, PhD – University of Munster, Germany ### 1660053###Co-Author###Biostatistician###University of Munster, Germany###Co-Author: Adam J. Streeter, PhD – University of Munster, Germany
###Co-Author: Alem Zekarias – Uppsala Monitoring Centre
### @@@ Eva-Lisa Meldau, MSc – Uppsala Monitoring Centre ### 1077343###Presenting Author###Senior Data Scientist###Uppsala Monitoring Centre###Presenting Author: Eva-Lisa Meldau, MSc – Uppsala Monitoring Centre
### @@@ Sara Hedfors Vidlin – Uppsala Monitoring Centre ### 1358944###Co-Author###Data Scientist###Uppsala Monitoring Centre###Co-Author: Sara Hedfors Vidlin – Uppsala Monitoring Centre
### @@@ Ingrid Lönnstedt – Uppsala Monitoring Centre ### 1991663###Co-Author######Uppsala Monitoring Centre###Co-Author: Ingrid Lönnstedt – Uppsala Monitoring Centre
### @@@ Ghita Benabdallah, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc - RCC ### 1991664###Co-Author###Pharmacist###Centre Anti Poison et de Pharmacovigilance du Maroc - RCC###Co-Author: Ghita Benabdallah, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc - RCC
### @@@ Loubna Alj, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc ### 1991665###Co-Author###Pharmacist Epidemiologist###Centre Anti Poison et de Pharmacovigilance du Maroc###Co-Author: Loubna Alj, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc
### @@@ Houda Sefiani, MD, Phd – Centre anti poison et de pharmacovigilance du Maroc-RCC ### 1991666###Co-Author######Centre anti poison et de pharmacovigilance du Maroc-RCC###Co-Author: Houda Sefiani, MD, Phd – Centre anti poison et de pharmacovigilance du Maroc-RCC
###Presenting Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Marion Bertrand – EPI-PHARE (ANSM/CNAM) ### 1359610###Co-Author###MSc###EPI-PHARE (ANSM/CNAM)###Co-Author: Marion Bertrand – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE###Co-Author: Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE
### he/him/his @@@ Stéphane Le Vu – EPI-PHARE (ANSM/CNAM) ### 1655649###Co-Author######EPI-PHARE (ANSM/CNAM)###Co-Author: Stéphane Le Vu – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE (ANSM/CNAM) ### 1360500###Co-Author######EPI-PHARE (ANSM/CNAM)###Co-Author: Jérôme Drouin – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill – EPI-PHARE ### 1358499###Co-Author######EPI-PHARE###Co-Author: Alain Weill – EPI-PHARE
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###Co-Author: Rosemary Dray-Spira – EPI-PHARE
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE
###Presenting Author: Harlan R. Pittell, PhD (he/him/his) – Flatiron Health
### he/him/his @@@ Jenny Guadamuz, PhD – Flatiron Health ### 1655497###Co-Author###Senior Health Equity Scientist###Flatiron Health###Co-Author: Jenny Guadamuz, PhD – Flatiron Health
### @@@ Amy Pierre, MSN, ANP-BC – Flatiron Health ### 1655504###Co-Author######Flatiron Health###Co-Author: Amy Pierre, MSN, ANP-BC – Flatiron Health
### @@@ Cleo Ryals, PhD – Flatiron Health ### 1991178###Co-Author###Head of Health Equity###Flatiron Health###Co-Author: Cleo Ryals, PhD – Flatiron Health
### @@@ Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California ### 1655507###Co-Author###Adjunct Associate Professor###University of Southern California###Co-Author: Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California
### he/him/hisLead Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university
### he/him/his @@@ Ana Tomas, MD, PhD – Faculty or Medicine, University of Novi Sad ### 1658321###Speaker###Assistant Professor###Faculty or Medicine, University of Novi Sad###Speaker: Ana Tomas, MD, PhD – Faculty or Medicine, University of Novi Sad
### @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Speaker###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
### @@@ Johanna Villén, MSc – Uppsala University ### 1991120###Speaker###PhD student###Uppsala University###Speaker: Johanna Villén, MSc – Uppsala University
###Presenting Author: Marc Simard (he/him/his) – Laval University
### he/him/his @@@ Elham Rahme, PhD – Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada ### 1358488###Co-Author###Associate Professor###Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada###Co-Author: Elham Rahme, PhD – Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada
### @@@ Marjolaine Dubé – Institut national de santé publique du Québec, Québec, QC, Canada ### 1658987###Co-Author######Institut national de santé publique du Québec, Québec, QC, Canada###Co-Author: Marjolaine Dubé – Institut national de santé publique du Québec, Québec, QC, Canada
### @@@ Véronique Boiteau – Institut national de santé publique du Québec, Québec, QC, Canada ### 1658988###Co-Author###Conseillère scientifique###Institut national de santé publique du Québec, Québec, QC, Canada###Co-Author: Véronique Boiteau – Institut national de santé publique du Québec, Québec, QC, Canada
### @@@ Denis Talbot, PhD (he/him/his) – Universite Laval ### 1360377###Co-Author###Professor###Universite Laval###Co-Author: Denis Talbot, PhD (he/him/his) – Universite Laval
### he/him/his @@@ Caroline Sirois – Université Laval, faculté de pharmacie ### 1656008###Co-Author###Professor-researcher###Université Laval, faculté de pharmacie###Co-Author: Caroline Sirois – Université Laval, faculté de pharmacie
###Co-Moderator: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Co-Moderator###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###Co-Moderator: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/hisPresenting Author: Kristina Parsons, RD – McGill University
### @@@ Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada ### 1397870###Co-Author######The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada###Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Farzin Khosrow-Khavar, PhD – Rutgers University ### 1658459###Co-Author###Instructor###Rutgers University###Co-Author: Farzin Khosrow-Khavar, PhD – Rutgers University
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###Co-Author: Laurent Azoulay, PhD – McGill University
###Presenting Author: Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Co-Author###Research Associate###School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Zi Xuan Wong – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358891###Co-Author######School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Zi Xuan Wong – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisPresenting Author: Timothy J. Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital / Harvard Medical School
### he/him/his @@@ Matthew P. Kronman, MD, MSCE – Seattle Children's Hospital / University of Washington ### 1991389###Co-Author###Professor, Pediatric Infectious Diseases###Seattle Children's Hospital / University of Washington###Co-Author: Matthew P. Kronman, MD, MSCE – Seattle Children's Hospital / University of Washington
### @@@ Sushama Kattinakere Sreedhara, MBBS, MSPH – Brigham and Womens Hospital ### 1360619###Co-Author######Brigham and Womens Hospital###Co-Author: Sushama Kattinakere Sreedhara, MBBS, MSPH – Brigham and Womens Hospital
### @@@ Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1658753###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Theresa Oduol, BS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1659306###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Theresa Oduol, BS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Presenting Author: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
### @@@ Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655578###Co-Author###Senior Research Specialist ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1991320###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
###Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael Wilkinson – Optum ### 1659347###Co-Author######Optum###Co-Author: Michael Wilkinson – Optum
### @@@ Wafa Tarazi, PhD, MHPA – Optum Serve Consulting ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve Consulting###Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve Consulting
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration ### 1991147###Co-Author###Epidemiologist###US Food and Drug Administration###Co-Author: Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Alexandra Stone, PhD – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###Co-Author: Alexandra Stone, PhD – Optum Serve
### @@@ Grace Yang – OptumServe ### 1659346###Co-Author######OptumServe###Co-Author: Grace Yang – OptumServe
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Co-Author###Health Statistician###US Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson, PhD – FDA/CBER
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hersPresenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael Wilkinson – Optum ### 1659347###Co-Author######Optum###Co-Author: Michael Wilkinson – Optum
### @@@ Alexandra Stone, PhD – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###Co-Author: Alexandra Stone, PhD – Optum Serve
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Wafa Tarazi, PhD, MHPA – Optum Serve Consulting ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve Consulting###Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve Consulting
### @@@ Grace Yang – OptumServe ### 1659346###Co-Author######OptumServe###Co-Author: Grace Yang – OptumServe
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Co-Author###Health Statistician###US Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson, PhD – FDA/CBER
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hersCo-Moderator: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Co-Moderator###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###Co-Moderator: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hersCo-Author: Luca Giraldi – European Medicines Agency
### @@@ Manuela Mura, DVM, PhD – European Medicines Agency ### 1991557###Co-Author###Scientific Officer###European Medicines Agency###Co-Author: Manuela Mura, DVM, PhD – European Medicines Agency
### @@@ Lorna Leal, MD, PhD – European Medicines Agency ### 1991504###Co-Author###Scientific Specialist###European Medicines Agency###Co-Author: Lorna Leal, MD, PhD – European Medicines Agency
### @@@ Kate Olsson – European Centre for Disease Prevention and Control ### 1991563###Co-Author######European Centre for Disease Prevention and Control###Co-Author: Kate Olsson – European Centre for Disease Prevention and Control
### @@@ Karam Adel – European Centre for Disease Prevention and Control ### 1991564###Co-Author###Policy Expert, Vaccine-preventable Diseases###European Centre for Disease Prevention and Control###Co-Author: Karam Adel – European Centre for Disease Prevention and Control
### @@@ Kim Brolin, PhD – European Centre for Disease Prevention and Control ### 1991562###Co-Author###Expert Vaccine Preventable Diseases###European Centre for Disease Prevention and Control###Co-Author: Kim Brolin, PhD – European Centre for Disease Prevention and Control
### @@@ Piotr Kramarz – European Centre for Disease Prevention and Control ### 1991560###Co-Author######European Centre for Disease Prevention and Control###Co-Author: Piotr Kramarz – European Centre for Disease Prevention and Control
### @@@ Sabrina Bacci – European Centre for Disease Prevention and Control ### 1991559###Co-Author######European Centre for Disease Prevention and Control###Co-Author: Sabrina Bacci – European Centre for Disease Prevention and Control
### @@@ Marco Cavaleri – European Medicines Agency ### 1991555###Co-Author######European Medicines Agency###Co-Author: Marco Cavaleri – European Medicines Agency
### @@@ Karl Ekdahl, MD, PhD, DTM&H – European Centre for Disease Prevention and Control ### 1991558###Co-Author###Head of Unit###European Centre for Disease Prevention and Control###Co-Author: Karl Ekdahl, MD, PhD, DTM&H – European Centre for Disease Prevention and Control
### @@@ Peter Richard Arlett – European Medicines Agency ### 1074391###Co-Author###Head of Data Analytics and Methods Task Force###European Medicines Agency###Co-Author: Peter Richard Arlett – European Medicines Agency
### @@@ Catherine Cohet, PhD (she/her/hers) – European Medicines Agency ### 1655442###Presenting Author###Pharmacoepidemiology/RWE Senior Specialist###European Medicines Agency###Presenting Author: Catherine Cohet, PhD (she/her/hers) – European Medicines Agency
### she/her/hersPresenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain ### 1991590###Co-Author######HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain###Co-Author: Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/hisPresenting Author: Eunsun Lim, MS – Department of Health Convergence, Ewha Womans University
### @@@ Yoo Hwan Kim – Department of Neurology, Hallym University Sacred Heart Hospital ### 1991738###Co-Author######Department of Neurology, Hallym University Sacred Heart Hospital###Co-Author: Yoo Hwan Kim – Department of Neurology, Hallym University Sacred Heart Hospital
### @@@ Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University ### 1062838###Co-Author###Ph.D. student###Department of Health Convergence, Ewha Womans University###Co-Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
### @@@ Jong-Seok Bae – Department of Neurology, Kangdong Sacred Heart Hospital ### 1991739###Co-Author######Department of Neurology, Kangdong Sacred Heart Hospital###Co-Author: Jong-Seok Bae – Department of Neurology, Kangdong Sacred Heart Hospital
### @@@ Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1660178###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###Co-Author: Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
###Co-Author: Kyle Hart – Department of Health Policy, VUMC
### @@@ Ashley Leech – Department of Health Policy, VUMC ### 1993652###Co-Author######Department of Health Policy, VUMC###Co-Author: Ashley Leech – Department of Health Policy, VUMC
### @@@ Avirath U. Vaidya – Department of Health Policy, VUMC ### 1993978###Co-Author######Department of Health Policy, VUMC###Co-Author: Avirath U. Vaidya – Department of Health Policy, VUMC
### @@@ Stacie B. Dusetzina, PhD – Department of Health Policy, VUMC ### 1062587###Co-Author###Associate Professor###Department of Health Policy, VUMC###Co-Author: Stacie B. Dusetzina, PhD – Department of Health Policy, VUMC
### @@@ Andrew Medvecz – 2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center ### 1993980###Co-Author######2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center###Co-Author: Andrew Medvecz – 2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center
### @@@ Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC ### 1062642###Presenting Author###Assistant Professor###Department of Health Policy, VUMC###Presenting Author: Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC
###Presenting Author: Adrienne YL Chan, MPH – Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands
### @@@ Amy Chan – University of Auckland ### 1991501###Co-Author######University of Auckland###Co-Author: Amy Chan – University of Auckland
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Chin-Yao Shen, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1063185###Co-Author###ph.D student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Chin-Yao Shen, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Author###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###Co-Author: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/his @@@ Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong ### 1358232###Co-Author###Head of Department of Pharmacology and Pharmacy###The University of Hong Kong###Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong
### he/him/hisPresenting Author: Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Huei-Kai Huang, MD – Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.) ### 1994118###Co-Author######Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.)###Co-Author: Huei-Kai Huang, MD – Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.)
### @@@ Tzu-Chi Liao – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1360580###Co-Author######Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Tzu-Chi Liao – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Peter Pin-Sung Liu, MS – Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.) ### 1994119###Co-Author######Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.)###Co-Author: Peter Pin-Sung Liu, MS – Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.)
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan ### 1062628###Co-Author###Pharmacist###Keelung Chang Gung Memorial Hospital, Keelung, Taiwan###Co-Author: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/hisCo-Moderator: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
### @@@ Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659932###Co-Moderator###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Moderator: Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
###Moderator: Brian L. Strom, MD, MPH (he/him/his) – Rutgers, The State University of New Jersey
### he/him/his @@@ Robert Califf, MD (he/him/his) – U.S. Food and Drug Administration ### 2045658###Keynote Speaker###Commissioner of Food and Drugs###U.S. Food and Drug Administration###Keynote Speaker: Robert Califf, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Pamela Aung-Thin – Health Canada ### 2045662###Keynote Speaker###Assistant Deputy Minister###Health Canada###Keynote Speaker: Pamela Aung-Thin – Health Canada
### @@@ Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Panelist###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###Panelist: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Melissa Kampman, PhD (she/her/hers) – Health Canada ### 1991542###Panelist###Manager, Data Analytics and Real-world Evidence Division###Health Canada###Panelist: Melissa Kampman, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ Yoshiaki Uyama, PhD – Pharmaceuticals and Medical Devices Agency ### 1360089###Panelist###Associate Executive Director###Pharmaceuticals and Medical Devices Agency###Panelist: Yoshiaki Uyama, PhD – Pharmaceuticals and Medical Devices Agency
### @@@ Michal Hirsch-Vexberg, PharmD – Israel Ministry of Health ### 2045663###Panelist###Head of Pharmaceutical Registration Department###Israel Ministry of Health###Panelist: Michal Hirsch-Vexberg, PharmD – Israel Ministry of Health
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Panelist###Head of Real World Evidence###European Medicines Agency###Panelist: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Panelist###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###Panelist: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
###Co-Moderator: Jason Simeone, PhD (he/him/his) – Cytel
### he/him/his @@@ Gabriel Sanfelix-Gimeno, PharmD, PhD – FISABIO ### 1062657###Co-Moderator###Head, Health Services Research and Pharmacoepidemiology Unit###FISABIO###Co-Moderator: Gabriel Sanfelix-Gimeno, PharmD, PhD – FISABIO
###Presenting Author: Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Udim Damachi, MSc – Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA ### 1659418###Co-Author###PhD Candidate###Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA###Co-Author: Udim Damachi, MSc – Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA
### @@@ Eberechukwu Onukwugha, MS, PhD – University of Maryland School of Pharmacy, Baltimore, USA ### 1402427###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, USA###Co-Author: Eberechukwu Onukwugha, MS, PhD – University of Maryland School of Pharmacy, Baltimore, USA
### @@@ Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy ### 1659618###Co-Author###Assistant Professor of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###Co-Author: Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy
### @@@ Paula Rosenblatt, MD – University of Maryland Medical Center, Baltimore MD, USA ### 1991719###Co-Author###Assistant Professor of Medicine###University of Maryland Medical Center, Baltimore MD, USA###Co-Author: Paula Rosenblatt, MD – University of Maryland Medical Center, Baltimore MD, USA
### @@@ Wendy Camelo Castillo, MD, MSc, PhD (she/her/hers) – University of Maryland School of Pharmacy, Baltimore MD, USA ### 1062923###Co-Author###Assistant Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore MD, USA###Co-Author: Wendy Camelo Castillo, MD, MSc, PhD (she/her/hers) – University of Maryland School of Pharmacy, Baltimore MD, USA
### she/her/hersPresenting Author: C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA
### he/him/his @@@ Catherine S. Hwang, MD, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1991430###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Catherine S. Hwang, MD, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Heba H. Edrees, PharmD – Brigham and Women's Hospital ### 1359849###Co-Author######Brigham and Women's Hospital###Co-Author: Heba H. Edrees, PharmD – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
### @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
###Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Speaker###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###Speaker: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/hisPresenting Author: De-Kun Li, MD, PhD (he/him/his) – Division of Research, Kaiser Foundation Research Institute
### he/him/his @@@ Jeannette Ferber, MPH – Division of Research, Kaiser Foundation Research Institute ### 1655845###Co-Author###Data Reporting and Analytics Biostatistics Consultant###Division of Research, Kaiser Foundation Research Institute###Co-Author: Jeannette Ferber, MPH – Division of Research, Kaiser Foundation Research Institute
###Co-Author: Jagadeswara Rao Earla, PharmD, MBA, PhD – Merck, Center for Observational and Real-World Evidence
### @@@ Jieni Li, MPH – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy ### 1991698###Presenting Author###PhD Student/Research Assistant###University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy###Presenting Author: Jieni Li, MPH – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
### @@@ George J. Hutton, MD – Baylor College of Medicine ### 1358575###Co-Author###Professor###Baylor College of Medicine###Co-Author: George J. Hutton, MD – Baylor College of Medicine
### @@@ Rajender R. Aparasu, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy ### 1358573###Co-Author###Professor###University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy###Co-Author: Rajender R. Aparasu, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
###Presenting Author: Rutendo Muzambi, MPharm, PhD (she/her/hers) – London School of Hygiene and Tropical Medicine
### she/her/hers @@@ Krishnan Bhaskaran – London School of Hygiene and Tropical Medicine ### 1360175###Co-Author######London School of Hygiene and Tropical Medicine###Co-Author: Krishnan Bhaskaran – London School of Hygiene and Tropical Medicine
### @@@ Emily Herrett, PhD – London School of Hygiene and Tropical Medicine ### 1991300###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###Co-Author: Emily Herrett, PhD – London School of Hygiene and Tropical Medicine
###Co-Author: Mackenzie Henderson, PharmD, MS – Daiichi Sankyo, Inc.
### @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Co-Author###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###Co-Author: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/his @@@ Vikram Bhise, MD – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1991519###Co-Author######Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###Co-Author: Vikram Bhise, MD – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### @@@ Gian Pal, MD, MS – Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA ### 1991521###Co-Author######Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA###Co-Author: Gian Pal, MD, MS – Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
### @@@ Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Sciences ### 1358831###Co-Author###Assistant Professor###Center for Pharmacoepidemiology and Treatment Sciences ###Co-Author: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Sciences
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Presenting Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Presenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###Presenting Author: Julia Liaw, PharmD – Rutgers University
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Co-Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
### @@@ Deborah Liaw – University of South Florida ### 1991621###Co-Author######University of South Florida###Co-Author: Deborah Liaw – University of South Florida
###Presenting Author: Yueh-Yi Chiang, BS (she/her/hers) – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### she/her/hers @@@ Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1655866###Co-Author###Research Associate###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Haeyoung Lee – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1360378###Co-Author###Graduate student###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Haeyoung Lee – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1658122###Co-Author###PhD student###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
###Presenting Author: Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Elizabeth A. Suarez – Institute for Health, Health Care Policy and Aging Research, Rutgers University ### 1991274###Co-Author######Institute for Health, Health Care Policy and Aging Research, Rutgers University###Co-Author: Elizabeth A. Suarez – Institute for Health, Health Care Policy and Aging Research, Rutgers University
### @@@ Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991275###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359918###Co-Author######Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration###Co-Author: Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Di Zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research ### 1360258###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research###Co-Author: Di Zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research
### @@@ Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1359917###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Jane Liedtka, MD – 7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration ### 1360259###Co-Author###medical officer###7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration###Co-Author: Jane Liedtka, MD – 7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration
### @@@ Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration ### 1360260###Co-Author###Medical Officer###Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration###Co-Author: Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Co-Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Co-Author###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1358274###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###Co-Author: Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Inna Dashevsky, Ms. – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991276###Co-Author###Senior SAS Programmer###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Inna Dashevsky, Ms. – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute ### 1991682###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute
### @@@ Elizabeth Siranosian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991277###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Elizabeth Siranosian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hersPresenting Author: Chloe C. H. Smit, PharmD – University of Technology Sydney
### @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Co-Author###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###Co-Author: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
### @@@ Hamish Robertson – Queensland University of Technology ### 1991530###Co-Author######Queensland University of Technology###Co-Author: Hamish Robertson – Queensland University of Technology
### @@@ Katja Taxis, MSc, PhD, FISPE – University of Groningen ### 1086972###Co-Author###Professor###University of Groningen###Co-Author: Katja Taxis, MSc, PhD, FISPE – University of Groningen
### @@@ Kris Rogers – University of Technology Sydney ### 1991531###Co-Author######University of Technology Sydney###Co-Author: Kris Rogers – University of Technology Sydney
### @@@ Caitlin Keighley, Dr – University of Wollongong ### 1991532###Co-Author######University of Wollongong###Co-Author: Caitlin Keighley, Dr – University of Wollongong
### @@@ Spiros Miyakis, MD, PhD, FRACP – University of Wollongong ### 1991643###Co-Author######University of Wollongong###Co-Author: Spiros Miyakis, MD, PhD, FRACP – University of Wollongong
###Presenting Author: Pouneh Shahriari, PhD student – EPI-PHARE
### @@@ Jérôme Drouin – EPI-PHARE (ANSM/CNAM) ### 1360500###Co-Author######EPI-PHARE (ANSM/CNAM)###Co-Author: Jérôme Drouin – EPI-PHARE (ANSM/CNAM)
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###Co-Author: Rosemary Dray-Spira – EPI-PHARE
###Presenting Author: Máté Szilcz (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### he/him/his @@@ Jonas Wastesson – Karolinska Institutet ### 1655698###Co-Author######Karolinska Institutet###Co-Author: Jonas Wastesson – Karolinska Institutet
### @@@ Amaia Calderón-Larrañaga – Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet & Stockholm University, Stockholm, Sweden ### 1991554###Co-Author######Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet & Stockholm University, Stockholm, Sweden###Co-Author: Amaia Calderón-Larrañaga – Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet & Stockholm University, Stockholm, Sweden
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Pierre-Olivier Blotiere – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1660114###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###Co-Author: Pierre-Olivier Blotiere – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Géric Maura – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1660115###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###Co-Author: Géric Maura – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Kristina Johnell – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1655700###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###Co-Author: Kristina Johnell – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
###Co-Author: Maarten Pieter Rozing – Research Unit for General Practice & Section for General Practice, University of Copenhagen
### @@@ Marie Kim Wium-Andersen – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals ### 1991136###Co-Author######Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals###Co-Author: Marie Kim Wium-Andersen – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals
### @@@ Ida Kim Wium-Andersen – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals ### 1991137###Co-Author######Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals###Co-Author: Ida Kim Wium-Andersen – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals
### @@@ Terese Sara Høj Jørgensen – Department of Public Health, University of Copenhagen ### 1991138###Co-Author######Department of Public Health, University of Copenhagen###Co-Author: Terese Sara Høj Jørgensen – Department of Public Health, University of Copenhagen
### @@@ Martin B. Jørgensen – Psychiatric Center Copenhagen ### 1657920###Co-Author######Psychiatric Center Copenhagen###Co-Author: Martin B. Jørgensen – Psychiatric Center Copenhagen
### @@@ Merete Osler, MD, DMSc, PhD – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals ### 1062833###Presenting Author###Senior physician, clinical professor###Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals###Presenting Author: Merete Osler, MD, DMSc, PhD – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals
###Presenting Author: Dima M. Qato, PharmD, MPH, PhD – University of Southern California
### @@@ Jenny Guadamuz, PhD – Flatiron Health ### 1655497###Co-Author###Senior Health Equity Scientist###Flatiron Health###Co-Author: Jenny Guadamuz, PhD – Flatiron Health
### @@@ Andrew Shooshtari – University of Southern California ### 1655546###Co-Author######University of Southern California###Co-Author: Andrew Shooshtari – University of Southern California
### @@@ G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health ### 1991150###Co-Author###Professor of Epidemiology and Medicine###Johns Hopkins Bloomberg School of Public Health###Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health
###Co-Author: Andrew Mosholder, MPH, MD – US Food and Drug Administration
### @@@ Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA ### 1659297###Co-Author###Associate Director ###Office of Vaccines Research and Review, CBER/FDA###Co-Author: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
### @@@ Rongmei Zhang – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1359044###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Rongmei Zhang – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Shanlai Shangguan – Acumen LLC ### 1991517###Co-Author######Acumen LLC###Co-Author: Shanlai Shangguan – Acumen LLC
### @@@ Yun Lu, PhD – US Food and Drug Administration ### 1659299###Co-Author###Mathematical Statistician###US Food and Drug Administration###Co-Author: Yun Lu, PhD – US Food and Drug Administration
### @@@ Sandia Akhtar – Acumen, LLC ### 1655354###Co-Author######Acumen, LLC###Co-Author: Sandia Akhtar – Acumen, LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Presenting Author###Senior Research Manager###Acumen, LLC###Presenting Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991275###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Yoganand Chillarige, MPA – Acumen, LLC ### 1655508###Co-Author###Research Manager###Acumen, LLC###Co-Author: Yoganand Chillarige, MPA – Acumen, LLC
### @@@ Yuhui Feng, MS – Acumen LLC ### 1991518###Co-Author######Acumen LLC###Co-Author: Yuhui Feng, MS – Acumen LLC
### @@@ Armen Avagyan – Acumen LLC ### 1991520###Co-Author######Acumen LLC###Co-Author: Armen Avagyan – Acumen LLC
### @@@ Kira Leishear, PhD, MS – FDA ### 1655537###Co-Author###Lead Epidemiologist###FDA###Co-Author: Kira Leishear, PhD, MS – FDA
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Thomas E. MaCurdy, PhD – Acumen LLC ### 1358530###Co-Author###Senior Research Director###Acumen LLC###Co-Author: Thomas E. MaCurdy, PhD – Acumen LLC
### @@@ Jeffery A. Kelman – Centers for Medicare and Medicaid Services ### 1358531###Co-Author######Centers for Medicare and Medicaid Services###Co-Author: Jeffery A. Kelman – Centers for Medicare and Medicaid Services
### @@@ David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1655356###Co-Author###Associate director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
###Presenting Author: Michael Andrew Webster-Clark, PharmD, PhD – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health
### @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Co-Author###Associate Professor###McGill University###Co-Author: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/hisPresenting Author: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Svetlana V. Belitser – Utrecht University ### 1655669###Co-Author######Utrecht University###Co-Author: Svetlana V. Belitser – Utrecht University
### @@@ Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht ### 1655741###Co-Author###Postdoctoral researcher###Julius Global Health, University Medical Center Utrecht###Co-Author: Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands ### 1991418###Co-Author###PhD candidate###Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands###Co-Author: Judit Riera-Arnau, MD – Department of Datascience and Biostatistics, Julius Centrum, University Medical Center of Utrecht (UMCU), The Netherlands
### @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT ### 1360173###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT###Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991143###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine, London###Co-Author: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
### @@@ Juan José Carreras – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health). ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health).###Co-Author: Juan José Carreras – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health).
### @@@ Patricia García-Poza – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain ### 1655701###Co-Author######Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain###Co-Author: Patricia García-Poza – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Consuelo Huerta – 7. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1655395###Co-Author###Assistant Professor Epidemiology and Public Health###7. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Consuelo Huerta – 7. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Mar Martín-Perez – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain ### 1359445###Co-Author######Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain###Co-Author: Mar Martín-Perez – Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain
### @@@ Ivonne Martin – University Medical Center Utrecht ### 1655798###Co-Author######University Medical Center Utrecht###Co-Author: Ivonne Martin – University Medical Center Utrecht
### @@@ Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy ### 1359270###Co-Author###Researcher###Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy###Co-Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Elisa Correcher-Martínez – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991142###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Elisa Correcher-Martínez – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Patrick C. Souverein, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Patrick C. Souverein, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Arantxa Urchueguía, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991141###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Arantxa Urchueguía, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1062523###Co-Author###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
###Presenting Author: Yu-Chia (Sam) Hsu, PharmD, MSc – Department of Pharmaceutical Care & Heath Systems, College of Pharmacy, University of Minnesota
### @@@ Hezkiel A. Nanda, n/a – Institute for Health Informatics, University of Minnesota ### 1302871###Co-Author###PhD student###Institute for Health Informatics, University of Minnesota###Co-Author: Hezkiel A. Nanda, n/a – Institute for Health Informatics, University of Minnesota
### @@@ Paul Drawz, MD, MHS, MS – Division of Nephrology and Hypertension, Medical School, University of Minnesota ### 1991587###Co-Author######Division of Nephrology and Hypertension, Medical School, University of Minnesota###Co-Author: Paul Drawz, MD, MHS, MS – Division of Nephrology and Hypertension, Medical School, University of Minnesota
### @@@ Genevieve B. Melton, MD, PhD – Department of Surgery, Medical School, University of Minnesota ### 1991588###Co-Author######Department of Surgery, Medical School, University of Minnesota###Co-Author: Genevieve B. Melton, MD, PhD – Department of Surgery, Medical School, University of Minnesota
### @@@ Christopher Tignanelli, MD, MS, FACS, FAMIA – Department of Surgery, Medical School, University of Minnesota ### 1991714###Co-Author######Department of Surgery, Medical School, University of Minnesota###Co-Author: Christopher Tignanelli, MD, MS, FACS, FAMIA – Department of Surgery, Medical School, University of Minnesota
### @@@ Bronwyn Southwell, MD – Department of Anesthesiology, Medical School, University of Minnesota ### 1991589###Co-Author######Department of Anesthesiology, Medical School, University of Minnesota###Co-Author: Bronwyn Southwell, MD – Department of Anesthesiology, Medical School, University of Minnesota
### @@@ Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF – Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota ### 1659235###Co-Author###Professor###Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota###Co-Author: Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF – Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota
###Presenting Author: Madison Ponder, MPS (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Renae Boerneke – University of North Carolina at Chapel Hill ### 1991711###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Renae Boerneke – University of North Carolina at Chapel Hill
### @@@ Asher Schranz – University of North Carolina at Chapel Hill ### 1991712###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Asher Schranz – University of North Carolina at Chapel Hill
### @@@ Michael Swartwood, MSN, RN, CAPM – University of North Carolina at Chapel Hill ### 1991713###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Michael Swartwood, MSN, RN, CAPM – University of North Carolina at Chapel Hill
### @@@ Claire Farel – University of North Carolina Chapel Hill ### 1358644###Co-Author######University of North Carolina Chapel Hill###Co-Author: Claire Farel – University of North Carolina Chapel Hill
### @@@ Alan Kinlaw, PhD, MSPH – University of North Carolina at Chapel Hill ### 1659633###Co-Author###Assistant Professor###University of North Carolina at Chapel Hill###Co-Author: Alan Kinlaw, PhD, MSPH – University of North Carolina at Chapel Hill
###Lead Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
### @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Speaker###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
### @@@ Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University ### 1991816###Speaker###Associate Professor###College of Pharmacy, Dalhousie University###Speaker: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University
### she/her/hersPresenting Author: Michael Andrew Webster-Clark, PharmD, PhD – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health
### @@@ Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659732###Co-Author###Graduate Student###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Charles Poole, ScD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1655661###Co-Author###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Charles Poole, ScD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Kenneth J. Rothman – RTI ### 1655516###Co-Author######RTI###Co-Author: Kenneth J. Rothman – RTI
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### he/him/hisLead Speaker: Kevin Haynes, PharmD, MSCE (he/him/his) – Janssen Pharmaceuticals
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Matthew Reynolds, PhD, FISPE – Flatiron Health ### 1088323###Speaker###Vice President, Scientific Engagement###Flatiron Health###Speaker: Matthew Reynolds, PhD, FISPE – Flatiron Health
### @@@ Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research ### 1062536###Speaker###Sr. Director, Safety & Epidemiology###Carelon Research###Speaker: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
### he/him/his @@@ Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Speaker###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hersCo-Author: Jennifer Pigoga – CVS Health
### @@@ Patricia Shuminski – CVS Health ### 1359980###Co-Author###Senior Manager Business Analytics###CVS Health###Co-Author: Patricia Shuminski – CVS Health
### @@@ Djeneba Audrey Djibo, PhD – CVS Health ### 1655293###Presenting Author###Lead Director - Epidemiology###CVS Health###Presenting Author: Djeneba Audrey Djibo, PhD – CVS Health
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health Clinical Trial Services###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services
###Presenting Author: Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###Co-Author: Seanna Vine – Brigham and Women's Hospital
### @@@ Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991331###Co-Author###Instructor###Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###Co-Author: Massimiliano Russo, PhD – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Co-Author######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Co-Author: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1063282###Co-Author###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Co-Author: Wout Aarts – Julius Clinical Research
### @@@ Jungyeon Choi – Julius Clinical ### 1991279###Co-Author######Julius Clinical###Co-Author: Jungyeon Choi – Julius Clinical
### @@@ Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit ### 1359017###Co-Author###Head of Epidemiology and Research###Drug Safety Research Unit###Co-Author: Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit
### he/him/his @@@ Catherine Fry, PhD, MMedSci – Drug Safety Research Unit ### 1991145###Co-Author###Epidemiologist###Drug Safety Research Unit###Co-Author: Catherine Fry, PhD, MMedSci – Drug Safety Research Unit
### @@@ Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit ### 1062612###Co-Author###Head of Research###Institute of Pharmacovigilance Sciences, Drug Safety Research Unit###Co-Author: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
### she/her/hers @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Anna Girardi, PharmD, PhD – ARS Toscana, Florence ### 1659698###Co-Author######ARS Toscana, Florence###Co-Author: Anna Girardi, PharmD, PhD – ARS Toscana, Florence
### @@@ Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy ### 1359270###Co-Author###Researcher###Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy###Co-Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991143###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Associate Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Jing Zhao, PhD – University of Oslo ### 1991139###Co-Author###Researcher###University of Oslo###Co-Author: Jing Zhao, PhD – University of Oslo
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Samantha St Laurent – Moderna, Inc. ### 1991173###Co-Author######Moderna, Inc.###Co-Author: Samantha St Laurent – Moderna, Inc.
### @@@ Magalie Emilebacker – Moderna, Inc. ### 1991174###Co-Author######Moderna, Inc.###Co-Author: Magalie Emilebacker – Moderna, Inc.
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Signe Sørup, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1089981###Co-Author###Clinical specialist###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Signe Sørup, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers @@@ Brianna M. Goodale, PhD – Julius Clinical Research ### 1991133###Presenting Author###Head of Data Science###Julius Clinical Research###Presenting Author: Brianna M. Goodale, PhD – Julius Clinical Research
###Co-Moderator: Nkuchia M. M'ikanatha, DrPH, MPH – University of Pennsylvania School of Medicine
### @@@ Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc. ### 1359188###Co-Moderator###Senior Director###Infectious Disease Epidemiology, Moderna Therapeutics Inc.###Co-Moderator: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
### he/him/hisCo-Moderator: Priscilla Velentgas, MS, PhD (she/her/hers) – Merck
### she/her/hers @@@ Kathleen M. Andersen, PhD (she/her/hers) – Pfizer ### 1723628###Co-Moderator###Director, Vaccines Real World Evidence###Pfizer###Co-Moderator: Kathleen M. Andersen, PhD (she/her/hers) – Pfizer
### she/her/hersPresenting Author: Mengying Li, PhD, MSPH – IQVIA
### @@@ Megan Farris, MSc – IQVIA ### 1991233###Co-Author######IQVIA###Co-Author: Megan Farris, MSc – IQVIA
### @@@ Sophie Jacobovitz, MPH – IQVIA ### 1991234###Co-Author###Epidemiologist###IQVIA###Co-Author: Sophie Jacobovitz, MPH – IQVIA
### @@@ Laura K. Walsh, MSc – IQVIA Inc ### 1991235###Co-Author###Consultant Epidemiologist###IQVIA Inc###Co-Author: Laura K. Walsh, MSc – IQVIA Inc
### @@@ Shangzhi Gao, ScD – IQVIA ### 1991237###Co-Author###Consultant Epidemiologist###IQVIA###Co-Author: Shangzhi Gao, ScD – IQVIA
### @@@ Sarah Irvin – IQVIA ### 1991238###Co-Author######IQVIA###Co-Author: Sarah Irvin – IQVIA
### @@@ Camelia Graham, PhD, MSPH – IQVIA ### 1991239###Co-Author###Principal, Epidemiology and Drug Safety###IQVIA###Co-Author: Camelia Graham, PhD, MSPH – IQVIA
###Co-Author: Michael K. Stagner – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### @@@ Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration ### 1655443###Co-Author###Acting Deputy Director, Office of Pharmacovigilance and Epidemiology###U.S. Food and Drug Administration###Co-Author: David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Robert Rosofsky – Health Information Systems Consulting ### 1991243###Co-Author######Health Information Systems Consulting###Co-Author: Robert Rosofsky – Health Information Systems Consulting
### @@@ Daniel Kiernan – Harvard Pilgrim Health Care Institute ### 1991244###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Daniel Kiernan – Harvard Pilgrim Health Care Institute
### @@@ Laura A. Shockro, BA – Havard Pilgrim HealthCare Institute ### 1991245###Co-Author###Sr. Project Manager###Havard Pilgrim HealthCare Institute###Co-Author: Laura A. Shockro, BA – Havard Pilgrim HealthCare Institute
### @@@ Alexander Mai, n/a – Harvard Pilgrim Health Care Institute ### 1991246###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Alexander Mai, n/a – Harvard Pilgrim Health Care Institute
### @@@ Jessica E. Pritchard, PhD – Duke University ### 1991247###Co-Author###Research Program Leader###Duke University###Co-Author: Jessica E. Pritchard, PhD – Duke University
### @@@ Steven J. Lippmann, PhD – Duke University ### 1991248###Co-Author###Senior Analyst Programmer###Duke University###Co-Author: Steven J. Lippmann, PhD – Duke University
### @@@ Pratap Adhikari – Duke University ### 1991249###Co-Author###Analyst Programmer II###Duke University###Co-Author: Pratap Adhikari – Duke University
### @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Presenting Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Presenting Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/hisLead Speaker: Alicia W. Gilsenan, PhD, RPh, FISPE – RTI Health Solutions
### @@@ Tarek A. Hammad, MD, PhD, MSc, MS, FISPE – Takeda ### 1094009###Speaker###Vice President, Head of Medical Safety, Marketed Products, Global Patient Safety Evaluation###Takeda###Speaker: Tarek A. Hammad, MD, PhD, MSc, MS, FISPE – Takeda
### @@@ Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi ### 1094012###Speaker###VP and Global Head###Epidemiology & Benefit - Risk Evaluation, Sanofi###Speaker: Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi
### @@@ Bennett S. Levitan, MD-PhD – Janssen Pharmaceuticals ### 1647087###Speaker###Senior Director, Benefit-Risk / Epidemiology###Janssen Pharmaceuticals###Speaker: Bennett S. Levitan, MD-PhD – Janssen Pharmaceuticals
### @@@ Carol Mansfield, PhD – RTI Health Solutions ### 2086598###Speaker###Senior Economist & Head, Health Preference Assessment###RTI Health Solutions###Speaker: Carol Mansfield, PhD – RTI Health Solutions
###Keynote Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Keynote Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###Keynote Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/hisCo-Moderator: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Co-Moderator###Associate Professor###Department of Medical Informatics, Erasmus MC University###Co-Moderator: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hersCo-Moderator: Stanley A. Edlavitch, PhD, MA (he/him/his) – UMKC
### he/him/his @@@ Jacinthe Leclerc, RN, PhD, FAHA (she/her/hers) – Universite Laval ### 1991746###Co-Moderator###Professor-Researcher###Universite Laval###Co-Moderator: Jacinthe Leclerc, RN, PhD, FAHA (she/her/hers) – Universite Laval
### she/her/hers